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I. THE TANDEM CHAIN EXTENSION-ACYLATION REACTION
II. SYNTHESIS OF PAPYRACILLIC ACID A: APPLICATION OF THE 
TANDEM HOMOLOGATION-ACYLATION REACTION
III. SYNTHESIS OF TETRAHYDROFURAN-BASED PEPTIDOMIMETICS
by
Carley Meredith Spencer 
University of New Hampshire, September 2013
A zinc-mediated tandem chain extension-acylation reaction was successfully
developed. This reaction was optimized with the use of p-keto esters, amides, and imides
as well as a variety of acylating agents. The tandem homologation-acylation reaction was
successfully applied towards the total synthesis of papyracillic acid A.
Use of a tandem chain extension-aldol reaction, followed by a reductive
cyclization, allowed for the synthesis of tetrahydrofuran-based peptidomimetics. A
variety of amino acid derived p-keto imides and aldehydes were used during the initial
tandem homologation-aldol reaction. High diastereocontrol was achieved during
xx
reductive cyclization when a cis relationship was present between the substituents on the 
tetrahydrofuran ring. Use of p-keto imides during the chain extension reaction was 




Zinc Carbenoid-Mediated Chain Extension Reaction
In 1997, Brogan and Zercher reported the discovery of a mild and efficient zinc 
carbenoid-mediated homologation reaction in which P-keto esters were converted to their 
y-keto homologues.1 In an attempt to synthesize intermediate 2 through cyclopropanation 
of the terminal olefins of ketal 1, Brogan and Zercher discovered an unanticipated side 
product 3 in which an additional methylene unit had been inserted between the carbonyls 
forming a y-keto ester (Scheme 1). This homologation was mediated by the same zinc- 






Scheme 1: Discovery of the zinc-mediated chain extension reaction
This zinc-carbenoid mediated homologation was applied to simplified substrates 
in an attempt to elucidate the scope of the reaction. A variety of p-keto esters was 
subjected to a 1:1 mixture of diethylzinc and diiodomethane, which resulted in clean 
conversions in good yields to their respective y-keto esters (Table 1). In general, the 
chain extension reaction tolerates bulky groups as well as those containing olefins. The 
ability to obtain olefin-containing y-keto esters indicates that the chain extension reaction 
is more rapid than cyclopropanation of both electron rich (4g) and electron poor (4h) 
olefins. The low yield of compound 5i revealed a reduced efficiency in the homologation 
of a-substituted y-keto esters, possibly due to their increased steric bulk.
2
O O _  _ O R 3
R'-V^OR* "CBS* R'1 - - \ ' OR2
R3 O
4 5
Entry Starting Material R 1 R2 R3 Yield %
1 4a Me Me H 81%
2 4b Me t-Bu H 74%
3 4c /-Pr Et H 68%
4 4d t-Bu Me H 71%
5 4e Ph Et H 58%
6 4f Ph(CH2)2- Et H 73%
7 4g CH2=CH(CH2)2- Me H 74%
8 4h PhCH=CH- Me H 68%
9 4i Me Me Me 26%
Table 1: Homologation of p-keto esters
Both experimental and computational methods4, 5 have been used to study the 
mechanism of this homologation reaction (Scheme 2). On the basis of these studies, the 
following mechanistic description has been proposed. Initially, one of the methylene 
protons a  to the ester is removed resulting in the formation of zinc-enolate 7. The 
deprotonation is performed by the ethyl residue of either diethylzinc or of the zinc 
carbenoid, as the formation of ethane has been observed by NMR studies.4 This enolate is 
then alkylated by zinc carbenoid, which provides homoenolate 8.
From this point, there are two possible pathways by which the homologation can 
proceed. In pathway A, intramolecular cyclization of the homoenolate into the more 
electrophilic carbonyl affords a donor-acceptor cyclopropane (9). Fragmentation of this 
cyclopropane would afford zinc-enolate 10. The donor-acceptor cyclopropane is a 
proposed mechanistic intermediate for related reactions,6' 10 however spectroscopic
analysis of the zinc-mediated chain extension reaction failed to reveal this intermediate 
suggesting that this intermediate, if formed, is very short lived. Computational studies, in 
which the opening of the donor-acceptor cyclopropane is predicted to proceed with an 
energy barrier of 3-4 kcal/mol, are consistent with the short life of these proposed 
intermediates. Recent computations identified an alternate pathway in which 
homoenolate 8 is directly converted to zinc-enolate 10 (Path B).5
This zinc enolate (10) is thought to be the resting state of the reaction and appears 
similar to a Reformatsky-type intermediate.11 The low reactivity o f this organometallic 
intermediate is consistent with the oligomeric nature of the intermediate in solution.12 
Addition of a mild acid quenches the reaction and provides the desired y-keto ester.
EtZnCH?lEtZnCHpl
11 10 9
Scheme 2: Mechanistic pathway of the zinc-mediated chain-extension reaction
Since the initial report,1 the zinc-mediated homologation reaction has been shown 
to tolerate a variety of functional groups, as well as to be amenable to tandem reactions.
Various P-ketone-containing compounds have been shown to be suitable starting 
materials, and the ability to selectively functionalize both the a - and ^-positions of the y- 
keto product has been developed. Upon ring opening of intermediate 9, anionic character 
is generated regioselectively, adjacent to the carboxylic acid derivative, which would be 
difficult to accomplish through direct deprotonation of a y-keto ester. Addition of an 
electrophile to this zinc enolate allows for functionalization of this a-site. In addition, the 
proposed mechanism demonstrates incorporation of a methylene unit, originating from 
the zinc carbenoid, at the position p to the ester. Use of a substituted carbenoid allows for 
regioselective incorporation of functionality at the P-site. Use of 1,1-diiodoethane and 
a,a-diiodotoluene have allowed for incorporation of a p-methyl or P-phenyl group 
respectively. Details of these variations will be described below in greater depth.
The scope of the p-keto carbonyl starting materials capable of undergoing the 
zinc-mediated homologation reaction has been shown to include P-keto amides (12),13 P- 
keto phosphonates (13),14 P-keto imides (14),15"17 a-carboxyester imides (15),18’ 19 and P- 
diimides (16) (Scheme 3).18 p-Keto compounds 12 - 16 can be cleanly converted to their 
corresponding homologues within 30 -  60 minutes, while P-diimides require slightly 
longer reaction times and produce more complex reaction mixtures.
5
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Scheme 3: Scope of p-keto carbonyls capable of undergoing zinc-mediated
homologation
Subjection of amino acid derived P-keto esters, amides, and imides to the chain- 
extension reaction conditions has allowed for the facile synthesis of ketomethylene 
peptide mimetics (Scheme 4).20'22 Ketomethylene mimetics are compounds that replace 
the amide bond of a natural peptide with a hydrolytically stable ketone. Their hydrolytic 
stability has allowed for their use in protease inhibition.23, 24 The ability to obtain a 
ketomethylene backbone in one step from its easily prepared P-keto ester homologue 
makes the zinc-mediated chain extension a synthetically powerful tool.
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Scheme 4: Synthesis of the ketomethylene peptide mimetic
The zinc-mediated chain extension reaction has also been used as a key step in the 
synthesis of vibsane-type diterpenes. Williams and co-workers used chain extension 
reaction conditions to transform compound 25 to the ring-expanded homologue 26 
(Scheme 5).25 This reaction proceeded in good yield in spite of the a-substitution of the 







Scheme 5: Ring-expansion in the synthesis of vibsane-type diterpenes
7
Chain extension of P-diketones has resulted in slightly different results than those 
of other P-keto carbonyls. In the original report by Brogan and Zercher, the reaction of 
compound 27 with zinc carbenoid resulted in the formation of a y-keto cyclopropanol 
(Scheme 6).1
O
.—'’ n. Et2Zn, OH2I2
25%
27 28
Scheme 6: Chain extension-cyclopropanation of P-diketone
This chain extension-cyclopropanation reaction has since been demonstrated on a 
variety of P-diketone starting materials.26 The proposed reaction mechanism is similar to 
the homologation of P-keto esters; however, the zinc-intermediate 34 appears to react 
with a third equivalent of carbenoid to form a homoenolate (35) (Scheme 7). This 
homoenolate undergoes intramolecular cyclization to form cyclopropoxide 36. Upon 
addition of a mild acid, the cyclopropoxide is protonated to yield a y-keto cyclopropanol.
8
°  °  EtZnCH2 l
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35 36 37
Scheme 7: Proposed mechanism for the zinc-mediated homologation of a b-diketone
Functionalization of the B-Position of the v-Keto Backbone
In addition to the homologation of a variety of starting 1,3-dicarbonyls, the ability 
to regioselectively introduce functionality at both the a - and (3-positions of the y-keto 
homologues has been investigated. As mentioned previously, the mechanism of the zinc- 
mediated chain extension reaction allows for selective incorporation of functionality at 
both of these sites either through use of a substituted carbenoid or through addition of an 
electrophile. Due to the similarity of the pKa’s of ketones, esters, amides, and 
phosphonates,27 direct substitution of 1,4-dicarbonyls via deprotonation and electrophilic 
addition is not a practical method of introducing functionality to the y-keto carbonyl
9
backbone. The ability to add functionality during the homologation reaction is, therefore, 
a synthetically powerful tool.
Functionalization of the p-position of the 1,4-dicarbonyl backbone has been 
accomplished through the use of substituted carbenoids derived from diethylzinc and a 
gem-diiodoalkane. There are a number of methods for the synthesis of gem- 
diiodoalkanes.28, 29 Subjecting benzaldehyde to trimethylsilyliodide at room temperature 
results in the formation of a,a-diiodotoluene.30 1,1-Diiodoethane may be synthesized 
through exposure of 1,1-dichloroethane to ethyl iodide and catalytic aluminum chloride.31 
An alternative preparation of 1,1-diiodoethane is available in which acetaldehyde is first 
converted to its corresponding hydrazone, then treated with iodine in the presence of 
triethylamine.32
Carbenoids derived from both 1,1-diiodoethane and a,a-diiodotoluene have been 
used to homologate both P-keto esters and p-keto amides (Table 2).33 Incorporation of 
the p-substituent proceeded efficiently and in good yields when the zinc enolate was 
formed prior to the addition of the diiodoalkane. In some instances, a second portion of 
carbenoid was required for complete conversion to the y-keto carbonyl. This is likely due 
to decomposition of the substituted carbenoid, which undergoes chain extension more 
slowly than the reaction utilizing diiodomethane.
10
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Entry Starting Material R1 R2 R3 % Yield
1 6a Me Me Me 76
2 6b Me f-Bu Me 88
3 6c t-Bu Me Me 82
4 6d Me CH2CH=CH2 Me 74
5 6e Ph Et Me 84
6 6f Me Bn Me 80
7 6g Me Me Me 67
8 6h Me -(CH2)4- Me 74
9 6i Me Me Ph 74
10 6j Me t-Bu Ph 44
Table 2: Homologation using substituted carbenoids
Incorporation of a P-substituent during the homologation reaction results in the 
formation of a new stereocenter. Lin attempted to control the enantioselectivity of the 
reaction by introducing a chiral ligand into the reaction; however, a racemic mixture was 
obtained. 16 Lin also attempted to control diastereoselectivity through the use of a chiral 
P-keto imide, but a 1:1 mixture of diastereomers was obtained.
Homoallylic alcohols have been shown to provide high stereocontrol during 
cycloaddition reactions with methyl-substituted zinc carbenoid. For instance, 
cyclopropanation of 3-cyclopenten-l-ol (39) with methyl-substituted zinc-carbenoid 
resulted in exclusive formation of exo-6-methyl-c/.s'-3-hydroxybicyclo[3.1.0]hexane (40)
11
out of four possible isomers (Scheme 8). It is believed that the mechanism of this 
cyclopropanation involves complexation of the zinc carbenoid to the hydroxyl group 
prior to cyclopropanation, allowing for a stereoselective ethylidene transfer to the most 
accessible face of the alkene.34
Scheme 8: Stereocontrol of homoallylic alcohol 39 during zinc-carbenoid mediated 
cyclopropanation reaction
Mazzone exploited this homoallylic-directing effect by employing L-serine-
keto esters to substituted carbenoid resulted in a range of diastereomeric ratios of the (3- 
methylated y-keto esters (Table 3). High diastereoselectivity could be achieved, as seen 
in the homologation of compounds 41a-c. When the hydroxyl functionality was restricted 
as with compound 41e, all diastereocontrol was lost. This result suggests that the Lewis 
acid base interaction is important for high diastereoselectivity; however, more research is 
needed to understand the role that the oxygen is playing.
H
39 40
derived p-keto esters in the chain extension reactions.35 Exposure of L-serine-derived P-
12
R2
R1 O  O











Entry Starting Material R 1 R2 R3 dr
1 41a Boc H Bn 20:1a>b
2 41b Boc H TBDMS 20:lb
3 41c Boc H MOM 15:la
4 41d -C(0)0CH3 H Et 3:1a
5 41e Boc - Y V *
0 —'
1:1b
Table 3: Diastereoselective synthesis of P-methyl-y-keto esters (“Diastereomeric ratio was 
obtained from Bruker Top Spin line fit program, bDiastereomeric ratio was obtained from 
MestReNova line fit program)
Functionalization of the a-Position of the v-Keto Backbone
Functionalization of the a-position may be achieved through the addition of an 
electrophile to organometallic intermediate 10, which contains anionic character on the 
carbon a  to the less electrophilic carbonyl. Addition of an electrophile allows the 
intermediate to be trapped, converting a 1,3-dicarbonyl to an a-substituted 1,4-dicarbonyl 
in a one-pot reaction.
Addition of an aldehyde or ketone to organometallic intermediate (10) results in 
the formation of the corresponding aldol products with high diastereoselectivity (Table 
4). Treatment of P-keto esters and amides to the tandem chain extension-aldol reaction 
conditions has shown to favor the formation of syn aldol products. This high
13
diastereoselectivity for zinc enolate reactions is unprecedented as Reformatsky reactions 
have rarely exceeded 50% de.36




Entry Starting Material R1 R2 R3 Yield % syn:anti
1 29a r-Bu OMe Ph 97 12:1
2 29b r-Bu OMe Ar 61 9:1
3 29c Ar OEt Ar 57 7:1
4 29d Me OMe r-Bu 85 >20:1
5 29e Me OMe Ph 61 15:1
6 29f Me NPhMe Me 46 3:1
Table 4: Diastereoselectivity in the tandem-chain extension aldol reaction
Recent computational studies suggest that the dimeric organometallic 
intermediate seen in the zinc-mediated chain extension reaction exists in equilibrium 
between a keto tautomer and the energetically similar Z-enolate (Scheme 9). All attempts 
to calculate the energy of the E-enolate resulted in the immediate relaxation to the more 
stable Z-enolate. Additionally, calculations support the assertion that upon addition of an 
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Scheme 9: Keto-to-enol tautomerization of dimeric organometallic intermediate 44 
(Given numbers are Gibbs free energies relative to 44a in kJ/mol)
The Zimmerman-Traxler model has been used to predict stereochemistry for aldol 
reactions that proceed through six-membered closed transition states. While the 
organometallic intermediate of the chain extension reaction is believed to be present as a 
dimer in solution, the Zimmerman-Traxler remains relevant to predict the 
stereochemistry of the aldol reaction.37 The stereochemical outcome of the aldol reaction 
between Z-enolate 44b and an aldehyde depends on the facial selectivity of the aldehyde 
(Scheme 10). When the aldehyde approaches with the R-group in a pseudo-equatorial 
position (46), the syw-isomer is obtained. When the aldehyde approaches with its R- 
group in a pseudo-axial position (47), the anti product is obtained. Having the R group of 
the aldehyde in a pseudo-axial position creates a 1,3-diaxial interaction making the anti- 
product less favorable. The high syw-selectivity of the tandem chain-extension aldol 






















Scheme 10: Zimmerman-Traxler model for Z-enolate
Tandem chain extension-aldol reactions with (3-keto imides strongly favor the 
formation of ««t/-aldol products. This result is consistent with an open transition state 
model in which an equivalent of Lewis acid chelates between the two oxygen atoms of 
the imide and a second equivalent of Lewis acid activates the aldehyde (Scheme 11). 38 
In this open transition state model, attack of the enolate on one face of the aldehyde leads 
to a steric interaction between the R group of the aldehyde and the imide. Attack of the 
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Scheme 11: Open transition state of Z-enolate
Analysis of the diastereoselectivity in the tandem homologation-aldol reaction can 
be difficult due to an equilibrium that exists between both the open and closed 
(hemiketal) forms of each diastereomer (Scheme 12). The yyw-aldol products exist 
predominantly as the closed hemiketal isomers; whereas anti-aldol products typically 
contain less of the hemiketal forms. These preferences may be rationalized by steric 
interactions between the carbonyl and R3-substituent.
Scheme 12: Equilibrium between open chain and closed hemiketal isomers
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A method discovered by Lin allows selected hemiketals formed in the tandem 
homologation-aldol reaction to be transformed into substituted y-lactones via an oxidative 
cleavage in which eerie ammonium nitrate (CAN) is proposed to chelate to the hemiketal 
oxygen.16 Jacobine showed that it is possible to target the paraconic acid family of natural 
products through this methodology.39, 40 Paraconic acids are trisubstituted y- 
butyrolactones that have drawn interest due to their antibiotic and antitumor properties.41 
In order to synthesize these compounds through the zinc-mediated chain extension 
chemistry, both the a - and ^-positions of the y-keto ester need to possess substituents. 
Jacobine accomplished the synthesis of a phaseolinic acid derivative by performing a 
tandem chain extension-aldol reaction using a substituted carbenoid followed by CAN- 
oxidation to form the substituted y-butyrolactone (Scheme 13). This was the first 
example of a tandem chain extension reaction performed while using substituted 
carbenoid. The incorporation of a p-substituent before trapping the aldehyde gave an 
unanticipated result. In tandem chain extension-aldol reactions starting from a P-keto 
ester, the major product is normally the -syw-aldol product. Jacobine noted that the 
presence of a P-methyl substituent led to the formation of the anti-aldol product as the 
major isomer. In other words, the P-stereocenter controlled facial selectivity on the 
enolate and biased facial selectivity of the aldehyde.
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Scheme 13: Synthesis of phaseolinic acid derivative
The tandem chain extension-aldol reaction has also been applied towards the 
formal synthesis of CJ-12,954 and CJ-13,014.4’ 42 A tandem chain extension-aldol 
reaction followed by spirocyclization allows access to the spiroketal cores of the 
advanced intermediates of the two natural products (Scheme 14). Conversion of these 
intermediates to the natural products would be possible by application of the strategy 
outlined by Brimble and co-workers 43
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Scheme 14: Formal synthesis of CJ-12,954 and CJ-13,014 through the chain extension- 
spirocyclization reaction
Incorporation of a halogen at the a-position of a y-keto carbonyl followed by 
elimination provides access to a,(3-unsaturated y-keto carbonyls.44 The development of 
this tandem chain extension-oxidation-elimination reaction has lead to the formal 
syntheses of (-)-Pyrenophorin45 and (+)-Brefeldin A .'6
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Scheme 15: Formal synthesis of (-)-Pyrenophorin and (+)-Brefeldin A
The tandem chain extension-oxidation-elimination reaction has also been applied 
to the total synthesis of (+)-Patulolide A and (±)-Patulolide B (Scheme 16)46 The 
synthesis of these natural products demonstrated the applicability of the homologation- 
oxidation-elimination reaction to macrocyclic P-keto lactones. In addition, the olefin
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stereochemistry was influenced by use of kinetic or thermodynamic control in the 
elimination reaction.
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Scheme 16: Total synthesis of Patulolide A and B
Another set of tandem reactions allows for the synthesis of a-methylated47'49 and 
a-iodomethylated50, 51 y-keto carbonyls. Addition of a Lewis acid such as 
trimethylsilylchloride (TMSC1) appears to promote fragmentation of the dimeric zinc- 
enolate 77. This fragmentation results in the formation of an activated nucleophile 
capable of reacting with another equivalent of zinc-carbenoid. Anionic character of the 
newly formed homoenolate (79) may be quenched with a mild acid to form a-methylated 
y-keto carbonyls or with iodine to form a-iodomethylated y-keto carbonyls (Scheme 17). 
Formation of a-iodomethylated y-keto carbonyls introduces a handle that has been shown
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to be capable of being further manipulated, through both cross coupling reactions and 
nucleophilic displacement of the iodide.50’51
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Scheme 17: Synthesis of a-methylated or a-iodomethylated y-keto ester
An interesting byproduct seen in the tandem chain extension-methylation reaction 
of some p-keto imides was the corresponding y-keto cyclopropanol 83 (Scheme 18).!6, 50 
The mechanism for its formation is believed to involve attack of the homoenolate 82 into 
the imide carbonyl before the reaction is quenched. This reaction mechanism is believed 
to be similar to the tandem homologation cyclopropanation reaction of P-diketones. 
Formation of these cyclopropanol compounds is not observed with p-keto esters or 
amides; however, the imide functionality, which is a better electrophile than either an 
ester or amide, is able to react in a similar fashion to the P-diketones.
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Scheme 18: Synthesis of cyclopropanol 83 under chain extension-methylation reaction 
conditions
One of the more recently developed tandem homologation reactions involved the 
use of activated imines. Jacobine developed the tandem chain extension-Mannich 
reaction as a method to target the synthesis of (3-proline derivatives.39’ 52 The reaction 
between the organometallic intermediate and iV-phosphinoylimine 85 resulted in the 
formation of p-amino acid 86, albeit in modest yield. A one-pot protocol was developed 
to synthesize P-proline derivatives through deprotection of the phosphinoyl group and 
subsequent reduction of the resulting cyclic imine (Scheme 19).
85
Scheme 19: Tandem chain extension-imine capture reaction with diphenylphosphinoyl 
imine 85
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The tandem chain extension-imine capture reaction of the organometallic enolate 
with the more reactive Boc-activated aryl imines proceeds more rapidly and in higher 
yields than those achieved with diphenylphosphinoyl imine. Deprotection of the P-amino 
acid was effected through exposure to trifluoroacetic acid (TFA). The resulting cyclic 
imine could then be reduced to the corresponding P-proline derivative by treatment with 
sodium cyanoborohydride (NaCNBHs) (Scheme 20).
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Scheme 20: Tandem chain extension-imine capture reaction with Boc-activated imines
It was noted that the nitrogen-protecting group controls the diastereoselectivity of 
the chain extension-imine capture reaction. The complementary diastereocontrol seen 
between the phosphinoyl imines and Boc-protected imines allows for the synthesis of 
either anti or syn P-proline derivatives, respectively. In addition, control of the absolute
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stereochemistry of the P-proline derivatives through the homologation of a chiral P-keto 
imide is possible.
Use of tandem zinc-mediated chain extension reactions has been developed as an 
efficient and facile method of synthesizing substituted 1,4-dicarbonyl compounds. The 
ability to control diastereoselectivity in the incorporation of functional groups has proven 
useful in targeted synthesis. The expansion of the chain extension methodology to an 
even wider range of products continues to be a focal point of current research.
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CHAPTER II
THE TANDEM CHAIN EXTENSION-ACYLATION REACTION
Discovery of the Tandem Homologation-Acvlation Reaction
Jacobine recently reported that the chain extension methodology could be used to 
trap anhydrides in a tandem chain extension-acylation reaction.39 Methyl pivaloylacetate 
(84) was subjected to zinc carbenoid followed by treatment with acetic anhydride. An a - 
acylated y-keto ester 93 was efficiently produced (Scheme 21).
84 93
92
Scheme 21: First example of the tandem chain extension-acylation reaction
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Taddei and co-workers previously synthesized a similar a-acylated y-keto ester 
through a tandem homologation-aldol reaction followed by oxidation of the aldol product 
to the corresponding tricarbonyl compound (Scheme 22).53 A number of oxidizing agents 
were examined and it was found that pyridinium chlorochromate (PCC) was generally 
required for complete conversion. Direct conversion of P-keto esters to their a-acylated 
y-keto ester counterparts offers an advantage to the Taddei approach, since a synthetic 
step is avoided and the use of a toxic oxidizing agent, PCC, is not required.
O O
Et2Zn, C H 2l2 
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84 94 95
Scheme 22: Synthesis of a-acylated y-keto esters by tandem chain extension-aldol 
followed by oxidation
Use of a Paal-Knorr synthesis allows for the conversion of the a-acylated y-keto 
carbonyl products to highly functionalized furans, pyrroles, and thiophenes (Scheme 23). 
These heterocycles are of synthetic interest as they are found abundantly in natural 
products and have found wide use in pharmaceuticals as well as materials science.54 S8 
Use of the tandem chain extension-acylation reaction to form the precurser for 
heterocycle formation is attractive, since the chain extension methodoogy allows for 
substitution to be controlled at every position of the heterocycle.
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Scheme 23: Paal-Knorr synthesis of highly functionalized heterocycles
Tandem Chain Extension-Acvlation with Cyclic Anhydrides
Initial investigations into the scope of the tandem chain extension-acylation
Cyclic anhydrides were used in an attempt to target a spiroketal ring system, a common 
motif found in natural products (Scheme 24).59
99
Scheme 24: Synthesis of spiroketal 99 through the tandem chain extension-acylation 
reaction
Mazzone began by subjecting methyl pivaloylacetate to chain extension reaction 
conditions and then treating the intermediate with maleic anhydride. This gave rise to a 
mixture of products. Analysis of the crude reaction mixture by 'H and 13C NMR showed 
the main product to be the a-acylated y-keto ester, in which the double bond of maleic
reaction performed by Mazzone made use of cyclic anhydrides as acylating agents.35
0 O
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anhydride had under gone isomerization to the more thermodynamically stable £-alkene 
(Scheme 25). This identification was made through the measurement of the dominant 
alkene coupling constants in the 'H NMR spectrum. A V  coupling constant of 15.8 Hz 
was observed, which is consistent with that of an £-alkene.60 The acylated product 
existed as a mixture of both the keto and enol tautomers. The relatively high 
concentration of the enol tautomer was most likely due to an extended conjugation 







Scheme 25: Tandem chain extension-acylation of methyl pivaloylacetate using maleic 
anhydride
Mazzone also investigated alternative starting (3-keto carbonyls.3S Treatment of a 
more sterically bulky P-keto imide with the same tandem homologation-acylation 
reaction conditions did not prevent isomerization of the initial Z-alkene. Upon analysis of 
the crude reaction mixture an alkene 3J coupling constant of 15.8 Hz was observed, 
suggesting that steric bulk plays no role in preventing isomerization (Scheme 26).
29
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Scheme 26: Tandem chain extension-aldol reaction of |3-keto imide 81 with maleic 
anhydride 100
Next, Mazzone studied the use of an aliphatic cyclic anhydride since it removed 
the possibility of double bond isomerization. Exposure of methyl pivaloylacetate to zinc 
carbenoid followed by treatment with succinic anhydride resulted in the formation of the 
a-acylated y-keto ester in equilibrium with two other isomeric compounds, including the 
desired spiro-ketal (104) (Scheme 27). This result demonstrated the ability to obtain a 
spiro-ketal under tandem chain extension-acylation conditions.
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Scheme 27: Tandem chain extension acylation with succinic anhydride
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While Mazzone was able to show that cyclic anhydrides can be trapped by the 
zinc-enolate formed during the chain extension reaction, the ability for the acylation 
products to exist as multiple isomers made purification and analysis difficult. General 
yields of the acylation reaction, as well as the ability to use a broader range of acylating 
agents, were not investigated by Mazzone.
Expansion of Methodology
Our initial studies into the more general scope of the tandem chain extension- 
acylation reaction included the use of acid chlorides as possible acylating agents. 
Treatment of methyl benzoylacetate (105) with zinc carbenoid followed by addition of 
acetyl chloride resulted in the formation of unsubstituted y-keto ester 107 (Scheme 28). 
The lack of a-acylated product was believed to result from protonation of organometallic 
intermediate 106 via acidic impurities in the acid chloride. Additionally, intermediate 106 
could have been quenched by deprotonation of acetyl chloride. This would result in the 
formation of both unsubstituted y-keto ester 107 as well as a ketene derived from the acid 
chloride.
Scheme 28: Tandem chain extension-acylation using an acid chloride acylating agent
105 106 107
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Protonation of intermediate 106 when using an acid chloride turned focus back to 
the use of anhydrides as the acylating agent of choice. Optimization of the acylation 
reaction conditions demonstrated that order of addition and the stoichiometry of reagents 
played important roles in minimizing the formation of unwanted byproducts. Treatment 
of methyl pivaloylacetate with three equivalents of carbenoid followed by the addition of 
acetic anhydride led to the formation of three products: yketo ester 109, the desired 
acylated product (93), as well as a further homologue of the acylation product (110) 
(Table 5). Formation of compound 110 was most likely due to the homologation of the 
p-keto ester formed in the initial chain extension-acylation reaction.
The formation of P-keto ester 93 introduced an acidic proton capable of 
quenching intermediate 108, thereby providing the first by-product, y-keto ester 109. 
Once the acylated product 93 is deprotonated, the enolate can react with another 
equivalent of carbenoid, producing the second by-product (110). The yield of the desired 
acylated product was greatly improved upon treatment of methyl pivaloylacetate with 
three equivalents of diethylzinc, followed by one equivalent of diiodomethane and finally 
1.5 equivalents of acetic anhydride. The first equivalent of diethylzinc deprotonated 
methyl pivaloylacetate (84), while a second equivalent reacted with diiodomethane to 
effect homologation to the y-keto ester. Formation of only one equivalent of carbenoid 
prevented further homologation of compound 93. The third equivalent of diethylzinc was 
used to deprotonate the acidic proton on compound 93, preventing the organometallic 
intermediate 108 from being quenched before acylation was able to take place.
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(equiv) 109(%)a 93(%)a 110(%)a
1 3 3 1 30 24 46
2 3 1 1.5 17 83 0
3b 4 4 1 28 11 61
Table 5: Optimization of tandem homologation acylation reaction using methyl 
pivaloylacetate (a Relative abundance using relative integrations from 'H NM R analysis o f  the crude 
reaction mixtures; b Diethylzinc and methyl pivaloylacetate were stirred for 10 min prior to adding 
diiodomethane)
Treatment of methyl pivaloylacetate with four equivalents o f carbenoid followed 
by the addition of acetic anhydride demonstrated that it is possible to bias the tandem 
chain extension-acylation reaction toward the formation of the further homologated 
product 110. The double chain extension reaction was further investigated by St. Jean, 
who demonstrated that double chain extended products were most easily obtained when 
using an acylating agent with little steric bulk.61 In addition, the second homologation can 
be accomplished with bulkier acyl groups by resubjecting the a-acylated y-keto ester to 
zinc carbenoid.
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Order of addition of the reagents also plays a role in minimizing unwanted 
byproducts. When acetic anhydride was added to the homologation reaction of methyl 
benzoylacetate before the initial chain extension reaction took place, a regioisomer of the 
acylated y-keto ester was observed (Scheme 29). The formation of two isomers may be 
explained by the formation of compound 111 prior to homologation. Compound 111 
contains two (3-keto esters, both capable of undergoing homologation. By ensuring that 
the starting p-keto ester has chain-extended before addition of the anhydride, the 
formation of the undesired regioisomer is avoided.
Scheme 29: Formation of a regioisomer during the tandem chain extension-acylation 
reaction (“Relative integrations from !H NMR analysis of the crude reaction mixture)
Upon optimization of the tandem homologation acylation reaction conditions, a 
range of p-keto carbonyl substrates and acylating agents were used to examine their
organometallic intermediate, benzoic anhydride and isobutyric anhydride provided higher 
yields than acetic anhydride. It is possible that bulkier acylating agents slow the 
deprotonation of the acylated products, therby preventing the quenching of the 
organometallic intermediate and conversion to the double chain extended product. This is
6:1a92 111
impact of the efficiency of the reaction (Table 6). Of the acylating agents used to trap the
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consistent with the results seen by St. Jean, which showed slower formation of double 
chain extended products containing bulky R groups.
Use of a range of p-keto esters demonstrated that the presence of bulky or 
aromatic sustituents on the ketone or ester do not hinder the efficiency of the acylation 
reaction. Use of a P-keto amide in the tandem acylation reaction also proved to be 
efficient in the production of an a-acylated y-keto amide. When P-keto imide 120 (entry 
11) was subjected to tandem chain extension-acylation reaction conditions, the y-keto 
homologue was obtained as a 6:1 mixture of diastereomers in a combined yield of 80%. 
Reduced yields were observed in the tandem homologation-acylation reactions of allyl 
acetoacetate and /-butyl acetoacetate. These reduced yields may be explained by Lewis 
acid-catalyzed decomposition of the esters.
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Entry StartingMaterial R1 R2 R3 Product Yield (%)
1 84 t-Bu OMe Me 93 63
2 84 t- Bu OMe z-Pr 117 80
3 84 t-Bu OMe Ph 95 95
4 117 Me V 0^ Me 118 36
5 117 Me v ° ^ < Ph 119 51
6 118 Me OAllyl Me 120 44
7 118 Me OAllyl Ph 121 73
S 105 Ph OMe Me 112 55
9 105 Ph OMe Ph 122 51




M , Ph 124 80
Table 6: Scope of the tandem chain extension-acylation reaction
Phenyl formate was used as an acylating agent during the tandem homologation 
acylation reaction in an attempt to obtain an a-formylated y-keto ester (Scheme 30). 
Upon exposure of methyl pivaloylacetate to zinc carbenoid and subsequent treatment 
with phenyl formate, 'H NMR analysis showed consumption of all starting material; 
however, none of the desired product was present. It is possible that the a-formylated y- 
keto ester was synthesized and was too reactive under the tandem chain extension-
acylation reaction conditions, undergoing further chemistry and preventing compound 
130 from being isolated.
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Scheme 30: Tandem chain extension-formylation
One drawback to using an anhydride as an acylating agent is that half of the 
corresponding carboxylic acid is sacrificed. If the tandem homologation-acylation 
reaction were to be used in a longer synthetic pathway, avoiding this sacrifice would be 
desirable. Even though acid chlorides were shown to be ineffective acylating agents, an 
activated carboxylic acid was proposed to be an acylating agent that would circumvent 
the inefficiency of the anhydride.
Benzotriazole-activated carboxylic acids are easily prepared through treatment of 
a carboxylic acid with lH-benzotriazole and thionyl chloride (Scheme 31). The activated 
products are usually obtained as solids with clean conversion, which makes them easy to 
handle. Addition of benzotriazole-activated acetic acid to the intermediate zinc enolate 
resulted in the formation of the a-acylated y-keto ester in a slightly reduced yield (48%) 
as compared to that obtained when using acetic anhydride. Benzotriazole activation of 
carboxylic acids, therefore, provides a useful alternative to the use of anhydrides 
generated from precursor carboxylic acids.
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Scheme 31: Tandem homologation acylation with activated acetic anhydride
Similar to the cyclic anhydrides that were used by Mazzone to target a spiro-ketal 
core, the use of a Boc-protected lactam was proposed to allow access to an azaspiro-fused 
ring system. Treatment of methyl pivaloylacetate under tandem chain extension-acylation 
reaction conditions in which Boc-pyrrolidine (132) was used as an acylating agent 
resulted in the formation of a-acylated y-keto ester (Scheme 32). The acylated product 
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Scheme 32: Tandem chain extension-acylation using a cyclic imide
In summary, the tandem chain extension-acylation reaction is an efficient 
reaction. A variety of both starting P-keto substrates and acylating agents are tolerated, 
allowing access to a vast array of a-acylated y-keto carbonyls and spiro-fused ring 




SYNTHESIS OF PAPYRACILLIC ACID A: APPLICATION OF THE TANDEM 
HOMOLOGATION-ACYLATION REACTION
Papyracillic Acid Family of Natural Products
Papyracillic acid A was isolated from the ascomycete fungus Lachnum 
papyraceum in 1996.62 The structure of papyracillic acid A was determined to contain a 
spiro-fused acetal core with structural similarities to penicillic acid, a classical mycotoxin 
(Figure 1). Both of these natural products exist in equilibrium with open-chained 
isomers. Papyracillic acid A has been reported to exist as a 1:1:2:4 mixture of isomers.
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Figure 1: Structural comparison of papyracillic acid A (134) and penicillic acid (135)
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Due to the structural similarities between papyracillic acid A and penicillic acid, it 
has been proposed that the biosynthetic pathways could be similar as well. The last steps 
of penicillic acid formation makes use of a Bayer-Villiger type oxidation of a 
benzoquinone intermediate followed by a ring opening.63’ 64 While it has yet to be isolated 
from L. papyraceum, compound 136 has been proposed as a biosynthetic intermediate in 
the formation of papyracillic acid A. Oxidation to seven-membered lactone 137 followed 
by ring opening and reductive elimination would yield papyracillic acid in the same 




Scheme 33: Proposed biosynthetic pathway for the formation of papyracillic acid A
More recently, papyracillic acid A was obtained in very high yield from
Ascochyta agropyrina var. nana, a strain of a fungus isolated from diseased leaves of the
perennial weed quack grass.6S Papyracillic acid was shown to have phytotoxic activity
against its host plant, quack grass, as well as against other non-host plants. This
phytotoxicity suggests a potential application of papyracillic acid as a natural herbicide.
In addition to phytotoxic activity, papyracillic acid has been reported to have
antimicrobial and cytotoxic activity. The bioactivity appears dependent on papyracillic
acid’s ability to act as an electrophile. Nucleophiles, such as amino acids are suggested to
attack through conjugate addition at either C-3 in the lactone ring, or the a,(3-unsaturated
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ketone in the open-chain form. Shan and co-workers proposed that the a,|3-unsaturated 
ketone present in the open-chain form, rather than the unsaturated lactone, is responsible 
for papyracillic acid A’s biological activity.66
Two other derivatives of papyracillic acid were isolated from Microphaeropsis sp, 
an endophytic fungus extracted from the branch of the tree Larix decidua found in 
Hjerting, Denmark. Neither of these compounds, papyracillic acid B and C, contain the 
a,(3-unsaturated ketone found in the open-chain form of papyracillic acid A (Figure 2). 
Therefore, while the biological activity of these two new members of the papyracillic 
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Figure 2: Papyracillic acid B (139) and C (140)
Previous Synthesis of Papyracillic Acids
Recently, Mazzone reported the total synthesis of 4-e/?/-papyraci 11 ic acid C and 
papyracillic acid B.35, 67 The key step in the synthesis of these two compounds was the 
formation of the spirofused cyclic ketal core of the papyracillic acids. Installation of this 
spirofused ketal was accomplished through the combination of two variations of the chain 
extension reaction. The first variation made use of the tandem chain extension-acylation
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reaction, using 3-methoxymaleic anhydride as the acylating agent. As described earlier, 
tandem chain extension-acylation reactions using maleic anhydride resulted in a Z- to E- 
isomerization, preventing formation of the spiro-ketal core present in the papyracillic 
acids. In contrast, reaction with 3-methoxymaleic anhydride resulted in products 
containing a Z-alkene. The retention of the Z-alkene could be explained by the presence 
of the methoxy group, which provides the opportunity for facile interconversion of the Z- 
and Zs-alkenes, facilitating closure to the required spiro-ketal.
Mazzone’s approach to the papyracillic acid core also made use of a methyl- 
substituted carbenoid, allowing for incorporation of the CIO methy 1-substituent found in 
the spiro-fused ketal backbone of the papyracillic acids. Synthesis o f the spiro-fused ketal 
found in the papyracillic acids was the second example of a tandem chain extension 
reaction being used with a substituted carbenoid. Jacobine’s synthesis of a phaseolinic 
acid derivative revealed that incorporation of a methyl group at the (3-position has a 
stereodirecting influence on the facial selectivity of the zinc-enolate in an aldol 
reaction.39 If a similar facial selectivity was operative for the acylation reaction, a cis- 
stereochemical relationship between the methyl group and the ester would be generated.
Unexpectedly, a traws-stereochemical relationship between these two functional groups
1 1 was observed through a H NMR coupling constant ( J=  12.3 Hz) and was confirmed by
X-ray crystallographic analysis. Studies performed by Mazzone indicated that an
equilibrium between the kinetic c/s-isomer and the thermodynamic /raws-isomer
(Scheme 34) was established. It was hypothesized that equilibration involved
epimerization via the enol of the a-stereocenter of the open-chained isomer 142.
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Scheme 34: Equilibrium between cis- and traws-isomers of spiro-fused ketal core
Due to the existence of interconverting isomers of the hemiketal, Mazzone 
converted hemiketal 146 to a mixed ketal in order to facilitate handling. In the case of 
papyracillic acid B, the methyl ketal was required for the product; however, during her 
synthetic approach to epz-papyracillic acid C, the methyl ketal proved difficult to 
deprotect, leading to the use of a trichloroethyl protecting group. Conversion to the 
hydroxymethyl substituent of 148b and the exo-cyclic alkene present in 148a required 
selective reduction of the ester functionality. This selectivity was accomplished through 
the use of an allyl ester. Deallylation followed by reduction of an activated carboxylic 
acid resulted in the formation of the desired hydroxymethyl spirofused ketal. 
Deprotection of the trichloroethyl acetal furnished 4-e/?/-papyracillic acid C, while 
conversion of the hydroxymethyl group to an exo-cyclic double bond resulted in the 
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Scheme 35: Synthesis of papyracillic acid B (139) and 4-e/?/-papyracillic acid C (149)
Synthesis of Papyracillic Acid A
Papyracillic acid A contains the exo-cyclic double bond found in papyracillic acid 
B, as well as the hemiketal found in papyracillic acid C. Mazzone had not reported efforts 
directed toward the synthesis of papyracillic acid A, which is the member of the 
papyracillic acid family with the most intriguing biological activity. A synthetic strategy 
targeting papyracillic acid A, therefore, was proposed to make use of lessons learned in 
the earlier synthetic approaches. The synthetic approach to papyracillic acid A began 
with the tandem chain extension-acylation reaction between ally! acetoacetate and methyl
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substituted carbenoid followed by treatment with 3-methoxymaleic anhydride (Scheme 
36). The reaction mixture was stirred for 24 hours to allow for isomerization to the tram  
product (146b). The equilibrium studies performed by Mazzone demonstrated that a 24- 
hour time period allows for conversion of the cis product to the trans product, similar to 
hemiketal 143b. Analysis of the crude reaction mixture by 'H NMR spectroscopy 
revealed a doublet at 3.40 ppm with a 3J  coupling constant of 12.4 Hz. This resonance 
corresponds to the proton a  to the ester and suggests a tram-relationship between the 
methyl substituent and the ester of hemiketal 146b. This result is consistent with the trend 
in 'H NMR and X-ray crystallography data observed by Mazzone, who proved the major 
product of the tandem chain extension-acylation of methyl acetoacetate and 3- 
methoxymaleic anhydride to have the same traws-relationship.
a) Et2Zn
b) CH3CHI2
1 4 6 b  Q1 4 6 a
Scheme 36: Concise synthesis of spiro-fused ketal core of papyracillic acid A
Exposure of hemiketal 146b to 2,2,2-trichloroethanol with catalytic p- 
toluenesulfonic acid (p-TsOH) followed by column chromatography resulted in the 
isolation of the major ketal diastereomer in 32% yield over two steps (Scheme 37). The 
trichloroethyl protecting group was chosen as it has been reported to be a protecting
group for hemiketals capable of being deprotected through a mild, selective, non-acidic 
reaction via a zinc-insertion-elimination reaction.68 The chemoselectivity of the eventual 
deprotection step was important, since other functionalities present in papyracillic acid 
could be sensitive to alternate deprotection reaction conditions.
1 4 6  Q
/  Oc u e  _ \
CI3C C H 2O H  V - O y. / O ^  .'
o p-T sO H
32%  o v e r  2  s t e p s
Scheme 37: Protection of hemiketal 146 as a trichloroethyl ketal
The spirocenter of ketal 147 was assigned as having R stereochemistry. This 
assignment was made based on the similarity of the ]H NMR data to to Mazzone’s ‘H 
NMR data of ketal 147a. Mazzone obtained a crystal structure of ketal 147a, which 
allowed for the assignment of the relative stereochemistry. This stereochemistry was 
further confirmed later in the synthetic pathway when a crystal structure was obtained for 
ketal 159 (Figure 3), as discussed below.
The next step in the synthesis of papyracillic acid A was the deallylation of the 
ester functionality. Incorporation of an allyl functionality allowed for the selective 
conversion to the corresponding carboxylic acid without affecting the lactone. Treatment 
of ketal 147 with catalytic tetrakis(triphenylphosphine)palladium(0) resulted in the 
efficient conversion to the corresponding carboxylic acid (148) in 79% yield (Scheme 
38). Activation of the carboxylic acid with carbonyldiimidazole (CDI) followed by
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treatment with sodium borohydride allowed for efficient reduction in a one-pot 
procedure, producing the alcohol (149) in 89% yield.
CI3C.
O/ CX (PPh3)4Pd
"O' 'O  m orpholine, THF  
- Q  79%
1470 v - \
CI3C.
a) C P I, T H F  
O  b) N aB H 4 
89%
Q, .0 . .'
Scheme 38: Deallylation and reduction of ester 147
In the synthesis of papyracillic acid B, Mazzone attempted a number of methods 
to convert the hydroxymethyl functionality to the required exo-cyclic alkene. The method 
used to access papyracillic acid B involved activation of alcohol 150 as the mesylate 
(Scheme 39). The mesylate was then displaced by a selenium anion, obtained through 
treatment of diphenyl diselenide with sodium borohydride. Exposure of the resulting 
selenide (153) to hydrogen peroxide and subsequent heating in refluxing toluene 
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Scheme 39: Mazzone’s conversion of hydroxymethyl functionality to exo-cyclic alkene
In an attempt to shorten the synthetic pathway in the formation to papyracillic 
acid A, conversion to the exo-cyclic alkene was attempted through the use of a Grieco 
reaction.69’ 70 The Grieco reaction converts an alcohol to the corresponding alkene 
through an intermediate aryl selenide. The presence of a substituent on the (3 or y carbons 
of primary alkyl phenyl selenoxides, such as in the case of compound 154, tend to result 
in low yields of terminal alkenes. A method that has been shown to greatly increase the
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ability of the selenoxide to undergo elimination is the addition of an electron- 
withdrawing group on the aromatic selenide. Treatment of alcohol 149 with o- 
nitrophenylselenocyanate and tri-w-butylphosphine resulted in the formation of selenide 
157 in 84% yield within 30 minutes (Scheme 40). Oxidation of the selenide was 
accomplished through addition of 30% hydrogen peroxide. The resulting selenoxides 
were not isolated, but rather gently heated in toluene to effect elimination to the terminal
alkene 159.
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Scheme 40: Synthesis of exo-cyclic alkene 159 through the Grieco elimination
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During the synthesis of papyracillic acid B, Mazzone observed epimerization of 
the spiroketal center during elimination of the selenoxide in refluxing toluene. This was 
rationalized to occur through fragmentation of the spiro-fused ketal to reveal a 3°, allylic, 
oxocarbenium ion. Energy differences between the two spiroketal epimers were expected 
to be small, which was confirmed with in a 1:1 mixture of isomers of papyracillic acid B.
During the selenoxide elimination of compound 158, the reaction was maintained 
at a lower temperature of 55 °C in the hope of preventing a similar epimerization. 
Analysis of 'H NMR spectrum of the crude reaction mixture showed clean conversion to 
a single diastereomer of compound 159. Slow evaporation from ethyl acetate afforded a 
crystal suitable for X-ray crystal analysis (Figure 3).71 The crystal structure analysis 
confirmed the relative stereochemistry at C4 to be the opposite of that seen in the natural 
product. The same spiroketal stereochemistry was found by Mazzone in the major 
product formed in the tandem chain extension-acylation reaction (146) in the approach to 
papyracillic acid B and papyracillic acid C.
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mFigure 3: X-Ray crystal structure of spiroketal 159
The final step required for the synthesis of papyracillic acid A was the 
deprotection of trichloroethyl ketal 159, which would form the required hemiketal. 
During the synthesis of papyracillic acid C, Mazzone attempted the deprotection of the 
trichloroethyl ketal through a number of different methods.35 A protocol specifically 
reported for the deprotection of trichloroethyl ketals makes use of freshly activated zinc 
dust in refluxing ethyl acetate or tetrahydrofuran.68 Application of this method yielded 
only starting material as seen by 'H NMR analysis of the crude reaction mixture.
An alternative method for the deprotection of tricholoroethyl groups, reported by 
Marinier et al., makes use of granular zinc in 70% acetic acid.72 Application of this 
method by Mazzone resulted in the production of 4-e/?/-papyraci 1 lie acid C in a 40% 
yield. Analysis of the 'H NMR spectrum of the crude reaction mixture revealed the 
desired hemiketal (149) and dichloroethyl ketal to be present in a 1:1 ratio. While this
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result demonstrates that protonation of the zinc anion competes with the elimination 
reaction, formation of the hemiketal did complete the synthesis of 4-e/?/-papyracillic acid 
C.
Deprotection of trichloroethyl ketal 159 in the synthesis of papyracillic acid A 
was attempted using the same acetic acid-mediated zinc insertion-elimination reaction 
(Scheme 41). Exposure of ketal 159 to freshly activated zinc dust in 70% acetic acid for 
16 hours produced papyracillic acid A (134) in 27% yield, with the reduced dichloroethyl 
ketal 160 observed as the major product of the reaction.
CloHC,Cl3c
Zn°
O70%  a c e t ic  ac id
159 134 160
Scheme 41: Zn-mediated deprotection of trichloroethyl ketal 159 in acetic acid
Analysis of the ]H NMR spectrum of the purified hemiketal 134 showed a 
mixture of three isomers in a 1:1:2 ratio. This ratio was obtained by comparing the 
integrations of the three singlets representing the methoxy group at 3.94, 3.90, and 3.88 
ppm. This ratio of isomers does not match that reported for papyracillic acid A in the 
literature, which reports a 1:1:2:4 mixture of four papyracillic acid isomers, but with no 
detailed NMR data.62, 6 5 ,73 Support for the synthesis of papyracillic acid A came from 
analysis of the 13C NMR spectrum, which showed a resonance consistent for a hemiketal 
at 111.7 ppm. Slow evaporation from ethyl acetate afforded a crystal suitable for X-ray
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crystal analysis (Figure 4) 74 The crystal structure analysis confirmed the formation of 
papyracillic acid A. The crystal structure demonstrated that epimerization of the 
spirofused stereocenter had occurred. This is easily explained by the equilibration 
between the open and closed forms of the hemiacetal under the acidic reaction conditions 
utilized in the zinc-mediated deprotection. Due to the presence of multiple isomers in 
solution, it is possible that the R stereochemistry of the spiro-fused center of ketal 159 is 
also present. Selective crystallization of the isomer containing S  stereochemistry has lead 





Figure 4: X-Ray crystal structure of papyracillic acid A
In an attempt to increase the yield of the trichloroethyl deprotection, alternative 
routes were investigated. A model trichloroethyl acetal was prepared by stirring 3,4- 
dihydropyran in dichloromethane with 2,2,2-trichloroethanol and K-10 montmorilIonite
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clay.7S The resulting acetal 161 was used in a number of deprotection attempts. In a 
recent report by Zhang and coworkers, non-activated zinc dust and ammonium chloride 
(N H 4 C I )  in refluxing acetonitrile was used to deprotect a 2,2,2-trichloroethyl group at the 
anomeric position of carbohydrates.76 When trichloroacetal 161 was subjected to these 
deprotection conditions, only starting material was returned. The reaction was attempted 
again, using freshly activated zinc dust. Analysis of the crude reaction material by *H 
NMR spectroscopy showed a 10:1 mixture of starting material 161 and the dichloroethyl 
acetal 162 (Table 7).
In a return to the acetic acid-mediated protocol, trichloroethyl acetal 161 was 
stirred with activated zinc (20 mesh) in a 70% solution of glacial acetic acid in dioxane. It 
was hoped that replacing water with dioxane would help slow protonation and allow 
more of the eliminated product to be formed. After stirring the reaction mixture for eight 
hours, only starting material was recovered. Following a similar deprotection protocol, 
trichloroethyl acetal 161 was stirred at room temperature with activated zinc dust and 
sodium acetate in acetic acid for three hours. Analysis of the crude reaction mixture by 
‘FI NMR spectroscopy showed a 2:2:3 mixture of starting material, dichloroethyl acetal 
162, and the desired hemiacetal 163.
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. 0 .  .O . ,CCI3 . 0 .  . 0 .  ,C H C !2 / O ^ . O H  
f  T  Conditio ns  ^ f  Y  ^  + C  X  C T
161 161  1 6 2  1 6 3
Zn° Additive Solvent 161:162:163
dusta N H 4 C I Acetonitrile 1 0 0 :0 :0
dustb N H 4 C I Acetonitrile 90:10:0
granular0 Dioxane Acetic acid 1 0 0 :0 :0
dustb Sodium acetate Acetic acid 30:30:40
Table 7: Attempted insertion-elimination deprotections of trichloroethyl group (“Non­
activated, bActivated by washing with 3 N HC1 for 45 min, filtered, washed with 3 N HC1, water, 
ethanol, ether, dried under reduced pressure (5 mmHg) at 77 °C over P2O5, 'Activated by washing 
with 3 N HC1 for 45 min, filtered, washed with 3 N HC1, water, ethanol, ether, dried under 
reduced pressure (0.5 mmHg))
Even though formation of the dichloroethyl acetal 162 was still competing with 
formation of the desired hemiacetal, deprotection of trichloroethyl ketal 159 with zinc 
and sodium acetate in acetic acid was attempted. Upon analysis of the jH NMR spectrum, 
the major product was determined to be the dichloroethyl ketal rather than papyracillic 
acid A.
At this point, hydrolysis was explored in an effort to identify a suitable method 
for the removal of the trichloroethyl-protecting group. In an attempt to remove the 
trichloroethyl protecting group, acetal 161 was stirred at room temperature with p-TsOH 
and water in THF (Scheme 42). After 2 days, only starting material was observed by 
TLC. At this point it was determined that an alternative protecting group would be 
required to effect efficient deprotection to papyracillic acid A.
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Scheme 42: Attempted hydrolysis of trichloroethyl ketal 161
2-<TrimethvlsilvDethvI Protecting Group
The 2-(trimethylsilyl)ethyl protecting group was an attractive protecting group as 
it has been reported to be easily cleaved through the use of boron trifluoride diethyl 
etherate in dichloromethane at 0 °C .77 Since one of the previously attempted 
trichloroethyl deprotection methods involved stirring ketal 159 under these same reaction 
conditions, deprotection of the 2 -(trimethylsilyl)ethyl group was anticipated to proceed 
chemoselectively with no decomposition of any of the other functionality in the 
molecule. Alternatively, tetrabutylammonium fluoride (TBAF) could be used as a source 
of a fluoride ion. Fluoride would preferentially attack the silicon atom, eliminating an 
equivalent of ethylene to form the desired hemiketal (Scheme 43).
SiMe.
TBAF HO-. /O ,
O
16 4 1 3 4
Scheme 43: Proposed deprotection of the 2-(trimethylsilyl)ethyl protecting group
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An initial attempt at synthesizing 2-(trimethylsilyl)ethyl ketal 165 was performed 
by exposing tandem chain extension-acylation product 146 to 2-(trimethylsilyl)ethanol 
and p-TsOH in toluene (Scheme 44). After stirring at room temperature for 2 days, TLC 
showed only starting material. The reaction was heated to reflux, but after heating for 
another 24 hours, again no change was seen by TLC.
OHHO
O  p-T sO H , to lu e n e , A
6 ^ \1 4  ^  1 6 5
Scheme 44: Attempted 2-(trimethylsilyl)ethyl protection of hemiketal 146
In summary, the tandem chain extension-acylation reaction was successfully 
applied to the synthesis of papyracillic acid A in 7 steps in 4% overall yield. It is possible 
that this overall yield could be increased through the use of a 2 -(trimethylsilyl)ethyl 
protecting group in place of the trichloroethyl protecting group, as the deprotection is 
predicted to be more higher yielding.
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CHAPTER IV
SYNTHESIS OF TETRAHYDROFURAN-BASED PEPTIDOMIMETICS
Introduction to Peptide Mimetics
Proteases are a class of enzymes that promote hydrolytic cleavage of peptide
bonds with high selectivity and efficiency. They are classified by the varying amino acid
residues acting as their active site participants and can be classified into two broad classes
based on their mechanism of action.78 The first class of protease enzymes makes use of
an activated water molecule to initiate hydrolysis of a peptide substrate. In the case of
zinc metalloproteinases activation of this water molecule is achieved by a zinc cation. In
the case of aspartate proteases, such as HIV-1 protease, this activation is achieved by the
two aspartyl residues found in the enzyme’s active site (Scheme 45) . 79 The second class
of protease enzymes initiates peptide hydrolysis through attack by a nucleophilic amino
acid residue, forming an ester or thioester acyl intermediate. Before nucleophilic attack,
•  * 80this amino acid residue is activated by a second amino acid side chain, such as histidine. 
The resulting acyl-enzyme intermediate is eventually hydrolyzed by a water molecule, 
activated by active site functionality.
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Scheme 45: Aspartic protease-mediated hydrolysis of peptide bond
While proteases are involved in many critical physiological reactions such as 
digestion, blood clotting, and immune response, they also aid in viral replication. 
Selective protease inhibitors, therefore, have great potential in drug design. One of the 
main strategies developing protease inhibitors has focused on the use of peptide isosteres.
The term isostere was introduced in 1919 by Langmuir to describe molecules 
containing the same number of atoms and valence electrons.81 Since the introduction of 
the concept of isosteres, the definition has been broadened. In medicinal chemistry, 
bioisosterism has been used to describe the application of isosterism to modify biological 
activity.82 Bioisosteres describe compounds that are related in structure and have similar 
antagonistic properties.83 Isosteres can be classified as either classical or non-classical. 
Classical isosteres follow a more ridgid steric and electronic definition, while one of the 
distinguishing characteristics of non-classical isosteres is that they do not have the same 
number of atoms as the molecule they are mimicking.
Bioisosteric replacement of an amide group has been an area that has received 
considerable attention due to its implications in peptide chemistry and in the development
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of peptide mimetics. When developing peptide isosteres, a number of factors must be 
considered including structural concerns such as bond angles, functionality and 
stereochemistry of side chains, hybridization of the amide mimic, as well as the hydrogen 
bonding capability.
When the amide nitrogen of a peptide bond (166) is replaced with a methylene 
unit, the resulting compound is referred to as a ketomethylene isostere (Figure 5). An 
advantage of the ketomethylene isostere is that the ketone, just as with the amide bond of 
compound 166, is able to accept a nucleophile and adopt a tetrahedral geometry, yet the 
ketone is hydrolytically stable. While ketomethylene isosteres have been successfully
84 85used for protease inhibition, ’ an important distinction between the ketomethylene and 
amide groups must be considered. Amide resonance is responsible for restricted rotation 
around the amide bond of a natural peptide and biases its ground state geometry to a 
conformation that has a high affinity for the active site of a targeted protease. 
Incorporation of a methylene unit removes the amide resonance and introduces free 
rotation that makes the ketomethylene isostere less likely to adopt the geometry needed to 
bind in the enzyme’s active site.86
Another type of peptide isostere that has found successful application in protease 
inhibition is the hydroxyethylene isostere (168).78, 87 Hydroxyethylene isosteres have 
been developed to mimic the tetrahedral intermediate formed during hydrolytic cleavage 
of the peptide bond. These isosteres maintain both hydrolytic stability and the ability to 
hydrogen-bond in the enzyme’s active site; however, free rotation about the carbon- 
carbon bond impacts their ability to closely mimic the amide bond. In the case of 
cyclopropane isosteres, stereochemical rigidity is mandated.88 While this rigidity can be
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viewed as mimicking the amide bond, all hydrogen-bonding capability is lost, which 
would be expected to result in decreased binding affinities.
O R2
p ep tid e  bon d  (1 6 6 )
O R2 OH R2 R2
k e to m eth y len e  is o s te r e  (1 6 7 ) h y d ro x y eth y len e  is o s te r e  (1 6 8 ) c y c lo p r o p a n e  is o s te r e  (1 6 9 )  
Figure 5: Isosteric replacement of amide bond
While these three classes of peptide isosteres have found utility in protease 
inhibition, they all lack certain desirable structural features. A series of compounds that 
may better mimic natural peptides are both the embedded hemiketal 170, and the 
embedded tetrahydrofuran 171 isosteres (Figure 6 ). In both of these structures, a 
hydrolytically stable, sp3-hybridized, oxygen-containing functional group replaces the 
amide bond. In this way they are similar to the hydroxyethylene isosteres and are able to 
mimic the tetrahedral intermediate observed during hydrolysis of the natural peptide. In 
addition, the cyclic nature of these compounds allows for a restricted rotation about the 
carbon-carbon bond, which more closely mimics the amide bond.
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Figure 6 : Novel heterocyclic peptide isosteres
The synthesis of an embedded tetrahydrofuran isostere could be achieved through 
reduction of an embedded hemiketal (Scheme 46). Use of triethylsilane and boron 
trifluoride diethyl etherate would allow for initial formation of an oxocarbenium ion, 
followed by hydride addition to form the tetrahydrofuran ring. The embedded hemiketal 
isostere would be easily synthesized through the use of a tandem chain extension-aldol 
reaction of the appropriate amino acid derived |3-keto ester. Use of the tandem chain 
extension-aldol reaction with a variety of starting (3-keto carbonyls and aldehydes has the 








O R 4 b) R3C H O
a ) Et2Z n, C H 2I2
O R 4
17 3 1 7 0
Scheme 46: Synthetic route for the synthesis of embedded hemiketal and tetrahydrofuran 
isosteres
Previous Syntheses of Substituted Tetrahvdrofurans
Previous work in the Zercher group has focused on the use of amino acid-derived 
systems in the zinc carbenoid-mediated chain extension reaction as an approach to 
peptide isosteres (Scheme 47) .22 A variety of TV-protected amino acid-derived (3-keto 
esters were synthesized in order to establish the efficiency of the chain extension 
reaction. It was determined that a wide range of protecting groups was tolerated, and that 
the efficiency of the reaction was not dependent upon the starting amino acid. 
Epimerization of the amino acid stereocenter was shown not to occur under zinc- 
mediated chain extension reaction conditions.
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H 9  9  EtgZn, C H 2I2 ■■ °
R 1 • v ^ ^ ^ ' O R 3 R 1
R2 R2 O
1 7 4  1 7 5
R 1 =  B oc , C bz, B z, F m oc  
R2 =  H, M e, P h, Bn 
R3 =  M e, Bn
Scheme 47: Chain extension of amino acid derived |3-keto esters
While mono-protected amino acids are tolerated in the chain extension reaction, 
the moderately acidic NH-amide proton would most likely quench the organometallic 
intermediate thereby preventing opportunities for further functionalization of the y-keto 
backbone through tandem reaction methods. Bis-protection of the amino acid N-terminus 
has been shown to allow for the application of tandem chain extension reactions. When 
an alanine-derived (3-keto ester (174) was subjected to a tandem chain extension-aldol 
reaction using formaldehyde as the electrophile, the aldol products were generated as an 
approximately 1:1 ratio of diastereomers.20 This result suggests that the amino acid 
stereocenter was too far removed to influence the facial selectivity of the intermediate 
enolate.
Use of a proline-derived P-keto amide in the tandem chain extension-aldol 
reaction using benzaldehyde as the electrophile resulted in the formation of the syn aldol 
product with greater than 95% diastereoselectivity. 16 Conversion of tandem chain 
extension-aldol products 177 to tetrahydrofurans 178 has been shown to proceed 
efficiently, albeit with modest diastereocontrol (Scheme 48).89 Facial selectivity in the
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hydride addition to an intermediate oxocarbenium ion is poor when a single stereocenter 
is present on the tetrahydrofuran backbone.
9  a) Et2Zn, CH2I2 HO ^  R
~ ^ N ^ \ b )  R2CO " B F 3 Et20
Et3SiH
176
O C H 3 c o 2c h 3 178 C 0 2CH3
R =  H, dr = 2:1 
R =  M e, dr =  2 .5 :1
Scheme 48: Synthesis of substituted tetrahydrofurans through tandem homologation 
aldol reaction of chiral (5-keto amide
While use of a proline-based chiral auxiliary allowed for stereocontrol in the aldol 
reaction and the triethylsilane reduction, application of the chain extension-aldol- 
reduction sequence to the stereocontrol led synthesis of dipeptide mimetics would have 
additional value if both the N-terminus and the C-terminus were available for further 
modification. The N-terminus of a dipeptide mimic would be accessible from an amino 
acid starting material with appropriate protection. Access to the C-terminus by hydrolysis 
of a proline amide would required harsh reaction conditions, which if performed in the 
presence of amino acid functionality may lead to epimerization of the amino acid 
stereocenter. Alternatively, higher diastereoselectivity in the tandem chain extension- 
aldol reaction could be available from a p-keto imide.15 Another benefit of using a P-keto 
imide in the tandem chain extension-aldol reaction is the formation of the anti-aldol 
product. The hemiketal isomer of the anti-aldol product possesses a c/s-relationship 
between the imide and aldehyde-derived R-group (Scheme 12), which suggests one face
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of the hemiketal would be more sterically crowded. This steric hindrance would be 
expected to bias hydride addition into the intermediate oxocarbenium ion during 
reduction to the tetrahydrofuran.
Evans’ chiral auxiliaries, derived from amino acids, have found wide use in 
asymmetric synthesis.90,91 Previous use of a chiral p-keto imide in the stereocontrol of a 
tandem chain extension-aldol reaction demonstrated the potential of amino acid-derived 
p-keto imides in the synthesis of peptide isosteres.15 An important benefit of the Evans 
auxiliaries is their ability to be easily hydrolyzed under mild reaction conditions, 
allowing for the opportunity to functionalize the C-terminus of a targeted peptide mimic.
Previous work by Lin demonstrated the successful synthesis of an amino acid- 
derived P-keto imide through a modified Claisen condensation reaction, with no 
epimerization of the amino acid stereocenter. Lin subjected this P-keto imide (179) to 
tandem chain extension-aldol reaction conditions using paraformaldehyde as the 
electrophile. When the P-keto imide was exposed to zinc-carbenoid prior to the addition 
of paraformaldehyde, a cyclopropane byproduct (180) was formed instead of the desired 
aldol product 181 (Scheme 49).16 Formation of this cyclopropane was presumably a 
result of alkylation by excess carbenoid, followed by cyclization into the imide carbonyl. 
Lin avoided the formation of this byproduct through addition of paraformaldehyde to the 
carbenoid mixture prior to the addition of the starting P-keto imide. Under these modified 
reaction conditions, aldol product 181 was isolated as the major product without 












Scheme 49: Order of addition during the tandem chain extension-aldol reaction of p-keto 
imide 179
Once the tandem chain extension-aldol reaction was shown to be applicable to the 
synthesis of amino acid derived y-keto imides, conversion to the substituted 
tetrahydrofuran was attempted. Lin successfully synthesized tetrahydrofuran 183 as a 1:1 
mixture of diastereomers through a triethylsilane reduction of aldol product 182 (Scheme 
50). This result suggested that the proline stereocenter did not influence the 
stereoselectivity of the reduction of the hemiketal.
1 :1 m ixture o f d ia s te r e o m e r s
Scheme 50: Synthesis of substituted tetrahydrofuran 183
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When Lin subjected (S)-alanine derived P-keto imide 181 to tandem 
homologation-aldol reaction conditions followed by triethylsilane reduction, an 
unexpected byproduct (185) was obtained rather than the desired tetrahydrofuran 184 
(Scheme 51). This byproduct was not unambiguously identified, but it was presumed to 
be formed though an intramolecular Friedel-Crafts reaction between the oxocarbenium 
ion and the PMB protecting group. It was proposed that synthesis o f this byproduct could 
be avoided through addition of the triethylsilane into the reaction mixture prior to 
addition of the Lewis acid.
185
ten ta tiv e  a s s ig n m e n t  
Scheme 51: Lin’s attempted synthesis of substituted tetrahydrofuran 184
The PMB protecting group has been used in the tandem chain extension-aldol 
reaction of P-keto imides for multiple reasons. As previously mentioned, diprotection of 
the N-terminus of amino acid substrates like 181 is required to avoid quenching the zinc-
Et3SiH
Et3SiH
O M e O
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enolate intermediate. The PMB protecting group is able to withstand zinc-mediated chain 
extension reaction conditions. Additionally, the PMB group can be efficiently and 
selectively removed from the amine, providing access for manipulation of the N-terminus 
following the homologation reaction.
The general strategy that targets dipeptides with embedded tetrahydrofurans had 
been shown to be successful, albeit with a limited number of amino acid-derived starting 
materials. Formaldehyde had been the only electrophile incorporated during the tandem 
chain extension-aldol reaction with amino acid-derived P-keto imide starting materials.16 
Investigation into the use of alternative amino acid derived systems and a broader range 
of electrophiles was needed to more fully understand the scope and utility of this 
synthetic approach to the novel peptide isosteres.
Utility of p-Methoxvbenzvl Protecting Group
To test our ability to synthesize substituted tetrahydrofurans through a 
triethylsilane mediated reduction of substrates that possessed a PMB protecting group, a 
model P-keto ester was prepared (Scheme 52). Due to the high solubility of glycine in 
water, the methyl ester (187) was prepared prior to protection. Protection with a PMB 
group was effected through reductive amination.92 The resulting secondary amine (188) 
was then converted to the carbamate (189) through carbobenzyloxy (Cbz) protection.93 
Saponification of the methyl ester through exposure to potassium hydroxide94 afforded 
the diprotected amino acid.
Conversion of an amino acid to the corresponding P-keto ester can be achieved 
through the use of the Masamune-Brooks reaction.95 A^V-Protected glycine 190 was
70
activated with carbonyldiimidazole, generating acyl imidazole intermediate 191. This 
intermediate was transferred to a solution of the magnesium salt of monobenzylmalonate 
192. Upon purification, the glycine derived P-keto ester 193 was obtained in 55% yield.
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Scheme 52: Synthesis of an amino acid derived P-keto ester
Subjection of P-keto ester 193 to tandem chain extension-aldol reaction 
conditions using acetone as the electrophile resulted in the formation of hemiketal 194 in 
33% yield. Hemiketal 194 was treated with 4 equivalents of triethylsilane at -78 °C 
followed by addition of boron trifluoride diethyl etherate and allowed to stir for 22 h, 
while warming to room temperature, giving rise to tetrahydrofuran derivative 195 as a 1:1 
mixture of diastereomers (Scheme 53). In addition to reduction to the tetrahydrofuran 
ring, ’H NMR analysis revealed that the PMB group had been removed.
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Scheme 53: Utility of the PMB protecting group during the synthesis of a 
tetrahydrofuran derivative
The absence of a Friedel-Crafts alkylation byproduct similar to that observed by 
Lin (185) indicated that the PMB-protecting group would be suitable for the synthesis of 
a wider variety of tetrahydrofuran derivatives. Removal of the PMB protecting group 
under triethylsilane reduction reaction conditions was unanticipated, but prevention of its 
removal by shortening the reaction time and maintaining a reduced temperature was 
proposed.
Model B-Keto Imide
All previous attempts at synthesizing tetrahydrofuran derivatives from P-keto 
imides used formaldehyde as the electrophile during the initial tandem chain extension- 
aldol reaction.16 To test this methodology with other aldehydes, simple p-keto imide 201 
was prepared as a model substrate (Scheme 54). Synthesis of chiral P-keto imide 201 
began with the formation of a L-valine derived oxazolidinone 99.96, 97 This chiral 
oxazolidinone was then reacted with acylated Meldrum’s acid 200 in refluxing toluene to 
yield a P-keto imide in 77% yield.
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Scheme 54: Synthesis of a simple chiral P-keto imide
Exposure of the resulting P-keto imide to tandem chain extension-aldol reaction 
conditions with three different aldehydes gave rise to the corresponding hemiketals 202a- 
c in good yield, and high diastereoselectivity (Table 8). Triethylsilane reduction of the 
purified aldol products resulted in the formation of tetrahydrofuran derivatives 203a-c. 
The diastereoselectivity seen in the formation of these tetrahydrofuran derivatives was 
higher than those seen previously. Use of a P-keto imide in the tandem chain extension- 
aldol reaction results in the formation of anti-aldol products.98 The hemiketal isomers of 
these products have a cis relationship between the imide and R functionality rather than 
the trans relationship seen in the hemiketals formed from ^«-selective aldol reactions 
involving ester and amide starting materials. Having both functional groups on the same 
side of the five-membered ring appears to bias addition of the hydride into the opposite 
face of the oxocarbenium ion formed during the reduction.
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b) R C H O  C H 2CI2, -7 8  °C  ' ^ J ,
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201^J V N /  ° V N /o <  I><
2 0 2 a -c  2 0 3 a -c
Entry R 202 yield (%) Diastereomeric ratio of 203 203 yield (%)
la f-Bu 40 6:1 94
2b Ph 63 8:1 64
3c C4H9 18 8:1 69
Table 8: Synthesis of substituted tetrahydrofurans from simple p-keto imide
Amino Acid-Derived B-Keto Imides
Once it was determined that tetrahydrofuran derivatives could be prepared with 
high diastereoselectiveity, the next step was to apply this same methodology to amino 
acid-derived p-keto imides. Three representative primary and secondary amino acids 
were chosen as starting materials for the methodological study. L-Proline was selected, as 
it was a secondary amino acid containing an aliphatic side chain. L-Phenylalanine was 
selected as a primary amino acid containing an aromatic side chain. Glycine, which 
contains no side chain, was chosen as a third amino acid to investigate the influence of 
the amino acid stereocenter on the diastereoselectivity of the triethylsilane reduction.
The first amino acid studied was L-proline. Synthesis of a proline derived P-keto 
imide began with Cbz protection (Scheme 55). The protected amino acid 205 was 
subjected to a jV,iV-dicyclohexylcarbodiimide (DCC) coupling with Meldrum’s acid,
forming the Meldrum’s acid adduct 206 in 83% yield. Exposure of this adduct to L- 
valine-derived oxazolidinone 199 in boiling toluene resulted in the formation of proline 
derived p-keto imide 207 as a single diastereomer.
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Scheme 55: Synthesis of Cbz-derived p-keto imide
P-Keto imides are more reactive than p-keto esters and amides under zinc 
carbenoid-mediated chain extension reaction conditions. Previous studies of the exposure 
of P-keto imides to zinc carbenoid for extended reaction times have resulted in the 
identification of two major by-products, a-methylated y-keto imide (212) and bicyclic 
lactone 213 (Scheme 56).35,99
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Scheme 56: Byproducts observed during the tandem chain extension of a P-keto imide
In an attempt to reduce the amount of unwanted byproducts formed in the tandem 
chain extension aldol reaction of p-keto imide 207, the electrophile was added to the 
carbenoid prior to addition of the imide. The amount of carbenoid used in the reaction 
was limited to 2.5 equivalents. Conversion of p-keto imide 207 to hemiketal 215 was 
accomplished through the use of a tandem chain extension-aldol reaction using 
pivaldehyde as an electrophile (Scheme 57). Exposure of the purified aldol product to 
triethylsilane followed by addition of boron trifluoride diethyl etherate resulted in the 
formation of substituted tetrahydrofuran 216 in 69% yield. Analysis of the ]H NMR 
spectrum was complicated by the presence of rotameric forms of compound 216; 
however, it appeared as though only a single configurational diastereomer was formed. 
Addition of the hydride was predicted to occur on the face opposite to the imide and t-
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butyl groups due to their steric bulk. This prediction was confirmed by NOESY NMR 
data for similar tetrahydrofuran derivatives and will be discussed below.
Synthesis of p-keto imides through the use of a Meldrum’s acid adduct can be 
challenging, since the presence of moisture results in the formation of a methyl ketone 
byproduct. In order to avoid formation of this byproduct, p-keto imide 120 was 
synthesized through the use of a mixed Claisen reaction. Benzotriazole-activated 
carboxylic acid 218 was reacted with the lithium enolate of acylated oxazolidinone 219 to 
afford p-keto imide in 46% yield.
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Scheme 58: Synthesis of p-keto imide 120
p-Keto imide 120 was subjected to the tandem chain extension-aldol reaction 
using pivaldehyde as an electrophile (Scheme 59). Pivaldehyde was added just prior to 
the addition of the P-keto imide in order to prevent the formation of any unwanted 
byproducts. The purified aldol product was treated with triethylsilane and BF3 Et20  at -78 
°C for 1 h to afford tetrahydrofuran derivative 222. Analysis o f the crude reaction 
mixture showed a single observable diastereomer of the tetrahydrofuran derivative 222, 
which once again confirmed the high diastereoselectivity of this reduction.
While the triethylsilane reduction proceeded very cleanly with high mass 
recovery, a significant amount of material was lost during purification by preparative thin 
layer chromatography, resulting in an isolated yield of only 24%. Repetition of this 
reaction and purification through an alternative method, such as flash chromatography, is 
predicted to result in a much higher yield.
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Scheme 59: Synthesis of substituted tetrahydrofuran 222
In order to establish the stereochemistry of the tetrahydrofuran, NMR 
investigations were undertaken. A COSY NMR experiment was performed to assign each 
proton resonance in the 'H NMR spectrum. A NOESY NMR experiment was performed 
to show a NOE correlation between protons on the tetrahydrofuran ring (Figure 7). These 
correlations suggest that a cz's-relationship exists between all of the substituents of the 
tetrahydrofuran ring. This is consistent with the predicted model in which the imide and 
R-group, installed stereoselectively during the tandem chain extension-aldol reaction, 




Figure 7: NOESY correlations between protons on the tetrahydrofuran ring
Based on the successful results observed during the reductive cyclization of the 
proline-derived systems, other amino acid-derived systems were investigated. L- 
Phenylalanine was chosen as an example of a primary amino acid. Di-protection of the 
N-terminus of L-phenylalanine can be accomplished in one step by stirring with phthalic 
anhydride and triethylamine in refluxing toluene (Scheme 60). The phthalimide 
protecting group was chosen since its symmetry avoids the appearance of rotameric 
forms.
O
OH Et3N, to luene, \\ 
92%
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Scheme 60: Phthalimide protection of L-phenylalanine
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Phthalimide-protected fi-keto ester 226 was prepared previously by Lin. When 
exposed to chain extension reaction conditions, a tricyclic byproduct (229) was formed 
instead of the expected y-keto ester 228 (Scheme 61).16 Formation of this byproduct 
appears to be due to attack of the zinc-enolate into one of the phthalimide carbonyl 
groups.









Scheme 61: Chain extension of p-keto ester 226
Since addition of pivaldehyde to the carbenoid before the addition of a P-keto
imide was shown to avoid a-methylation of the zinc-enolate (Scheme 49), it was
proposed that cyclization into the phthalimide protecting group could also be avoided by
early introduction of the electrophilic aldehyde. P-Keto imide 231 was prepared through
the use of a mixed Claisen reaction, in which benzotriazole-activated phenylalanine 230
was added to the enolate of an acylated oxazolidinone 218 (Scheme 62). The purified p-
keto imide was subjected to the tandem chain extension-aldol reaction, which afforded
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the aldol product in 18% yield. Triethylsilane reduction of the purified aldol product 
resulted in the synthesis of 233, a single diastereomer of the substituted tetrahydrofuran 
as determined by 'H NMR.
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Scheme 62: Synthesis of embedded tetrahydrofuran 233
In order to probe the effect of the amino acid stereocenter on the 
diastereoselectivity of the triethylsilane reduction, a glycine-derived P-keto imide was 
prepared (Scheme 63). Diprotected glycine 234 was prepared through a three-step 
process. Glycine was first converted to the methyl ester so as to reduce its water
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solubility and allow for easier handling during protection of its N-terminus. Diprotection 
was achieved through an. initial reductive amination with /7-anisaldehyde followed by 
treatment with />-TsCl in excess 2M NaOH. The excess 2M NaOH in the second 
protection step allowed for simultaneous saponification of the methyl ester. Diprotected 
glycine 234 was activated with benzotriazole and then converted to P-keto imide 236 
through a modified mixed Claisen reaction.
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Scheme 63: Synthesis of glycine derived p-keto imide 236
Exposure of P-keto imide 236 to tandem chain extension-aldol reaction 
conditions, again using pivaldehyde as the electrophile, gave rise to hemiketal 237 in 
71% yield (Scheme 64). This hemiketal was then treated with triethylsilane and BF3 Et2 0  
at -78 °C to afford substituted tetrahydrofuran 238 as a 2:1 mixture of diastereomers. The 
diastereomeric ratio was calculated based on the integrations of the methoxy protons at 
3.80 and 3.79 ppm. Unlike the result seen by Lin, the diastereoselectivity of this reductive 
cyclization suggests that the amino acid adjacent to the oxocarbenium ion does play a
83
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role in biasing the facial selectivity of the intermediate oxocarbenium ion. In addition, it 
is possible that the presence of less hindered protecting groups blocked access to the top 
face of the oxocarbenium ion, resulting in the lower diastereocontrol. Subjection of a 
phenylalaine-derived P-keto imide, protected with both PMB and Ts protecting groups, to 
the same synthetic strategy may shed light on the influence of these bulky protecting 
groups.
The successful synthesis of a variety of amino acid derived tetrahydrofuran 
derivatives supports the utility of the tandem chain extension-aldol reaction as a route to 
embedded tetrahydrofuran isosteres. The cis relationship between the imide and
. L v
Et3SiH , C H 2CI2
Scheme 64: Synthesis of embedded tetrahydrofuran 238
aldehydic functional groups appears to bias addition of a hydride to the opposite face of
the intermediate oxocarbenium ion.
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Alternate Aldehydes and Ketones as Electrophiles
The next step in developing this methodology was to make use of aldehydes and 
ketones other than pivaldehyde. Due to ease of preparation, p-keto imide 120 was chosen 
as a starting material for these studies.
The first electrophile used to study this methodology was acetone. Acetone was 
chosen to probe the effect of having substitution on both faces of the five membered ring 
during the triethylsilane reduction. The tandem chain extension-aldol reaction between P- 
keto imide 120 and acetone resulted in the formation of aldol product 239 (Scheme 65). 
When this hemiketal was exposed to triethylsilane and boron trifluoride diethyl etherate 
at -78 °C, an intermediate oxocarbenium ion, in which both faces of the five membered 
ring possessed substituents, was proposed to form. A 3:1 mixture of tetrahydrofuran 
diastereomers was calculated from the ]H integrations of the methyl groups on the 
tetrahydrofuran ring at 1.26 and 1.24 ppm. This reduced diastereocontrol is expected, as 
hydride addition would encounter substituents on both faces of the tetrahydrofuran ring 
rather than on only one face, as is the case when an aldehyde is used as the electrophile.
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Scheme 65: Synthesis of substituted tetrahydrofuran 241
Use of benzaldehyde as an electrophile during the tandem chain extension-aldol 
reaction would allow for the incorporation of a phenylalanine-like side chain. This benzyl 
side chain has been previously incorporated into three different hydroxyethylene 
isosteres: Crixivan, Norvir, and Lopinavir (Figure 8).100' 104 These three hydroxyethylene 
isosteres have been used successfully as HIV-protease inhibitors. Due to the similarities 
between hydroxyethylene isosteres and tetrahydrofuran-containing isosteres, it was 
desired to incorporate the benzyl functionality into a tetrahydrofuran derivative.
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Crixivan (2 4 2 )  L opinavir (2 4 3 )
Norvir (2 4 4 )
Figure 8: Hydroxyethylene isosteres
Treatment of P-keto imide 120 to the optimized tandem chain extension aldol 
reaction conditions with benzaldehyde acting as the electrophile resulted in the formation 
of anfr'-aldol product 245. Exposure of the purified hemiketal to triethylsilane and 
BF3 Et2 0  resulted in the formation of the corresponding tetrahydrofuran derivative 247 as 
a single diastereomer in 30% yield.
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Scheme 66: Synthesis of tetrahydrofuran derivative 247
A tandem chain extension reaction was performed on p-keto imide 120 with 
formaldehyde in an attempt to incorporate a serine-type side chain as well as to probe the 
diastereoselectivity of the reduction with only one stereocenter present on the 
tetrahydrofuran ring. Due to the gaseous nature of formaldehyde, paraformaldehyde, a 
polymeric form of formaldehyde, was used in the reaction. The hemiketal (248) formed 
during this reaction was subjected to triethylsilane reduction, which resulted in the 
formation of tetrahydrofuran 249 in 71% yield. Analysis of the 'H NMR spectrum of the 
crude reaction mixture showed a 1.4:1 mixture of diastereomers. This low 
diastereoselectivity corresponds to the results observed by Lin (Scheme 50) in studies 
using formaldehyde, as well as to the results obtained in the reductive cyclization of
compound 239 (Scheme 65), which used acetone in the aldol reaction.
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Scheme 67: Synthesis of tetrahydrofuran derivative 250
Conclusion
Use of the tandem chain extension-aldol reaction starting from amino acid derived 
P-keto imides provides easy access to the corresponding anti-aldol products. These 
compounds are cleanly converted to the corresponding tetrahydrofuran derivatives in 
good yield through the use of triethylsilane and boron trifluoride diethyl etherate. When 
an aldehyde is used as an electrophile during the tandem chain extension-aldol reaction, 
the resulting substitution pattern leads to high diastereocontrol during reductive 
cyclization. The role of the amino acid adjacent to the oxocarbenium ion in the 
stereochemical outcome of the triethylsilane reduction is unclear. Use of an L-amino acid 
introduces a S stereocenter a  to the oxocarbenium ion. Through the use of the Felkin-Ahn
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model,105 hydride addition is predicted to be biased toward the re-face of the intermediate 
oxocarbenium ion. This influence appears to be mismatched with the influence of the 
steric bulk of the functional groups on the tetrahydrofuran ring, which would direct the 
hydride addition to the si-face of the same oxocarbenium ion. Never the less, application 
of the tandem homologation-aldol reaction followed by triethylsilane reduction to a (3- 






Anydrous solvents, dichloromethane, tetrahydrofuran, toluene, and methanol, were 
obtained from an Innovative Technology Inc. Solvent Delivery System prior to use by 
passing through drying agent with nitrogen pressure.
Reagents
Unless otherwise noted, all reagents were obtained from commercial sources and used as 
received. P-Keto esters, aldehydes, and amines were dried, distilled, and stored over 3 A 
sieves in a desiccator.
Reactions
Reaction glassware and magnetic stir bars were stored in an oven at 200 °C prior to use. 
Sigma-Aldrich Natural Rubber Septa and Teflon coated magnetic stir bars were used
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unless otherwise noted. Nitrogen gas was introduced into reaction vessels through a 
Tygon® tube with a needle or gas inlet adapter.
Chromatography
Flash column chromatography was performed using Silica-P Flash Silica Gel with 40-63 
pm particle size. Mobile phases were freshly prepared. Preparative chromatography was 
performed through the use of Analtech Uniplate Silica Gel GF 1000 microns with UV 
254 glass-backed plates. Thin layer chromatography (TLC) analysis was conducted on 
glass-backed Silica Gel 60 A 250 pm thickness with fluorescent indicator. TLC plates 
were visualized under UV light and through the use of anisaldehyde, phosphomolybdic 
acid, or potassium permanganate stain. Unless otherwise stated, TLC solvent systems 
were identical to the mobile phase used for column chromatography.
Spectroscopy
Nuclear Magnetic Resonance (NMR) spectroscopy was conducted using a Varian 
Mercury spectrometer operating at 500 or 400 MHz for 'H and at 126 or 100 MHz for 
l3C spectroscopy. All 'H resonances were reported relative to a TMS (6 0 ppm) reference. 
All ,3C resonances were referenced to CDCb (8 77.16 ppm) or TMS (8 0 ppm). Infrared 
(IR) spectroscopy was conducted using a Thermo Nicolet iSlO FTIR using a diamond 
ATR probe. Diastereomeric ratios were calculated from integrations obtained by applying 




Method A: An oven-dried, 50-mL round-bottomed flask equipped with a magnetic stir 
bar, rubber septum, and a nitrogen gas inlet was charged with dichloromethane (20 mL) 
and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 mmol) was added 
to the flask via syringe in one portion. Methyl pivaloylacetate (0.16 g, 0.16 mL, 1 mmol) 
was added to the solution via syringe and allowed to stir for 5 min before the slow 
addition of diiodomethane (0.08 mL, 1 mmol) over 30 seconds. The solution was stirred 
for 1 h before the addition of acetic anhydride (0.07 mL, 1 mmol) in one portion via 
syringe. The reaction was stirred for 2 h then quenched with saturated ammonium 
chloride. Saturated sodium chloride (10 mL) was added to the solution and the organic 
layer was removed. The remaining aqueous layer was extracted with dichloromethane (3 
x 10 mL). The combined organic layers were dried over sodium sulfate (ca 2 g), filtered, 
and concentrated via rotary evaporation (20 mmHg, 20 °C) to afford a yellow oil. The 
crude residue was purified by flash column chromatography on silica, eluting with a 
mobile phase of 8:1 hexane -  ethyl acetate (Rf = 0.15) to afford 136 mg (63%) of the title 
compound as a clear oil.
Method B: An oven-dried, 50-mL round-bottomed flask equipped with a magnetic stir 
bar, rubber septum, and a nitrogen gas inlet was charged with dichloromethane (20 mL) 
and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.51 mL, 5 mmol) was added
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to the flask via syringe in one portion. Methyl pivaloylacetate (0.16 g, 0.16 mL, 1 mmol) 
was added to the solution via syringe and allowed to stir for 10 min before the drop-wise 
addition of diiodomethane (0.08 mL, 1 mmol). The solution was stirred for 1 h before the 
addition of benzotriazole-activated acetic acid (131) (242 mg, 1.5 mmol) in 
dichloromethane (2 mL) in one portion via syringe. The solution was stirred for 17 h at 
room temperature before being quenched with saturated ammonium chloride. Saturated 
sodium chloride (10 mL) was added to the solution and the organic layer was removed. 
The remaining aqueous layer was extracted with dichloromethane (3 x 10 mL). The 
combined organic layers were dried over magnesium sulfate (ca 2 g), filtered, and 
concentrated via rotary evaporation (20 mmHg, 20 °C) to afford a yellow oil. The crude 
residue was purified by flash column chromatography on silica, eluting with a mobile 
phase of 20% diethyl ether in hexane (R f = 0.15), to afford 102 mg (48%) of the title 
compound as a clear oil. ‘H NMR (400 MHz, C D C I 3 )  6 3.98 (dd, J =  8.4, 5.6 Hz, 1 H), 
3.69 (s, 3H), 3.19 (dd, J =  18.5, 8.4 Hz, 1H), 2.98 (dd, J=  18.5, 5.6 Hz, 1H), 2.32 (s, 3H), 
1.11 (s, 9H); 13C NMR (126 MHz, C D C I 3 )  6 213.8, 206.5, 174.9, 52.2, 44.2, 37.7, 35.5, 
30.1,26.4; IR (neat) v 2969, 1743, 1702, 1479, 1435, 1397, 1362, 1249, 1148 cm'1.
2-(Methoxycarbonyl)-5,5-dimethyl-l-phenyI-l,4-hexanedione (95)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of methyl 
pivaloylacetate 84 (0.16 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 5 min
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before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. 
The resulting solution was allowed to stir for 45 min while warming to room temperature. 
Benzoic anhydride (0.34 g, 1.5 mmol) dissolved in dichloromethane (2 mL) was added at 
room temperature and stirred for 1 h. The reaction was quenched with saturated 
ammonium chloride (2 mL). Saturated sodium chloride (10 mL) was added to the 
solution and the organic layer was removed. The remaining aqueous layer was extracted 
with dichloromethane (3 x 25 mL). The combined organic layers were dried over 
magnesium sulfate (ca 2 g), filtered, and concentrated via rotary evaporation (20 mmHg, 
20 °C) to afford a viscous yellow oil. The crude residue was purified by flash column 
chromatography on silica, eluting with hexane -  ethyl acetate (6:1) (R f = 0.21), to afford 
the title compound 95 as a clear oil in 95% (261 mg) yield. 'H NMR (500 MHz, CDCI3) 
5 8.04 (d, J =  8.0 Hz, 2H), 7.59 (m, 1H), 7.49 (t, J =  7.9 Hz, 2H), 4.94 (dd, J =  7.7, 6.1 
Hz, 1H), 3.67 (s, 3H), 3.33 (dd, 7 =  18.3, 7.8 Hz, 1H), 3.23 (dd, 7 =  18.3, 6.1 Hz, 1H),
1.19 (s, 9H); 13C NMR (126 MHz, CDCI3) 6  213.1, 195.0, 170.0, 136.1, 133.7, 129.0, 
128.9, 52.8, 48.6, 44.1, 36.8, 26.5; IR (neat) v 2969, 2872, 1739, 1685, 1448, 1275, 1232 
cm'1.
Methyl 2-acetyI-4-oxo-4-phenylbutanate (112)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of methyl 
benzoylacetate 105 (0.18 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 10
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min before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via 
syringe. The resulting solution was allowed to stir for 1 h while warming to room 
temperature. Acetic anhydride (0.11 mL, 1.5 mmol) was added at room temperature and 
stirred for 2 h. The reaction was quenched with saturated ammonium chloride (2 mL). 
Saturated sodium chloride (10 mL) was added to the solution and the organic layer was 
removed. The remaining aqueous layer was extracted with dichloromethane (3 x 10 mL). 
The combined organic layers were dried over magnesium sulfate (ca 2 g), filtered, and 
concentrated via rotary evaporation (20 mmHg, 20 °C) to afford a viscous yellow oil. The 
crude residue was purified by flash column chromatography on silica, eluting with a 
gradient of 2%, 5%, 7%, 10%, 12%, 15%, 20%, 30%, 40%, 50% diethyl ether in hexane 
(R f = 0.36, 50% diethyl ether in hexane), to afford 125 mg (50%) of the title compound 
112 as a clear oil. 'H NMR (500 MHz, CDC13) 6  7.99 (m, 2H), 7.57, (tt, J =  7.4, 1.3 Hz, 
1H), 7.46 (m, 2H), 4.24 (dd, J=  8.2, 5.6 Hz, 1H), 3.77 (s, 3H), 3.73 (dd, J  = 18.4, 8.2 Hz, 
1H), 3.53 (dd, J =  18.4, 5.6 Hz, 1H), 2.44 (s, 3H); 13C NMR (126 MHz, CDC13) 6  202.3,
197.1, 169.4, 136.0, 133.6, 128.7, 128.2, 53.7, 52.8, 37.5, 30.3; IR (neat) v 3005, 2954, 
2923, 2851, 1741, 1716, 1682, 1597, 1449, 1358, 1263, 1168, 1001, 754 cm'1.
l-((iS')-4-Isopropyl-2-oxooxazolidin-3-yl)-3-((1S')-l-tosylpyrrolidin-2-yl)propane-l,3- 
dione (120)
An oven-dried, 250-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dry tetrahydrofuran 
(150 mL) and cooled to 0 °C in an ice-water bath. Diisopropylamine (2.8 mL, 20 mmol) 
was added, followed by the slow addition of 2.5M n-butyl lithium ( 8  mL, 20 mmol). The
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solution was stirred for 15 min to allow for formation of lithium diisopropylamine 
(LDA), then cooled to -78  °C in a dry ice-acetone bath. Acylated oxazolidinone 219 (3 .71  
g, 2 0  mmol) was dissolved in tetrahydrofuran (2 0  mL) then slowly added to the LDA 
solution via syringe pump over 100 min. Benzotriazole-activated proline 218 (3 .71 g, 10  
mmol) was dissolved in tetrahydrofuran (4 0  mL) and added to the reaction mixture then 
allowed to stir at -7 8  °C for 1 h. The reaction was quenched with 3 M  hydrochloric acid 
(1 0  mL) then extracted with ethyl acetate (3 x 2 0  mL). The organic layers were pooled, 
dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to 
afford a viscous yellow oil. The crude product was purified by flash chromatography on 
silica, eluting with a mobile phase of 40%  ethyl acetate in hexane (R f =  0 .2 8 )  to yield (3- 
keto imide 120 (1 .9 3  g, 46% ) as a light yellow, viscous oil. 'H N M R  (5 0 0  M H z, CDCI3) 5 
7 .7 2  (d, 8 .6  H z, 2H ), 7 .3 4  (d, 8 .0  H z, 2 H ), 4 .5 8  (d, J =  17.3 H z , 1H ), 4 .4 8  (dt, J  =
8 .2 , 3 .7  H z, 1H ), 4 .3 3  (m, 1H), 4 .3 0  ( d, J  = 8 .7  H z , 1H ), 4 .2 3  (dd, J =  9 .1 , 3 .0  H z, 1H ), 
4 .1 4  (m, 1H), 3 .5 4  (ddd, J  = 10.3, 7 .3 , 5 .0  H z , 1H ), 3 .2 7  (dt, J =  9 .8 , 7 .6  H z, 1H ), 2 .5 0  
(septet of doublets, J  = 7 .2 , 3 .6  H z, 1H ), 2 .4 4  (s, 1H ), 2 .2 4  (m, 3 H ), 1 .88  (ddd, J =  15.2 ,
10.5 , 7 .2  H z, 1H ), 1 .67  (m, 1H), 1 .53 (m, 1H ), 0 .9 5  (d, J =  6 .7  H z, 6H ); ,3C N M R  (1 2 6  
M H z, CDCI3) 6 2 0 4 .2 , 166 .8 , 1 5 4 .3 , 1 4 4 .1 , 1 3 3 .6 , 1 2 9 .9 , 1 2 7 .8 , 6 7 .3 , 6 3 .7 , 5 8 .5 , 4 9 .6 ,
4 8 .4 , 2 9 .0 , 2 8 .3 , 2 4 .6 , 2 1 .6 , 17.9, 14.5; IR  (neat) v 2 9 6 5 , 1 7 7 4 , 1 7 2 4 , 1699 , 1389 , 1334 , 
1211, 1158  cm'1.
Methyl 2-(isobutyryl)-5,5-dimethyl-4-oxohexanoate (121)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20
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mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of methyl 
pivaloylacetate 84 (0.16 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 10 min 
before the slow addition, over 30 sec, of diiodomethane (0.09 mL, 1.1 mmol) via syringe. 
The resulting solution was allowed to stir for 1 h while warming to room temperature. 
Isobutyric anhydride (0.25 mL, 1.5 mmol) was added to the solution via syringe and 
allowed to stir for 3 h. The reaction was quenched with saturated ammonium chloride (2 
mL) and diluted with saturated sodium chloride (10 mL). The aqueous layer was 
extracted with dichloromethane (3 x 10 mL). The combined organic layers were dried 
over magnesium sulfate, filtered, and concentrated via rotory evaporation (20 mmHg, 20 
°C) to afford a viscous yellow oil. The crude residue was purified by flash column 
chromatography on silica, eluting with a gradient mobile phase of 2%, 5%, 7%, 10%, 
15%, 20%, 30%, diethyl ether in hexane (R f = 0.43, 30% diethyl ether in hexane) to 
afford 194 mg (80%) of the title compound 121 as a clear oil. NMR (500 MHz, 
CDCb) 5 4.21 (dd, J =  8.2, 5.7 Hz, 1H), 3.72 (s, 3H), 3.20 (dd, J  = 18.3, 8.2 Hz, 1H), 
2.99 (dd, J =  18.3, 5.7 Hz, 1H), 2.93 (septet, J =  6.9 Hz, 1H), 1.18 (d, / =  7.1, 3H), 1.17 
(s, 9H), 1.12 (d, J =  6 .8 , 3H); 13C NMR (126 MHz, CDC13) 5 213.1, 208.5, 170.0, 52.7,
5 1 .4 , 44.1,41.0,35.9, 26.6, 18.8, 18.0; IR (neat) v 2971, 2875, 1743, 1704 cm'1.
tert-Butyl 2-acetyl-4-oxopentanoate (122)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3
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mmol) was added via syringe in one portion followed by the addition of tert-butyl 
acetoacetate 117 (0.16 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 10 min 
before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. 
The resulting solution was allowed to stir for 1 h while warming to room temperature. 
Acetic anhydride (0.11 mL, 1.5 mmol) was added at room temperature and stirred for 3 h. 
The reaction was quenched with saturated ammonium chloride (2 mL). Saturated sodium 
chloride (10 mL) was added to the solution and the organic layer was removed. The 
remaining aqueous layer was extracted with dichloromethane ( 3 x 1 0  mL). The combined 
organic layers were dried over magnesium sulfate (ca 2  g), filtered, and concentrated via 
rotory evaporation (20 mmHg, 20 °C) to afford a viscous yellow oil. The crude residue 
was purified by flash column chromatography on silica, eluting with a gradient of 2 %, 
5%, 7%, 10%, 15%, 20%, 25% diethyl ether in hexane (R f = 0.18, 25% diethyl ether in 
hexane), to afford 107 mg (50%) of the title compound 122 as a clear oil. !H NMR (500 
MHz, CDCL) 5 3.94 (dd, J=  8.2, 5.7 Hz, 1H), 3.09 (dd, J=  18.5, 8.3 Hz, 1H), 2.90 (dd, J  
= 18.5, 5.7 Hz, 1H), 2.35 (s, 3H), 2.19 (s, 3H), 1.46 (s, 9H); 13C NMR (126 MHz, CDC13) 
6  205.9, 202.8, 167.9, 82.5, 54.9, 41.7, 30.2, 29.9, 28.0; IR (neat) v 2979, 2934, 1737, 
1712, 1368, 1257, 1141 cm 1.
tert-Butyl 2-benzoyl-4-oxopentanoate (123)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of t-butyl
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acetoacetate 117 (0.18 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 5 min 
before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. 
The resulting solution was allowed to stir for 30 min while warming to room temperature. 
Benzoic anhydride (0.34 g, 1.5 mmol) was added to the solution via syringe and allowed 
to stir for 2 h. The reaction was quenched with saturated ammonium chloride (2 mL) and 
diluted with saturated sodium chloride (10 mL). The aqueous layer was extracted with 
dichloromethane (3><10 mL). The combined organic layers were dried over magnesium 
sulfate, filtered, and concentrated via rotary evaporation (20 mmHg, 20 °C) to afford a 
viscous yellow oil. The crude residue was purified by flash column chromatography on 
silica, eluting with a mobile phase of hexane -  ethyl acetate (6:1) (R f = 0.21) to afford 
128 mg (73%) of the title compound 123 as a clear oil. 'H NMR (500 MHz, C D C I3 )  5
8.02 (m, 2H), 7.59 (m, 1H), 7.48 (m, 2H), 4.81 (dd, J =  7.7, 6.1 Hz, 1H), 3.20 (dd, J  =
18.2, 7.7 Hz, 1H), 3.09 (dd, J =  18.2, 6.1 Hz, 1H), 2.24 (s, 3H), 1.33 (s, 9H); 13C NMR 
(126 MHz, C D C I3 )  5 205.8, 195.1, 168.4, 136.4, 133.5, 129.0, 128.7, 82.54, 50.1, 42.2, 
30.1,27.9; IR (neat) v 2979, 1737, 1721, 1688, 1369, 1249, 1148 c m 1.
Allyl 2-acetyl-4-oxopentanoate (124)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of allyl acetoacetate 
118 (0.14 g, 0.14 mL, 1 mmol). The solution was stirred at 0 °C for 5 min before the slow 
additiori, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. The resulting
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solution was allowed to stir for 30 min while warming to room temperature. Acetic 
anhydride (0.11 mL, 1.5 mmol) was added to the solution via syringe and allowed to stir 
for 2 h. The reaction was quenched with saturated ammonium chloride (2 mL) and 
diluted with saturated sodium chloride (10 mL). The aqueous layer was extracted with 
dichloromethane (3 x 10 mL). The combined organic layers were dried over magnesium 
sulfate, filtered, and concentrated via rotary evaporation (20 mmHg, 20 °C) to afford a 
viscous yellow oil. The crude residue was purified by flash column chromatography on 
silica, eluting with a gradient mobile phase of 2%, 5%, 7%, 10%, 12%, 15%, 20%, 25%, 
30% diethyl ether in hexane (R f = 0.15, 30% diethyl ether in hexane) to afford 87 mg 
(44%) of the title compound 124 as a clear oil. 'H NMR (500 MHz, CDCI3) 5 5.90 (ddt, J  
= 17.2, 10.4,5.8 Hz, 1H), 5.33 (dq, J =  17.2, 1.5 Hz, 1H), 5.27 (dq, 10.4, 1.2 Hz, 1H),
4.64 (dt, J =  5.8, 1.4 Hz, 2H), 4.06 (dd, J =  8.3, 5.7 Hz, 1H), 3.16 (dd, J =  18.3, 8.3 Hz, 
1H), 2.97 (dd, J =  18.5, 5.7 Hz, 1H), 2.37 (s, 3H), 2.20 (s, 3H); 13C NMR (126 MHz, 
CDCI3) 5 205.7, 2 0 2 .2 , 168.6, 131.4, 119.3, 66.4, 53.8, 41.7, 30.3, 29.8; IR (neat) v 3005, 
1742, 1712, 1359, 1261, 1158, 934 cm'1.
2-(Allyloxycarbonyl)-l-phenyl-l,4-pentanedione (125)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of allyl acetoacetate 
118 (0.14 g, 0.14 mL, 1 mmol). The solution was stirred at 0 °C for 5 min before the slow 
addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. The resulting
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solution was allowed to stir for 30 min while warming to room temperature. Benzoic 
anhydride (0.34 g, 1.5 mmol) dissolved in dichloromethane (2 mL) was added at room 
temperature and stirred for 2.5 h. The reaction was quenched with saturated ammonium 
chloride (2 mL). Saturated sodium chloride (10 mL) was added to the solution and the 
organic layer was removed. The remaining aqueous layer was extracted with 
dichloromethane ( 3 x 1 0  mL). The combined organic layers were dried over magnesium 
sulfate (ca 2 g), filtered, and concentrated via rotory evaporation (20 mmHg, 20 °C) to 
afford a viscous yellow oil. The crude residue was purified by flash column 
chromatography on silica, eluting with a gradient mobile phase of 2%, 5%, 7%, 10%, 
12%, 15%, 20%, 25% diethyl ether in hexane (R f = 0.15, 25% diethyl ether in hexane), to 
afford 143 mg (55%) of the title compound 125 as a clear oil. 'H  NMR (500 MHz, 
CDC13) 6  8.03 (m, 2H), 7.60 (m, 1H), 7.48 (m, 2H), 5.78 (ddt, J =  17.2, 9.6, 5.6 Hz, 1H), 
5.20-5.15 (m, 2H), 4.95 (dd, J =  7.2, 6.5 Hz, 1H), 4.57 (dt, J  = 5.6, 1.3 Hz, 2H), 3.24 (dd, 
7 =  18.3, 7.4 Hz, 1H), 3.17 (dd, J =  18.3, 6.4 Hz, 1H), 2.23 (s, 3H); 13C NMR (126 MHz, 
C D C I3 )  6  205.4, 194.6, 169.0, 135.9, 133.8, 131.4, 129.0, 128.8, 118.6, 66.2, 48.7, 42.4, 
29.9; IR (neat) v 3064, 2949, 1737, 1716, 1682, 1269, 1155 c m 1.
Methyl 2-benzoyl-4-oxo-4-phenylbutanote (126)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of methyl 
benzoylacetate 105 (0.18 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 5 min
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before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. 
The resulting solution was allowed to stir for 1 h while warming to room temperature. 
Benzoic anhydride (0.3396 g, 1.5 mmol) was dissolved in dichloromethane (2 mL) and 
added to the solution and allowed to stir for 2 h. The reaction was quenched with 
saturated ammonium chloride (2 mL) and diluted with saturated sodium chloride (10 
mL). The solution was extracted with dichloromethane (3 x 10 mL). The combined 
organic layers were dried over magnesium sulfate (ca 2  g), filtered, and concentrated via 
rotory evaporation (20 mmHg, 20 °C) to afford a viscous yellow oil. The crude residue 
was purified by flash column chromatography on silica, eluting with hexane — 
dichloromethane (2:3) (R f = 0.24), to afford 185 mg (62%) of the title compound 126 as a 
clear oil. 'H NMR (500 MHz, CDC13) 6  8.10 (m, 2H), 8.00 (m, 2H), 7.61 (m, 1H), 7.57 
(m, 1H), 7.50 (m, 2H), 7.46 (m, 2H), 5.15 (dd, J =  7.6, 6.1 Hz, 1H), 3.83 (dd, J =  18.2, 
7.6 Hz, 1H), 3.74 (dd, J =  18.2, 6.0 Hz, 1H), 3.70 (s, 3H); 13C NMR (126 MHz, CDC13) 5
197.0, 194.8, 169.9, 136.2, 136.2, 133.8, 133.7, 129.1, 128.9, 128.8, 128.4, 53.0, 48.7, 
38.5; IR (neat) v 3343, 2954, 2923, 2853, 1738, 1680, 1596, 1448, 1274, 1274 cm 1.
2-Benzoyl-AyV-dimethyl-4-oxopentanamide (127)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of NJV- 
dimethylacetoacetamide 119 (0.10 g, 0.12 mL, 1 mmol). The solution was stirred at 0 °C 
for 5 min before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via
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syringe. The resulting solution was allowed to stir for 30 min while warming to room 
temperature. Benzoic anhydride (0.34 g, 1.5 mmol) dissolved in dichloromethane (2 mL) 
was added via syringe at room temperature turning the solution a bright yellow color. The 
reaction was stirred for 2  h before being quenched with saturated ammonium chloride ( 2  
mL). Saturated sodium chloride (10 mL) was added to the solution and the organic layer 
was removed. The remaining aqueous layer was extracted with dichloromethane (3 x 10 
mL). The combined organic layers were dried over magnesium sulfate, filtered, and 
concentrated via rotary evaporation (20 mmHg, 20 °C) to afford a viscous yellow oil. The 
crude residue was purified by flash column chromatography on silica, eluting with a 
gradient mobile phase of 2%, 5%, 7%, 10%, 12%, 15%, 20%, 30% 40%, 50%, 60%, 70% 
ethyl acetate in hexane (Rf = 0.13, 1:1 ethyl acetate - hexane), to afford 199 mg (80%) of 
the title compound 127 as a clear oil. ]H NMR (500 MHz, CDCI3) 5 7.95 (m, 2H), 7.59 
(m, 1H), 7.48 (m, 2H) 5.08 (dd, J =  8.0, 5.1 Hz, 1H), 3.23 (dd, J=  17.7, 8.0 Hz, 1H), 3.02 
(s, 3H), 2.97 (s, 3H), 2.94 (dd, J =  17.8, 5.1 Hz, 1H), 2.26 (s, 3H); 13C NMR (126 MHz, 
CDCI3) 5 205.8, 195.9, 169.0, 135.5, 133.8, 129.1, 128.5, 47.9, 42.5, 37.6, 36.1, 30.3; IR 
(neat) v 2931, 1715, 1692, 1636, 1396, 1263, 1166 cm'1.
2-Benzoyl-l-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-4-((S)-l-tosylpyrrolidin-2- 
yl)butane-l,4-dione (128)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (17 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion. p-Keto imide 120 (0.42 g, 1 mmol) (see
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formation of 217 -  218 for the formation of 120) was dissolved in dichloromethane (3 
mL) then added to the solution via syringe. The solution was stirred at 0 °C for 5 min 
before the slow addition, over 30 sec, of diiodomethane (0.08 mL, 1 mmol) via syringe. 
The resulting solution was allowed to stir for 1 h while warming to room temperature. 
Benzoic anhydride (0.34 g, 1.5 mmol) dissolved in dichloromethane (2 mL) was added 
via syringe at room temperature. The reaction was stirred for 1 h before being quenched 
with saturated ammonium chloride (2 mL). Saturated sodium chloride (10 mL) was 
added to the solution and the organic layer was removed. The remaining aqueous layer 
was extracted with dichloromethane (3 x 10 mL). The combined organic layers were 
dried over magnesium sulfate, filtered, and concentrated via rotary evaporation ( 2 0  
mmHg, 20 °C) to afford a 6:1 mixture of diastereomers as a yellow oil. The crude residue 
was purified by flash column chromatography on silica, eluting with a gradient mobile 
phase of 2%, 5%, 10%, 15%, 20%, 30% 40%, 50%, 60%, ethyl acetate in hexane (Rf = 
0.35, 1:1 ethyl acetate - hexane), to afford 287 mg (53%) of the title compound 128 as a 
clear oil. ‘H NMR (500 MHz, CDC13) 8  8.01 (m, 2H), 7.67 (m, 2H), 7.59 (m, 1H), 7.50 
(m, 2H), 7.32 (d, J =  8.0 Hz, 2H), 5.86 (dd, J =  11.7, 2.5 Hz, 1H), 4.44 (dt, J =  8.3, 2.9 
Hz, 1H), 4.32 (t, J=  9.0 Hz, 1H), 4.23 (dd, J =  9.2, 2.8 Hz, 1H), 3.91 (dd, J =  9.0, 6.1 Hz, 
1H), 3.60 (dt, J =  12.7, 6.3 Hz, 1H), 3.48 (dd, J  = 18.6, 11.7 Hz, 1H), 3.27 -  3.20 (m, 
2H), 2.52 (septet of doublets, J  = 7.1, 4.0 Hz, 1H), 2.43 (s, 3H), 2.17 (m, 1H), 1.99 (m, 
1H), 1.93 (m, 1H), 1.54 (m, 1H), 0.94 (t, J =  6.7, 6 H); 13C NMR (126 MHz, CDC13) 8
208.0, 197.2, 169.4, 154.2, 144.3, 134.7, 133.8, 133.0, 129.1, 128.9, 127.9, 67.7, 63.8,
60.5, 58.7, 50.0, 49.8, 37.0, 30.4, 28.4, 24.9, 21.7, 18.1, 14.6; IR (neat) v 2963, 1774, 
1703, 1389, 1342, 1205, 1159 cm'1.
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l-(l//-Benzo[<f][l,2,3]triazol-l-yl)ethanone (131)
An oven-dried, 250-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dry dichloromethane 
(75 mL). l-/7-Benzotriazole (7.15 g, 60 mmol) was added as a solid. Thionyl chloride 
(1.1 mL, 15 mmol) was added via syringe and stirred at room temperature for 30 min. 
Acetic acid (0.86 mL, 15 mmol) was added via syringe and stirred for 2 h. The resulting 
solution was filtered and the filtrate was washed with 2M sodium hydroxide (3 x 75 mL), 
dried over anhydrous sodium sulfate, and concentrated by rotary evaporation to afford
1.81 g (75%) of the title compound 131 as a white solid, (m.p. 46.2 — 47.5 °C) (Lit. 49-51 
°C)106; 'H NMR (500 MHz, CDC13) 6  8.28 (d, J =  8.3 Hz, 1H), 8.12 (d, J =  8.3 Hz, 1H),
7.65 (ddd, J =  8.2, 7.1, 1.0 Hz, 1H), 7.51 (ddd, J =  8.2, 7.1, 1.1 Hz, 1H), 3.01 (s, 3H); 13C 
NMR (126 MHz, CDC13) 5 169.7, 146.4, 131.1, 130.5, 126.3, 126.1, 120.2, 114.5, 23.3; 
IR (neat) v 1735, 1484, 1448, 1378, 1287, 1207, 1074 cm'1.
te/7-Butyl 2-oxopyrrolidine-l-carboxylate (132)107
An oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dry acetonitrile (20 
mL). 2-Pyrrolidinone (0.76 mL, 10 mmol) was added to the flask followed by the 
addition of di-tert-butyl dicarbonate (2.62 g, 12 mmol) and dimethylaminopyridine (0.13 
g, 1 mmol). The solution was stirred at room temperature for 2 h then concentrated by 
rotary evaporation. The residue was dissolved in ethyl acetate (20 mL) and washed with 
water (10 mL), and saturated sodium chloride (10 mL). The organic layer was dried over
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anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to afford a 
clear oil. The crude product was purified by flash chromatography on silica, eluting with 
a mobile phase of 20% ethyl acetate in hexane (Rf = 0.30) to yield 1.85 g (100%) of the 
title compound 132 as a colorless oil. 'H NMR (500 MHz, CDCI3) 5 3.75 (ddd, J  = 7.3,
6 .8 , 0.8 Hz, 2H), 2.51 (ddd, J  = 8.4, 7.8, 1.0 Hz, 2H), 2.00 (m, 2H), 1.53 (s, 9H); ,3C 
NMR (126 MHz, CDCI3) 8  174.3, 150.3, 82.8, 46.5, 33.0, 28.1, 17.5; IR (neat) v 2979, 
2360, 1780, 1748, 1709, 1366, 1297, 1250, 1146 cm'1.
6-tert-Butyl-4-methyI-2-(tert-butyI)-2-hydroxy-l-oxa-6-azaspiro[4.4]nonane-4,6- 
dicarboxylate (133)
An oven-dried, 50-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL) via syringe and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.31 mL, 3 
mmol) was added via syringe in one portion followed by the addition of methyl 
pivaloylacetate 84 (0.16 g, 0.16 mL, 1 mmol). The solution was stirred at 0 °C for 10 min 
before the slow addition, over 30 sec, of diiodomethane (0.09 mL, 1.1 mmol) via syringe. 
The resulting solution was allowed to stir for 2 h while warming to room temperature. 
1,1-Dimethylethyl 2-oxo-l-pyrrolidinecarboxylate (0.26 mL, 0.28 g, 1.5 mmol) was 
added at room temperature and stirred for 3 h. The reaction was quenched with saturated 
ammonium chloride (2 mL). Saturated sodium chloride (10 mL) was added to the 
solution and the organic layer was removed. The remaining aqueous layer was extracted 
with dichloromethane (3 x 10 mL). The combined organic layers were dried over 
magnesium sulfate (ca 2 g), filtered, and concentrated via rotory evaporation (20 mmHg,
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20 °C) to afford a viscous yellow oil. The crude residue was purified by flash column 
chromatography on silica, eluting with a gradient mobile phase of 2%, 5%, 7%,  10%, 
12%, 15%, 20%, 30% diethyl ether in hexane (Rf = 0.17, 30% diethyl ether in hexane), to 
afford 227 mg (64%) of the title compound 133 as a clear oil. ]H NMR (500 MHz, 
CDC13) 5 4.44 (dd, 12.6, 7.5 Hz, 1H), 3.71 (s, 3H), 3.56 (m, 1H), 3.35 (dt, J =  13.9, 
7.0 Hz, 1H), 2.82 (m, 1H), 2.58 (t, J =  6 . 6  Hz, 1H), 2.49 (t, J =  12.6 Hz, 1H), 2.05 (dd, J  
= 12.6, 7.5 Hz, 1H), 1.97-1.79 (m, 2H), 1.48 (s, 9H), 1.00 (s, 9H); 13C NMR (125 MHz, 
CDC13) 6  172.6, 154.5, 108.6, 100.6, 81.2, 52.0, 48.0, 46.4, 37.5, 36.9, 36.5, 28.6, 25.4, 
21.7; IR (neat) v 3398, 2971, 1744, 1701, 1515, 1366, 1249, 1166 cm'1.
3-Methoxyfuran-2,5-dione (3-methoxymaleic anhydride) (145)108 
An oven-dried 100-ml round-bottomed flask equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet was charged with dry methanol (50 mL). 
Dimethylacetylenedicarboxylate (3.7 mL, 4.3 g, 30 mmol) was added in one portion. 
Triethylamine (2.4 mL, 1.7 g, 17 mmol) was added to the reaction drop wise via syringe 
to produce a deep amber solution. The reaction was stirred for 2.5 h then concentrated by 
rotary evaporation (20 mmHg, 25 °C) to yield dimethyl 2-methoxybut-2-enedioate as a 
dark orange oil (5.3 g, 100%). The product did not require further purification and was 
carried on as a mixture of E- and Z-isomers in a 2:1 ratio. ’H NMR (400 MHz, CDCI3) E- 
isomer: 5 6.19 (s, 1H), 3.95 (s, 3H), 3.85 (s, 3H), 3.76 (s, 3H). Z-isomer 5 5.21 (s, 1H), 
3.89 (s, 3H), 3.75 (s, 3H), 3.71 (s, 3H); ,3C NMR (100 MHz, CDC13) E-isomer: 6  164.8,
163.3, 154.9, 107.8, 57.1, 51.9. Z-isomer: 5 166.3, 164.0, 162.6, 93.2, 61.2, 53.0; IR 
(neat) v 2954, 1717, 1628, 1435, 1370, 1261, 1209, 1171, 1144, 1030 c m 1.
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A 300-mL round-bottomed flask was equipped with a magnetic stir bar and charged with 
dimethyl 2-methoxybut-2-enedioate and methanol (90 mL). A 4 N aqueous potassium 
hydroxide solution (80 mL) was added to the reaction and allowed to stir for 20 h at room 
tempurature. The resulting solution was cooled to 0 °C in an ice-water bath then acidified 
to pH 2 with 10 M hydrochloric acid solution, and extracted with diethyl ether (5 x 150 
mL). The combined organics were dried over anhydrous sodium sulfate, gravity filtered, 
and concentrated by rotary evaporation (20 mmHg, 25 °C) to afford 2-methoxybut-2- 
enedioic acid as a white solid (3.7 g, 85%). The product did not required further 
purification and was carried on as a mixture of E- and Z-isomers in a 2:1 ratio. 'H NMR 
(400 MHz, acetone-de) £-isomer: 6  6.17 (s, 1H), 3.93 (s, 3H), Z-isomer: 5 5.34 (s, 1H),
3.81 (s, 3H); 13C NMR (100 MHz, acetone-d6) 8  165.8, 164.6, 162.8, 154.7, 107.4, 91.8,
59.9,56.3, 50.4, 48.9; IR (neat) v 2957, 1689, 1403, 1269, 1221, 1113 cm'1.
An oven-dried, 25-mL, round-bottomed flask equipped with a magnetic stir bar, reflux 
condenser, and nitrogen gas inlet was charged with 2 -methoxybut-2 -enedioic acid (0 . 8 8  
g, 6.0 mmol). Thionyl chloride (13 mL) was added directly to the flask via syringe 
producing a gaseous evolution. The solution was stirred at room temperature for 1 h 
before being heated to reflux for 18 h. The solvent was removed by distillation under 
reduced pressure (4 mmHg, 25 °C) to afford a yellow solid. The crude product was 
purified by flash chromatography on silica, eluting with a mobile phase of 2 0 % ethyl 
acetate in hexane (Rf = 0.3) to afford 498 mg of the title compound 145 as an off white 
solid (65%). (m.p. 152 -  155 °C; Lit. 152 -  155 °C)108; 'H NMR (400 MHz, CDCI3) 5
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5.79 (s, 1H), 4.05 (s, 3H); 13CNMR (100 MHz, CDCh) 5 162.8, 161.7, 160.6, 98.7, 60.4; 
IR (neat) v 3129, 1855, 1765, 1640, 1455, 1439, 1341, 1219 c m 1.
Allyl (3S,4S)-2-hydroxy-9-methoxy-2,3-dimethyl-7-oxo-l,6-dioxaspiro[4.4]non-8- 
ene-4-carboxyIate (146)
An oven-dried, 100-mL, round-bottomed flask, equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet, was charged with dry dichloromethane (60 mL) and 
cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.77 mL, 7.5 mmol) was added in 
one portion via an oven-dried needle. Allyl acetoacetate 144 (0.41 mL, 3 mmol) was 
added and stirred for 10 min before the dropwise addition of 1,1-diiodoethane (0.76 mL,
7.5 mmol). The reaction was stirred for 30 min while warming to room temperature then 
cooled back to 0 °C. A second portion of diethylzinc (0.77 mL, 7.5 mmol) was added and 
stirred for 10 min. 1,1-Diiodoethane (0.76 mL, 7.5 mmol) was slowly added and the 
reaction was stirred for another 3 h while warming to room temperature. A solution of 3- 
methoxymaleic anhydride (410 mg, 3.2 mmol) in dichloromethane (4 mL) was slowly 
added to the reaction mixture then stirred at room temperature for 1 day. The reaction 
was quenched with 3N hydrochloric acid (30 mL) and extracted with ethyl acetate (5 x 20 
mL). The organic layers were washed with saturated sodium chloride (10 mL), dried over 
anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to afford a 
brown, viscous oil (0.97 g, ~100% of expected mass recovery). The title compound was 
carried on without further purification. Characteristic resonances for the major isomer of 
hemiketal 146b: 'H NMR (500 MHz, C D C I3 )  6  5.28 (s, 1H), 4.00 (s, 3H), 3.48 (d, J  =
12.4 Hz, 1H), 2.75 -  2.65 (m, 1H), 1.61 (s, 3H), 1.21 (d, J  = 6.7 Hz, 3H); All carbon
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resonances for the crude product mixture: 13C NMR (126 MHz, CDCI3) 6  177.1, 167.1,
131.3, 119.7, 108.4, 107.6, 98.8, 95.1, 90.8, 6 6 .6 , 65.9, 61.5, 60.6, 54.4, 43.2, 42.8, 37.0,




An oven-dried, 100-mL, round-bottom flask equipped with a magnetic stir bar, rubber 
septum, and calcium sulfate drying tube was charged with crude hemiketal 146 (2.84 g, 3 
mmol) and toluene (30 mL). 2,2,2-Trichloroethanol (0.43 mL, 0.67 g, 4.5 mmol) was 
added via syringe followed by the addition of p-toluene sulfonic acid (49 mg, 0.28 mmol) 
as a solid. The solution was stirred at room temperature for 2 days. The reaction mixture 
was then concentrated by rotary evaporation yielding a viscous black oil. The crude 
product was purified by flash chromatography on silica, eluting with a gradient mobile 
phase of 2%, 5%, 7%, 10%, 12%, 15%, 20%, 22.5%, 25% ethyl acetate in hexane to 
afford the title mixed ketal 147 as a white solid (0.39 g, 32%). (Rf = 0.23, 20% ethyl 
acetate in hexane); (m.p. 106.4-107.2 °C); ]H NMR (500 MHz, C D C I 3 )  5 5.83 (ddt, J  =
17.2, 11.9, 6.0 Hz, 1H), 5.29 (m, 1H), 5.25 (m, 1H), 5.14 (s, 1H), 4.61 (dd t,J  = 13.0,5.7,
1.2 Hz, 1H), 4.54 (ddt, J  = 13.0, 6.1, 1.4 Hz, 1H) 4.16 (d, J =  10.4 Hz, 1H), 4.07 (d, J  =
10.4 Hz, 1H) 3.95 (s, 3H), 3.56 (d, J =  12.3 Hz, 1H), 2.79 (dq, J =  13.3, 6.7, 1H), 1.60 (s, 
3H), 1.26 (d, J= 6.7 Hz, 3H); l3C NMR (126 MHz, CDC13) 5 176.1, 168.5, 166.9, 131.4,
119.3, 109.9, 107.3, 96.7, 90.7, 74.5, 66.2, 59.8, 53.9, 44.6, 20.7, 11.8; IR (neat) v 3126, 




An oven-dried, 10-mL, round-bottom flask equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet was charged with allyl ester 147 (0.39 g, 0.93 mmol) and 
dry tetrahydrofuran ( 8  mL). Morpholine (0.08 mL, 0.08 g, 0.94 mmol) was added in one 
portion via syringe. Tetrakis(triphenylphosphine)palladium(0) (0.11 g, 0.09 mmol, 10 
mol%) was added as a solid and allowed to stir at room temperature for 3 h. The reaction 
was quenched with 1 N hydrochloric acid ( 8  mL), then extracted with ethyl acetate ( 4 x 8  
mL). The pooled organics were washed with 1 N hydrochloric acid ( 2 x 8  mL), dried over 
anhydrous sodium sulfate, gravity filtered, and concentrated by rotary evaporation to 
yield a viscous orange oil. The crude product was dissolved in dichloromethane (10 mL) 
and extracted with saturated sodium bicarbonate (4 x 10 mL). The aqueous layer was 
cooled to 0 °C in an ice-water bath and acidified to pH 2 with 10 N hydrochloric acid. 
The acidified solution was extracted with ethyl acetate (5 x 30 mL). The pooled organics 
were washed with saturated sodium chloride (10 mL), dried over anhydrous sodium 
sulfate, gravity filtered, and concentrated by rotary evaporation to afford the title 
compound 148 as a white solid (279 mg, 79%). (Rf = 0.0-0.2 streak, 1:1 ethyl acetate- 
hexane); (m.p. 188.5 -  188.9 °C, decomposition); 'H NMR (500 MHz, CDCb) 5 5.17 (s, 
1H), 4.15 ( d , J  = 10.4 Hz, 1H), 4.06 (d, J =  10.4 Hz, 1H), 3.96 (s, 3H), 3.59 (d, J =  12.3 
Hz, 1H), 2.76 (dq, J=  12.8, 6 . 8  Hz, 1H), 1.60 (s, 3H), 1.27 (d, J =  6.7 Hz, 3H); ,3C NMR 
(126 MHz, CDCh) 6  175.9, 171.0, 168.9, 109.9, 107.1, 96.7, 90.9, 74.6, 59.9, 53.6, 44.6,




An oven-dried, 10-mL, round-bottom flask equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet was charged with carboxylic acid 148 (129 mg, 0.34 
mmol) and tetrahydrofuran (4 mL). Carbonyldiimidazole (60 mg, 0.36 mmol) was added 
as a solid in one portion and stirred at room temperature for 2 h. The reaction was cooled 
to 0 °C in an ice-water bath and sodium borohydride (45 mg, 1.1 mmol) was added as a 
solid in one portion. The reaction was stirred for 35 min until TLC analysis indicated 
consumption of starting material (Rf = 0.0 - 0.2 streak) and production of product (Rf = 
0.23) eluting with a 1:1 ethyl acetate-hexane mobile phase. A solution of IN hydrochloric 
acid (5 mL) was added cautiously at 0 °C and extracted with ethyl acetate ( 3 x 5  mL). 
The pooled organics were washed with saturated sodium bicarbonate ( 2 x 5  mL), dried 
over anhydrous sodium sulfate, vacuum filtered, and concentrated by rotary evaporation 
(20 mmHg, 25 °C) to yield a foamy white solid (0.11 g, 89%) which did not require 
further purification, (m.p. 118.5 -  120.3 °C); 'H NMR (500 MHz, CDC13) 8  5.11 (s, 1H),
4.16 (d, J  = 10.4 Hz, 1H), 4.07 (d, J =  10.4 Hz, 1H), 3.91 (s, 3H), 3.75 (d, J =  5.4, 2H),
2.78 (dt, J =  12.4, 5.4 Hz, 1H), 2.35 (dq, J =  12.4, 6.7 Hz, 1H), 1.58 (s, 3H), 1.18 (d, J  =
6 . 8  Hz, 3H); 13C NMR (126 MHz, CDCI3) 5 177.6, 169.1, 109.8, 109.6, 96.9, 89.9, 74.6, 




A 20-mL scintillation vial equipped with a magnetic stir bar, rubber septum, and nitrogen 
gas inlet was charged with alcohol 149 (127 mg, 0.15 mmol) and tetrahydrofuran (0.7 
mL). 2-Nitrophenyl selenocyanate (92 mg, 0.21 mmol) was added as a solid in one 
portion turning the solution orange. A 10 wt% solution of tri-w-butylphosphine in hexane 
(809 mg, 0.21 mmol) was added dropwise via syringe turning the reaction dark brown. 
The reaction was stirred for 30 min until TLC analysis indicated consumption of starting 
material (R f = 0.23) and production of product (R f = 0.55) eluting with a 1:1 ethyl 
acetate-hexane mobile phase. The reaction mixture was concentrated by rotary 
evaporation (20 mmHg, 25 °C) to afford an orange-brown solid. The crude product was 
purified by flash chromatography on silica, eluting with a mobile phase of 30% ethyl 
acetate in hexane to afford the title compound 157 as a yellow solid (161 mg, 84%). (R f =  
0.19, 30% ethyl acetate in hexane); (m.p. 142-148 °C); 'H NMR (500 MHz, CDCI3) 5
8.24 (dd, J =  8.2, 1.4 Hz, 1H), 7.55 (ddd, J =  8 .6 , 7.2, 1.5 Hz, 1H), 7.47 (dd, J  = 8.1, 1.2 
Hz, 1H), 7.35 (ddd, J =  8.3, 7.2, 1.3 Hz, 1H), 5.06 (s, 1H), 4.12 (d, J =  10.4 Hz, 1H), 4.03 
(d, J=  10.4 Hz, 1H), 3.84 (s, 3H), 3.09 (m, 1H), 2.90 (m, 2H), 2.26 (m, 1H), 1.56 (s, 3H),
1.25 (d, J =  6 . 8  Hz, 3H); 13C NMR (126 MHz, CDCI3) 6 176.9, 169.1, 147.5, 134.0,
132.3, 129.5, 126.5, 126.1, 109.2, 108.7, 96.8, 91.0, 74.4, 59.6, 48.5, 47.4, 21.9, 21.3,
11.4; IR (neat) v 2938, 1770, 1645, 1590, 1512, 1331, 1010, 885 cm '1.
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(5/?,7R,8S)-4-methoxy-7,8-dimethyl-9-methylene-7-(2,2,2-trichloroethoxy)-l,6- 
dioxaspiro [4.4] non-3-en-2-one (159)
A 20-mL scintillation vial equipped with a magnetic stir bar, rubber septum, and nitrogen 
gas inlet was charged with selenide 157 (161 mg, 0.29 mmol) in tetrahydrofuran (3 mL) 
and cooled to 0 °C in an ice-water bath. A 30% aqueous solution of hydrogen peroxide 
(0.33 mL, 2.9 mmol) was added drop-wise via syringe. The reaction was stirred for 1 h 
while warming to room temperature. TLC analysis indicated that starting material was 
still present (R f = 0.54, 50% ethyl acetate in hexane) so the reaction was cooled back to 0 
°C and another aliquot of hydrogen peroxide (0.15 mL, 1.5 mmol) was slowly added. The 
reaction was allowed to stir at room temperature for 1 h. The addition of hydrogen 
peroxide (0.15 mL, 1.5 mmol) at 0 °C was repeated and the reaction mixture was allowed 
to stir at room temperature for another hour at which point TLC showed consumption of 
starting material and the presence of selenoxide 158 (R f = 0;26, 50% ethyl acetate in 
hexane). The reaction was quenched with saturated sodium bicarbonate (1.5 mL) and 
extracted with diethyl ether ( 4 x 5  mL). The combined organics were dried over Na2S0 4 , 
vacuum filtered, and concentrated by rotary evaporation. The resulting yellow residue 
was suspended in toluene (25 mL) and gently heated to 55 °C. After 2 h, TLC analysis 
showed consumption of the intermediate selenoxide (158) so the reaction mixture was 
cooled to room temperature and washed with 1M sodium hydroxide (1 x 10 mL) to 
remove the selenic acid byproduct. The organic layer was dried over Na2S0 4 , vacuum 
filtered, and concentrated by rotary evaporation to yield a yellow solid. The crude residue 
was purified by flash column chromatography on silica, eluting with a mobile phase of 
25% ethyl acetate in hexane (R f = 0.28), to afford 82 mg (82%) of the title compound 159
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as a pale yellow solid, (m.p. 130 -  132 °C ); *H NMR (500 MHz, CDC13) 5 5.24 (s, 1H),
5.16 (dt, J =  3.0, 0.8 Hz, 1H), 5.12 (dt, J =  3.1, 0.8 Hz, 1H), 4.11, 4.10 (ABq, J =  10.8 
Hz, 2H), 3.92 (s, 3H), 2.94 (app tq, J =  6 .8 , 3.8, 3.4 Hz, 1H), 1.65 (s, 3H), 1.25 (d, J =  6 . 8  
Hz, 3H); 13C NMR (126 MHz, CDC13) 6  176.3, 168.9, 147.7, 109.7, 109.6, 108.0, 96.8,
91.5, 74.8, 59.7, 46.4, 21.6, 10.1; IR (neat) v 3514, 2990, 2940, 1773, 1645, 1389, 1372, 
1 2 0 0  cm'1.
(5S,7R,8S)-7-hydroxy-4-methoxy-7,8-dimethyl-9-methyIene-l,6-dioxaspiro[4.4]non-
3-en-2-one (papyracillic acid A) (134)
A 20-mL scintillation vial, equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet, was charged with trichloroethyl ketal 159 (10 mg, 0.03 mmol) in 70% 
acetic acid (0.75 mL). Freshly activated zinc granular 20 mesh (22 mg) was added in one 
portion and the heterogeneous solution was stirred vigorously for 16 h at room 
temperature. The aqueous solution was extracted with ethyl acetate ( 4 x 1  mL). The 
organic layers were pooled, dried over anhydrous sodium sulfate, gravity filtered, and 
concentrated by rotary evaporation to afford a light yellow residue. The crude product 
was purified by flash column chromatography on silica, eluting with 30% ethyl acetate in 
hexane (Rf = 0.23) to afford the papyracillic acid A (134) as a white solid (2 mg, 27%) in 
a 1:1:2 mixture of isomers. !H and 13C NMR data reported for only the major hemiketal 
isomer: 'H NMR (500 MHz, CDC13) 5 5.30 (d, J =  2.9 Hz, 1H), 5.27 (d, J =  2.7 Hz, 1H),
5.09 (s, 1H), 3.88 (s, 3H), 2.77 - 2.71 (m, 1H), 1.60 (s, 3H), 1.21 (d, J =  6 . 8  Hz, 3H); ,3C 
NMR (126 MHz, CDC13) 8  177.9, 169.9, 148.2, 111.7, 111.1, 107.3, 91.3, 88.7, 59.9,
47.6, 25.1,24.6, 11.2, 10.6; IR (neat) v 2953, 2923, 2854, 1765, 1643, 1461, 1365 cm"1.
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2 -(2 ,2 ,2 -Trichloroethoxy)-tetrahydro-2 //-pyran (161)
An oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (25 
mL), K-10 montmorillonite clay (503 mg), and 2,2,2-trichloroethanol (1.9 mL, 20 mmol). 
3,4-Dihydro-2//-pyran (2.7 mL, 30 mmol) was dissolved in dichloromethane (9 mL) and 
added to the reaction mixture dropwise over 5 min. The reaction was stirred at room 
temperature for 30 min then filtered to remove the K-10 clay. The filtrate was 
concentrated by rotary evaporation to afford a clear oil. The crude product was purified 
by flash chromatography on silica, eluting with a gradient mobile phase of 2%, 4%, 6 %, 
8 %, and 10% ethyl acetate in hexane (R f = 0.49) to yield 2.7 g (59%) of the title 
compound 161 as a colorless oil. 'H NMR (400 MHz, CDC13) 8  4.94 (t, J =  3.3 Hz, 1H), 
4.29 (d, J=  11.6 Hz, 1H), 4.10 (d, J =  11.6 Hz, 1H), 3.91 (m, 1H),3.59 (m, 1H), 1.89 (m, 
1H), 1.80 -  1.76 (m, 2H), 1.69 -  1.55 (m, 3H); ,3C NMR (100 MHz, CDC13) 8  99.4, 97.3,
79.5, 62.3, 30.2, 25.5, 18.8; IR (neat) v 2943, 2871, 1454, 1441, 1262, 1202, 1130, 1034 
cm'1.
Methyl glycine hydrochloride (187)109
An oven-dried 250-mL round-bottomed flask equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet was charged with dry methanol (200 mL) and glycine 
(1.50 g, 20 mmol). The solution was cooled to 0 °C in an ice-water bath and thionyl 
chloride (1.7 mL, 24 mmol) was slowly added via syringe. The resulting solution was 
allowed to stir overnight while warming to room temperature. The reaction mixture was
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concentrated by rotary evaporation to yield a white solid. The crude product was 
dissolved in a minimum of methanol and triturated with diethyl ether. The resulting 
precipitate was isolated by vacuum filtration to afford the title ester (187) as a white solid 
(2.38 g, 95%). (m.p. 167.1 -  167.8); 'H NMR (500 MHz, D20  - acetone reference) 6  3.94 
(s, 2H), 3.83 (s, 3H); ,3C NMR (126 MHz, D20) 8  169.3, 54.0, 40.7; IR (neat) v 3373, 
3012, 2882, 2686, 2634, 1744, 1584, 1495, 1438, 1257 cm'1.
Methyl 2-(4-methoxybenzylamino)acetate (188)
A dry, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet. The flask was charged with dry methanol (30 mL) and the 
methyl ester of glycine (187) (2.51 g, 20 mmol), then cooled to 0 °C in an ice-water bath. 
Triethylamine (2.79 mL, 20 mmol) was added to the flask and allowed to stir for 10 min. 
jp-Anisaldehyde (2.43 mL, 20 mmol) was added and stirred for 18 h while warming to 
room temperature. The reaction was cooled back to 0 °C and sodium borohydride was 
carefully added in small portions. The reaction mixture was stirred at 0 °C for 2 h then at 
room temperature for 1 h. The reaction mixture was acidified to pH 2 with 1M sodium 
bisulfate. The aqueous layer was washed with diethyl ether (30 mL). The ether layer was 
back extracted with 1M sodium bisulfate (2 x 30 mL). The combined aqueous layers 
were neutralized using sodium carbonate then extracted with diethyl ether (3 x 30 mL). 
The ether layers were pooled, dried over anhydrous sodium sulfate, filtered and 
concentrated by rotary evaporation to afford the title ester 188 as a colorless oil (2.98 g, 
71%). (Rf = 0.44, 1:1 ethyl acetate - hexane); ]H NMR (400 MHz, CDC13) 8  7.25 -  7.22 
(m, 2H), 6.87 -  6.84 (m, 2H), 3.78 (s, 3H), 3.72 (s, 2H), 3.71 (s, 3H), 3.39 (s, 2H), 2.11
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(s, 1H); 13C NMR (100 MHz, CDC13) 5 172.9, 158.8, 131.5, 129.5, 113.8, 55.2, 52.6,
51.7, 49.7; IR (neat) v 3012, 2882, 2687, 2635, 1742, 1585, 1556, 1497, 1458, 1437, 
1424, 1401, 1244 c m 1.
Methyl 2-(((benzyloxy)carbonyI)(4-methoxybenzyl)amino)acetate (189)
A dry 50-mL round-bottomed flask equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet was charged with dichloromethane (16 mL) and ester 188 (750 mg, 3.6 
mmol) then cooled to 0 °C in an ice-water bath. Triethylamine (0.56 mL, 4.0 mmol) was 
added followed by the addition of benzylchloroformate (0.58 mL, 4.0 mmol). The 
reaction was allowed to stir at 0 °C for 1.5 h then at room temperature for another 30 
min. The reaction mixture was washed with water (5 mL) then 0.5N hydrochloric acid (5 
mL). The remaining organics were dried over anhydrous sodium sulfate, filtered, and 
concentrated by rotary evaporation to afford a yellow oil. The crude reaction mixture was 
purified by flash column chromatography on silica, eluting with a mobile phase of 25% 
ethyl acetate in hexane (R f =0.15) to afford the title compound 189 as a clear oil (1.2 g, 
96%) as a mixture (1:1) of rotamers. lH NMR (500 MHz, CDCI3) 5 7.36-7.29 (m, 10H),
7.19 (d, J =  8.7 Hz, 2H), 7.1 (d, J =  8.5 Hz, 2H), 6.85 (d, J =  8 . 6  Hz, 2H), 6.83 (d, J =  8 . 6  
Hz, 2H), 5.22 (s, 2H), 5.18 (s, 2H), 4.54 (s, 2H), 4.53 (s, 2H), 3.95 (s, 2H), 3.86 (s, 2H),
3.78 (s, 6 H), 3.71 (s, 3H), 3.62 (s, 3H); 13C NMR (126 MHz, CDCI3) 5 170.19, 170.17, 
159.33, 159.28, 156.6, 156.4, 136.6, 136.5, 129.8, 129.2, 128.81, 128.76, 128.60, 128.56,
128.2, 128.1, 128.0, 127.9 114.1, 67.8, 67.6, 55.4, 52.2, 52.1, 51.1, 50.7, 47.6, 47.3; IR 
(neat) v 2952, 2837, 1749, 1699, 1612, 1512, 1434, 1231, 1173, 1119cm'1.
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2-(((Benzyloxy)carbonyl)(4-methoxybenzyl)amino)acetic acid (190)
A 100-mL round-bottomed flask was charged with starting ester 189 (409 mg, 1.2 mmol) 
in a 1:1:1 solution of tetrahydrofuran, methanol, and water (51 mL). Lithium hydroxide 
monohydrate (320 mg, 7.8 mmol) was added and the reaction was stirred at room 
temperature for 1 h. The reaction was quenched with IN hydrochloric acid (40 mL) and 
extracted with dichloromethane (3 x 50 mL). The combined organics were dried over 
anhydrous magnesium sulfate, filtered, and concentrated by rotary evaporation to afford 
368 mg of the title compound 190 as a colorless oil (94%) as a mixture of rotamers. *H 
NMR (500 MHz, CDC13) 5 7.37 -  7.28 (m, 10H), 7.19 (d, J =  8.5 Hz, 2H), 7.11 (d, J  =
8.5 Hz, 2H), 6 . 8 6  (d, J =  8.7 Hz, 2H), 6.84 (d, 8.7 Hz, 2H), 5.23 (s, 2H), 5.19 (s, 2H),
4.54 (s, 2H), 4.52 (s, 2H), 3.98 (s, 2H), 3.90, (s, 2H), 3.79 (s, 6 H); 13C NMR (100 MHz, 
CDC13) 5173.9, 173.8, 159.3, 156.8, 156.5, 136.4, 136.3, 133.0, 132.9, 129.8, 129.2,
128.8, 128.5, 128.2, 128.1, 128.0, 127.8, 127.1, 114.2, 114.0, 68.0, 67.8, 64.9, 55.3, 50.9,
50.7, 47.5, 46.9; IR (neat) v c m 1.
Benzyl 4-(((benzyloxy)carbonyl)(4-methoxybenzyl)am ino)-3-oxobutanoate (193)
An oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dry tetrahydrofuran 
(15 mL). Diprotected glycine 190 (0.60 g, 1.8 mmol) and carbonyldiimizazole (1.21 g,
2.4 mmol) were added to the flask and allowed to stir for approximately 15 min. A 
separate oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir 
bar, rubber septum, and nitrogen gas inlet and charged with monobenzylmalonate ( 1 .2 1  g,
6.2 mmol) in dry tetrahydrofuran (30 mL). The solution was cooled to 0 °C in an ice-
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water bath before adding dibutyl magnesium (3.2 mL, 3.2 mmol, 1M in heptanes), 
stirring until the solution was no longer cloudy, then warming to room temperature. The 
acyl imidazole solution was transferred via cannula into the magnesium malonate 
solution. The reaction was stirred for 48 h before being quenched with 1M hydrochloric 
acid (30 mL) and extracted with diethyl ether (3 x 50 mL). The organic layers were 
pooled, washed with a 5% solution of sodium bicarbonate (2 x 50 mL), dried over 
anhydrous sodium sulfate, filtered and concentrated by rotary evaporation to afford a 
viscous yellow oil. The crude product was purified by flash chromatography on silica, 
eluting with a mobile phase of 20% ethyl acetate in hexane (Rf = 0.20) to yield 364 mg 
(43%) of the title p-keto ester 193 as a colorless oil. *H NMR (500 MHz, CDC13) 5 7.37 -
7.26 (m, 10H), 7.13 (d, J =  8.3 Hz, 1H), 7.04 (d, J =  8.4 Hz, 1H), 6.83 (d, J =  8.3 Hz, 
1H), 6.80 (d, J =  8.6 Hz, 1H), 5.20 (s, 1H), 5.14 (s, 1H), 5.12 (s, 1H), 5.08 (s, 1H), 4.47 
(s, 1H), 4.44 (s, 1H), 4.08 (s, 1H), 4.00 (s, 1H), 3.78 (s, 3H), 3.46 (s, 1H), 3.32 (s, 1H); 
13C NMR (126 MHz, CDC13) 5 198.4, 198.3, 166.7, 166.5, 161.4, 159.3, 156.58, 156.25, 
136.40, 135.26, 129.93, 129.87, 129.33, 128.77, 128.73, 128.69, 128.65, 128.60, 128.56,
128.5, 128.4, 128.3, 128.13, 128.07, 128.06, 128.0, 114.2, 114.0, 68.0, 67.9, 67.4, 55.7, 




An oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dry dichloromethane
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(25 mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.43 mL, 4.2 mmol) 
was added in one portion via an oven-dried needle. Diiodomethane (0.34 mL, 4.2 mmol) 
was slowly added via syringe and stirred for 10 min. |3-Keto ester 193 (0.39 g, 0.85 
mmol) was added to the reaction mixture and stirred at 0 °C. After 2 h, no starting 
material was still present by TLC, so another aliquot of both diethylzinc (0.21 mL, 2 
mmol) and diiodomethane (0.17 mL, 2 mmol) were added to the solution. The reaction 
was stirred for 1.5 h at 0 °C then freshly distilled acetone (0.12 mL, 1.7 mmol) was 
added. The reaction was stirred for 18 h while warming to room temperature before being 
quenched with saturated ammonium chloride (10 mL) and extracted with 
dichloromethane (3 x 10 mL). The organic layers were dried over anhydrous sodium 
sulfate, filtered, and concentrated by rotary evaporation to afford a clear oil. The crude 
product was purified by flash chromatography on silica, eluting with a mobile phase of 
30% ethyl acetate in hexane (R f = 0.23) to yield 0.15 g (33%) of a rotameric mixture of 
the title hemiketal 194 as a colorless oil. 'H  NMR (400 MHz, CDCI3) 5 7.38 -  7.32 (m, 
10H), 7.19 -  7.08 (m, 2H), 6 . 8 6  -  6.79 (m, 2H), 5.26 -  5.03 (m, 4H), 4.79 -  4.37 (m, 2H),
3.79 (m, 3H), 3.60 -  3.23 (m, 2H), 2.93 -  1.97 (m, 4H), 1.63 -  0.79 (m, 6 H); 13C NMR 
(100 MHz, CDCI3) 5 171.8, 159.1, 159.0, 157.8, 136.6, 136.3, 135.7, 135.1, 130.0, 129.9,
129.8, 129.3, 129.1, 128.9, 128.8, 128.7, 128.63, 128.58, 128.5, 128.3, 128.2, 128.1,
128.0, 114.2, 114.1, 114.0, 106.8, 105.3, 84.3, 83.3, 68.0, 67.7, 67.5, 66.7, 55.4, 54.4,
53.1, 52.4, 51.5, 51.0, 50.6, 39.3, 38.6, 37.8, 30.7, 29.7, 25.6, 24.6; IR (neat) v 2929, 




An oven-dried, 50-mL, round-bottomed flask equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet was charged with hemiketal 194 (153 mg, 0.29 mmol) in 
dichloromethane (10 mL) and cooled to -  78 °C in a dry ice-acetone bath. Triethylsilane 
(0.19 mL, 1.2 mmol) was slowly added to the reaction via syringe followed by the 
dropwise addition of boron trifluoride diethyl etherate (0.11 mL, 0.92 mmol). The 
reaction was stirred at -78 °C for 1 h then at room temperature for 21 h. The reaction was 
quenched with saturated sodium bicarbonate (5 mL) and extracted with diethyl ether (3 x 
15 mL). The combined organics were washed with saturated sodium chloride (15 mL), 
dried over anhydrous sodium sulfate, and concentrated by rotary evaporation to afford a 
mixture of diastereomers in a 1.3:1 ratio as a viscous yellow oil. The crude reaction 
material was purified by flash column chromatography on silica, eluting with a mobile 
phase of 10:1 hexane-ethyl acetate.
Diastereomer 195a was isolated as a clear oil in 28 mg, 25%. (Rf = 0.09, 10:1 hexane -  
ethyl acetate); 'H NMR (500 MHz, CDC13) 5 7.39-7.30 (m, 10H), 5.15, 5.10 (ABq, J  =
12.2 Hz, 2H), 5.10*, 5.09* (ABq, J  = 12.4 Hz, 2H), 5.04 (br t, J  = 5.6, 1H), 4.24 -  4.20 
(m, 1H), 3.39 (ddd, J=  13.6, 6.1,3.7 Hz, 1H), 3.19 (dt, J =  12.3,6.1 Hz, 1H), 2.81 (t, J  =
8.9 Hz, 1H), 2.53 (dt, J =  16.9,8.5 Hz, 1H), 1.89 (ddd, J =  14.7, 9.0, 5.5 Hz, 1H), 1.39 (s, 
3H), 1.04 (s, 3H) ; ,3C NMR (126 MHz, CDC13) 6  171.7, 156.8, 136.6, 135.8, 128.8,
128.7, 128.6, 128.5, 128.3, 82.9, 75.6, 66.9, 6 6 .8 , 53.5, 45.5, 31.2, 29.0, 22.9; IR (neat) v 
3339, 3033, 2974, cm'1.
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* App br s. Chemical shifts were found in MestReNova by applying an exponential of - 
2.10 with a Gaussian of 1.00.
Diastereomer 195b was isolated as a clear oil in 2 2  mg, 19% . (R f =  0 .0 6 , 10:1 hexane — 
ethyl acetate); 'H  N M R  (5 0 0  M H z, CDC13) 6 7 .3 9  -  7 .2 9  (m, 10H ), 5 .2 7  (t, J =  5 .5  H z, 
1H) 5 .1 4 , 5.11 (ABq, J =  12.2 H z, 2 H ), 5 .1 1 , 5 .0 9  (ABq, J  = 1 4 .7  H z , 2 H ), 4 .1 2  -  4 .0 7  
(m, 1H ), 3 .5 2  (ddd, J =  13 .9 , 6 .4 , 3 .3  H z, 1H ), 3 .2 5  (dt, J =  13 .8 , 5 .9  H z , 1H ), 2 .9 2  (t, J  =
8.9  H z, 1H ), 2 . 1 9 - 2 . 1 0  (m, 2H ), 1 .35 (s, 3H ), 1 .0 8  (3 H ) ; ,3C N M R  (1 2 6  M H z, CDC13) 
5 172 .2 , 1 5 6 .7 , 136 .8 , 1 35 .7 , 1 2 8 .8 , 1 2 8 .7 , 1 2 8 .6 3 , 1 2 8 .5 6 , 1 2 8 .1 9 , 1 2 8 .1 8 , 8 2 .5 , 7 5 .9 ,  
6 6 .6 9 , 66 .66 , 5 3 .8 , 4 5 .0 , 31 .8 , 2 8 .6 , 2 5 .1 ; IR  (neat) v 3 3 3 4 , 2 9 7 4 , 1723 , 1525 , 1 4 5 5 , 
1383 , 1251 , 1161 c m 1.
L-Valinol (197)96
An oven-dried, 3-necked, round-bottomed flask was equipped with a mechanical stirrer, 
reflux condenser, glass stopper, and nitrogen gas inlet. The flask was charged with 
tetrahydrofuran (250 mL) and cooled to 0 °C in an ice-water bath. Lithium aluminum 
hydride (7.6 g, 200 mmol) was added to the flask followed by slow addition of Z-valine 
(11.7 g, 100 mmol). The solution was heated to reflux for 4 h then cooled to room 
temperature. The reaction was carefully quenched with a 2M aqueous solution of sodium 
hydroxide (30 mL) then heated at reflux for another 1 h. The solution was filtered and the 
lithium salts were washed with boiling tetrahydrofuran (2 x 100 mL). The combined 
filtrate was dried over anhydrous sodium sulfate, filtered, and concentrated by rotary 
evaporation to afford L-valinol as a colorless oil (9.9 g, 96%). The product was carried on
124
without further purification. 'H NMR (400 MHz, CDCI3) 8  3.64 (dd, J  = 10.6, 3.7 Hz, 
1H), 3.32 (dd, J  = 10.7, 8 .6  Hz, 1H), 2.58 (ddd, J =  8 .6 , 6.3, 3.7 Hz, 1H), 2.33 (br s, 2H),
1.60 (octet, J =  6 . 8  Hz, 1H), 0.93 (d, J =  6 . 8  Hz, 3H), 0.92 (d, J =  6 . 8  Hz, 3H); I3C NMR 
(100 MHz, CDCI3) 5 64.6, 58.5, 31.5, 19.4, 18.5; IR (neat) v 3287, 2958, 2873, 1586, 
1467, 1387, 1369, 1049 cm’1.
Ethyl (5)-l-hydroxy-3-methylbutan-2-ylcarbamate (198)97
A 250-mL round-bottomed flask was charged with a 1:1 solution of tetrahydrofuran -  
water (140 mL). Z-Valinol (9.2 g, 89 mmol) was added to the flask along with sodium 
bicarbonate (37.4 g, 446 mmol). Ethyl chloroformate (9.5 mL, 100 mmol) was added to 
the solution and stirred at room temperature for 1.5 h. The reaction was extracted with 
ethyl acetate (3 x 150 mL). The organic layers were pooled, washed with water (150 mL) 
then saturated sodium chloride (150 mL), dried over anhydrous sodium sulfate, filtered, 
and concentrated by rotary evaporation to afford the title carbamate 198 as a clear oil 
(13.6 g, 78%). The product was carried on without further purification. ]H NMR (500 
MHz, CDCI3) 8  4.96 (br s, 1H), 4.12 (q, J  = 7.2 Hz, 2H), 3.69 (m, 1H), 3.63 (m, 1H), 
3.48 (m, 1H), 2.74 (br s, 1H), 1.86 (heptet, J =  7.4 Hz, 1H), 1.25 (t, J =  7.1 Hz, 3H), 0.96 
(d, J =  6 . 8  Hz, 3H), 0.94 (d, J =  6 . 8  Hz, 3H); 13C NMR (126 MHz, CDC13) 8  157.6, 64.0,




A 100-mL round bottomed flask was equipped with a magnetic stir bar, and short-path 
distillation head. The flask was charged with ethyl carbamate 198 (12.6 g, 71 mmol) and 
potassium carbonate (59 mg, 0.42). The reaction was heated to 120 -  130 °C under 
reduced pressure (ca. 10 mmHg) until gas evolution has ceased. The reaction was 
allowed to cool to room temperature to afford a white solid. The crude product was 
recrystallized from diethyl ether to yield 6.8 g (74%) of the title compound 99 as a white 
crystalline solid, (m.p. 73.4 -  73.7 °C); ]H NMR (400 MHz, CDC13) 6 6.82 (br s, 1H), 
4.44 (t, J =  8.7 Hz, 1H), 4.10 (dd, J  = 8.7, 6.3 Hz, 1H), 3.62 (dddd, J =  8.7, 7.2, 6.3, 1.0 
Hz, 1H), 1.73 (octet, J =  6.7 Hz, 1H), 0.96 (d, J =  6.7 Hz, 3H), 0.91 (d, J =  6.8 Hz, 3H); 
13C NMR (100 MHz, CDC13) 5 160.6, 68.7, 58.5, 32.8, 18.1, 17.8; IR (neat) v3262, 2974, 
2961, 2914, 2874, 1744, 1720, 1471, 1403, 1385, 1242, 1089 cm'1.
(5)-l-(4-Isopropyl-2-oxooxazolidin-3-yl)butane-l,3-dione (201)
An oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, 
reflux condenser and nitrogen gas inlet. The flask was charged with acylated Meldrum’s 
acid (200)uo (1.26 g, 6.8 mmol) in toluene (25 mL). (S)-4-Isopropyloxazolidin-2-one 
(199) (0.88 g, 6.8 mmol) was added as a solid and the reaction was heated to reflux for 1 
h. Once cooled to room temperature, the reaction mixture was concentrated by rotary 
evaporation to yield a yellow oil. The crude product was purified by flash 
chromatography on silica, eluting with a mobile phase of 30% ethyl acetate in hexane (R f 
= 0.2) to afford the title compound 199 as a white solid (1.12 g, 77%). (m.p. 54-56 °C); 
*H NMR (500 MHz, CDC13) major keto tautomer 5 4.47 (dt, J =  8.4, 3.7 Hz, 1H), 4.30 (t,
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J =  9.0 Hz, 1H), 4.24 (dd, J =  9.1, 3.0 Hz, 1H), 4.11 (d, J  -  16.5 Hz, 1H), 3.97 (d, J  =
16.5 Hz, 1H), 2.46 (doublet of septets, J =  7.1, 3.8 Hz, 1H), 2.28 (s, 3H), 0.93 (t, J =  7.0 
Hz, 6 H) 13C NMR (126 MHz, CDCb) major tautomer 6  201.1, 166.4, 154.4, 63.7, 58.4,
51.5, 30.1, 28.4, 17.9, 14.6; IR (neat) v 2966, 1770, 1723, 1698, 1389, 1365, 1324, 1306, 
1211, 1187, 1061 cm 1.
(4*S')-3-((2S',31?)-2-(tei7-Butyl)-5-hydroxy-5-inethyltetrahydrofuran-3-carbonyl)-4- 
isoprpyloxazolidin-2 -one (2 0 2 a)
An oven-dried 25-mL round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane 
(8 mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.13 mL, 1.25 mmol) 
was added via oven-dried needle. 1,1-Diiodomethane (0.10, 1.25 mmol) was added in a 
dropwise manner via syringe. The reaction was stirred for 10 min before the addition of 
pivaldehyde (0.11 mL, 1 mmol), followed by the immediate addition of P-keto imide 201 
(106 mg, 0.5 mmol) dissolved in dichloromethane (2 mL). The reaction was stirred for 2 
h before being quenched with saturated aqueous ammonium chloride (3 mL) and diluted 
with saturated sodium chloride (10 mL). The aqueous layer was extracted with 
dichloromethane (3 x 1 0  mL). The combined organics were dried over anhydrous sodium 
sulfate, filtered and concentrated by rotary evaporation to afford a light yellow oil. The 
crude reaction mixture was purified by flash column chromatography on silica, eluting 
with a mobile phase of 30% ethyl acetate in hexane (R f = 0.19) to afford the title 
compound 202a as a clear oil (63 mg, 40%). 'H NMR (500 MHz, CDCI3) major 
diastereomer 5 4.90 (s, 1H), 4.57 (ddd, J =  11.2, 5.2, 2.2 Hz, 1H), 4.53 (dt, J =  8.5, 3.5
127
Hz, 1H), 4.31 i \ , J -  9.1 Hz, 1H), 4.23 (dd, J=  9.2, 3.3 Hz, 1H), 4.12 (d, J =  5.2 Hz, 1H), 
2.34 (septet of doublets, J  — 7.0, 3.9 Hz, 1H), 2.16 (dd, J=  13.5, 11.2 Hz, 1H),2.01 (dd, J  
= 13.5, 2.2 Hz, 1H), 1.54 (s, 3H), 0.94 (d, J =  6.8 Hz, 3H), 0.92 (s, 9H), 0.87 (d, J =  6.9 
Hz, 3H); 13C NMR (126 MHz, C D C I3 )  major diastereomer 8 178.8, 153.6, 105.0, 90.9,
63.3, 58.6, 43.7, 42.1, 34.4, 28.6, 26.1, 25.5, 18.0, 14.8; IR (neat) v 3421, 2961, 2875, 
1780, 1702, 1672,1388, 1196 cm'1.
(45)-3-((25,3i?)-5-Hydroxy-5-methyI-2-phenyltetrahydrofuran-3-carbonyI)-4- 
isopropyloxazoIidin-2-one (202b)
An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (8 
mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.13 mL, 1.25 mmol) was 
added in one portion via an oven-dried needle. Diiodomethane (0.10 mL, 1.25 mmol) was 
added in a dropwise manner and stirred for 15 min. Benzaldehyde (0.06 mL, 0.6 mmol) 
was added to the solution, immediately followed by the addition of P-keto imide 201 
(107 mg, 0.5 mmol) in dichloromethane (2 mL). The reaction was stirred at 0 °C for 1 h 
before it was quenched with saturated ammonium chloride (10 mL). The aqueous layer 
was extracted with dichloromethane (3 x 1 0  mL). The organic layers were pooled, dried 
over anhydrous sodium sulfate, vacuum filtered, and concentrated by rotary evaporation 
to afford a yellow oil. The crude product was purified by flash chromatography on silica, 
eluting with a mobile phase of 40% ethyl acetate in hexane (R f = 0.17) to yield 106 mg 
(63%) of a mixture of isomers of the title compound 202b as a white solid, (m.p 117 — 
119 °C); 'H NMR (500 MHz, CDCI3) 5 7.49 -  7.34 (m, 5H), 4.71 (ddd, J =  10.8, 8.8, 3.5
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Hz, 1H), 4.64 (t, J =  8.9 Hz, 1H), 4.42 (ddd, J =  8.2, 3.9, 2.2 Hz, 1H), 4.37 (t J =  8.5 Hz, 
1H), 4.23 (dd, J=  8.7, 2.2 Hz, 1H), 3.36 (d, J8 .9  Hz, 1H), 3.06 (dd, J  18.4, 10.9 Hz, 1H), 
2.31 (m, 1H), 2.03 (s, 3H), 0.90 (d, J =  7.0 Hz, 3H), 0.80 (d, J =  6.9 Hz, 3H); 13C NMR 
(126 MHz, CDC13) 6 206.5, 174.9, 171.1, 155.4, 141.8, 128.8, 128.5, 128.4, 128.3, 128.3,
128.2, 128.1, 128.0, 127.8, 126.8, 126.5, 126.4, 126.1, 126.0, 105.6, 104.7, 84.0, 82.9,
81.5, 73.2, 63.8, 63.7, 63.4, 63.4, 63.0, 59.4, 58.9, 58.9, 58.7, 58.6, 48.3, 46.9, 45.7, 44.6,
44.2, 43.8, 42.6, 40.5, 40.2, 29.9, 29.5, 29.01, 28.95, 28.5, 28.4, 26.9, 26.8, 26.7, 18.2,
18.1, 17.94, 17.89, 14.9, 14.8, 14.6, 14.2, 13.9; IR (neat) v 3477, 2964, 1774, 1693, 1385, 
1364, 1301, 1201 c m 1.
(45T)-3-((2/?,3/?)-5-hydroxy-5-methyl-2-pentyltetrahydrofuran-3-carbonvi)-4- 
isopropyloxazolidin-2-one (202c)
An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (8 
mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.12 mL, 1.2 mmol) was 
added in one portion via an oven-dried needle. Diiodomethane (0.10 mL, 1.2 mmol) was 
added in a dropwise manner and stirred for 15 min. Hexanal (0.07 mL, 0.53 mmol) was 
added to the solution, immediately followed by the addition of P-keto imide 201 (102 mg, 
0.48 mmol) in dichloromethane (2 mL). The reaction was stirred at 0 °C for 1 h before it 
was quenched with saturated ammonium chloride (3 mL) and diluted with saturated 
sodium chloride (10 mL). The aqueous layer was extracted with dichloromethane (3 x 1 0  
mL). The organic layers were pooled, dried over anhydrous sodium sulfate, vacuum 
filtered, and concentrated by rotary evaporation to afford a light yellow oil. The crude
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product was purified by flash chromatography on silica, eluting with a mobile phase of 
40% ethyl acetate in hexane (Rf = 0.16) to yield 29 mg (18%) of a mixture of isomers of 
the title compound 202c as a colorless oil. 'H (500 MHz, CDCI3) 5 4.49 (m, 1H), 4.44 
(m, 1H), 4.37 (m, 1H), 4.33 -  4.28 (m, 2H), 4.27 -  4.23 (m, 3H), 3.14 (ddd, J  = 18.3,
10.9, 2.5 Hz, 1H), 2.70 (dt, J  -  18.3, 3.7 Hz, 1H), 2.48 (d, J =  9.7 Hz, 1H), 2.42 -  2.31 
(m, 3H), 2.22 (m, 1H), 2.18 -  2.13 (m, 3H), 1 .71-1 .59  (m, 4H), 1.43 -  1.24 (m, 15H), 
0.97 -  0.85 (m, 22H); 13C NMR (126 MHz, CDCI3) 5 207.0, 177.1, 175.1, 174.8, 155.0,
154.4, 153.6, 105.4, 105.1, 83.6, 83.0, 82.3, 73.0, 71.8, 63.8, 63.4, 59.2, 58.7, 47.3, 43.9,
43.4, 41.6, 40.6, 35.7, 35.3, 34.5, 33.0, 31.7, 31.7, 29.9, 29.7, 29.0, 28.4, 26.7, 25.7, 25.2,
25.2, 22.6, 22.6, 18.0, 17.9, 15.0, 14.7, 14.01, 13.99; IR (neat) v3452, 2958, 2931, 2873, 
1777, 1697, 1386, 1301, 1202, 1101 cm 1.
(*S)-3-((25',3J?,5»S)-2-(/cr/-Butyl)-5-methyltetrahydrofuran-3-carbonyl)-4- 
isopropyloxazolidin-2-one (203a)
A 20-mL scintillation vial equipped with a magnetic stir bar, rubber septum, and nitrogen 
gas inlet was charged with hemiketal 202a (48 mg, 0.15 mmol) and dichloromethane ( 6  
mL). The vial was cooled to -78 °C in a dry ice-acetone bath. Triethylsilane (0.10 mL, 
0 . 6  mmol) was added to the vial followed by the addition of boron trifluoride diethyl 
etherate (0.06 mL, 0.45 mmol). The reaction was stirred at -78 °C for 45 min before 
being quenched with saturated sodium bicarbonate (1 mL) and diluted with saturated 
sodium chloride (10 mL). The aqueous layer was extracted with dichloromethane ( 3 x 5  
mL). The organic layers were pooled, dried over anhydrous sodium sulfate, gravity 
filtered, and concentrated by rotary evaporation to afford the title compound as a 6:1
130
mixture of diastereomers. The crude product was purified by flash column 
chromatography on silica, eluting with a mobile phase of 20% ethyl acetate in hexane (R f  
= 0.40) to afford 42 mg (94%) of the title compound 202a as a colorless oil. 'H N M R  
(500 M H z, CDC13) 5 4.47 (dt, J=  8.4, 3.4 H z, 1H ), 4.27 ( t ,J =  9.1 H z , 1H), 4.21 (d d ,J  =
9.1, 3.1 H z, 1H ), 4.14-4 .09  (m, 1H), 4.08 (d, J= 7 .1  H z, 1H), 2.34 (septet of doublets, J  
= 7.0, 3.7 H z, 1H ), 1.95 (ddd, J =  12.5, 6.0, 4.4 H z, 1H ), 1.83 (ddd, 12.5, 10.7, 9.1 
H z, 1H ), 1.24 (d, J=  6.1 H z, 3H ), 0.92 (d, J=  7.1 H z, 3 H ), 0.91 (s, 9 H ), 0.86 (d, J =  7.0 
H z, 3H ); 13C N M R  (126 M H z, C D C I3) 5175.5, 153.9, 90.1, 74.4, 63.1, 58.6, 43.2, 40.4,
33.7, 28.4, 25.9, 20.3, 18.1, 14.7; IR  (neat) v 2962, 2872, 1774, 1696, 1481, 1466, 1385, 
1362, 1203 cm 1.
(5)4-Isopropyl-3-((25,3i?,55)-5-methyl-2-phenyltetrahydrofuran-3- 
carbonyl)oxazolidin-2-one (203b)
A 20-mL scintillation vial was equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet. The flask was charged with dichloromethane (3 mL) and hemiketal 
202b (28 mg, 0.14 mmol) then cooled to -78 °C in a dry ice-acetone bath. Triethylsilane 
(0.05 mL, 0.32 mmol) and boron trifluoride diethyl etherate (0.03 mL, 0.24 mmol) were 
added to the vial in order then stirred at -78 °C for 45 min. The reaction was quenched 
with saturated sodium bicarbonate (1.5 mL) and diluted with saturated sodium chloride (5 
mL). The aqueous layer was extracted with dichloromethane ( 3 x 5  mL). The organic 
layers were pooled, dried over anhydrous sodium sulfate, filtered, and concentrated by 
rotary evaporation to afford a white solid. The crude product was purified by flash 
chromatography on silica, eluting with a mobile phase of 25% ethyl acetate in hexane (R f
131
= 0.25) to yield 16 mg (64%) of the title tetrahydrofuran 203b as a white solid. 'H NMR 
(400 MHz, CDCU) 5 7.40 - 7.30 (m, 2H), 7.30 - 7.16 (m, 3H), 5.35 (d, J =  9.4 Hz, 1H), 
4.54 (td, J =  9.4, 8.3 Hz, 1H), 4.20 - 4.05 (m, 3H), 4.02 (dd, 8.6, 2.0 Hz, 1H), 2.32 
(m, 1H), 2.15 (ddd, J  -  12.1, 8.1, 4.9 Hz, 1H), 1.54 (septet of doublets, J  = 6.9, 2.9 Hz, 
1H), 1.48 (d, J =  5.9 Hz, 3H), 0.64 (d, J =  7.1 Hz, 3H), 0.10 (d, J  = 6.8 Hz, 3H); 13C 
NMR (126 MHz, CDC13) 6 171.6, 153.9, 138.7, 128.5, 128.3, 128.2, 82.7, 75.3, 63.4,




A 20-mL scintillation vial was equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet. The vial was charged with dichloromethane (4 mL) and hemiketal 
202c (29 mg, 0.09 mmol) then cooled to -78 °C in a dry ice-acetone bath. Triethylsilane 
(0.06 mL, 0.35 mmol) and boron trifluoride diethyl etherate (0.03 mL, 0.26 mmol) were 
added in order then stirred at -78 °C for 1 h. The reaction was quenched with saturated 
sodium bicarbonate (5 mL) and extracted with dichloromethane (3 x 5mL). The organic 
layers were pooled, dried over anhydrous sodium sulfate, gravity-filtered, and 
concentrated to afford a clear oil. The crude product was purified by flash 
chromatography on silica, eluting with a mobile phase of 15% ethyl acetate in hexane (R f 
= 0.17) to yield 19 mg (69%) of a mixture of isomers of tetrahydrofuran 203c as a 
colorless oil. 'H NMR (500 MHz, C6D6) 5 4.66 -  4.10 (m, 5H), 3.95 -  3.74 (m, 3H), 3.39 
-  3.33 (m, 2H), 3.22 -  3.16 (m, 2H), 2.29 -  2.16 (m, 2H), 2.10 (m, 1H), 1.95 -  1.65 (m,
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5H), 1.57 -  1.53 (m, 2H), 1.41 -  1.35 (m, 2H), 1.34 (d, J - 6.0 Hz, 3H), 1.29 -  1.25 (m, 
8H), 1.22-1.14 (m, 3H), 0.86 -  0.83 (m, 6H), 0.63 -  0.59 (m, 3H), 0.54 -  0.50 (m, 4H), 
0.41 -  0.37 (m, 6H); 13C NMR (126 MHz, CDCb) 5 174.5, 173.7, 172.5, 154.0, 95.3,
83.4, 82.7, 80.8, 75.5, 75.0, 74.7, 62.6, 58.9, 58.3, 50.1, 48.9, 47.4, 38.8, 38.2, 37.1, 36.0,
35.4, 33.0, 32.3, 28.7, 27.1, 26.4, 23.0, 21.3, 20.6, 17.9, 17.6, 14.6, 14.3; IR (neat) v 
2960, 2930, 2872, 1777, 1696, 1464, 1385, 1300, 1203 c m 1.
(S)-l((Benzyk>xy)carbonyI)pyrrolidine-2-carboxyIic acid (205)
L-Proline (5.76 g, 50 mmol) was dissolved in aqueous 2 M NaOH (45 mL) and cooled to 
0°C. Benzylchloroformate (8 mL) was added dropwise in five portions alternating with 2 
M NaOH ( 5 x 4  mL). The solution was then allowed to stir at 0°C for one h then at room 
temperature overnight. The reaction mixture was washed with diethyl ether (3 x 20 mL) 
then acidified to pH = 2 with 3M HC1. The solution was then extracted with ethyl acetate 
(5 x 20 mL). The organic layers were washed with H20 , dried over Na2SC>4, filtered, and 
concentrated under vacuum (30 mmHg, then 1 mmHg). The title compound 205 was 
isolated as a clear, colorless oil as a mixture of rotamers (12.20 g, 98% yield) ‘H NMR 
(500 MHz, CDCb): 5 = 11.56 (br s, 2H), 7.37 -  7.25 (m, 10 H), 5.20 (d, J  = 12.4 Hz, 
1H), 5.14 (d, J =  12.4 Hz, 3H), 4.43 (dd, J =  8.9, 3.7 Hz, 1H), 4.37 (dd, J =  8.9, 3.7 Hz, 
1H), 3.65 -  3.57 (m, 2H), 3.55 -  3.42 (m, 2H), 2.29 (m, 1H), 2.22 -  2.14 (m, 2H), 2.10 
(m, 1H), 2.03 -  1.84 (m, 4H); 13C NMR (100 MHz, CDCb) S 178.4, 176.9, 155.8, 154.5, 
136.5, 136.4, 128.6, 128.5, 128.2, 128.03, 127.97, 127.7, 67.6, 67.2, 59.3, 58.7, 47.0,




An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with Cbz-proline 205 (2.50 
g, 10 mmol) and dichloromethane (11 mL) then cooled to 0 °C in an ice-water bath. N,N- 
dicyclohexylcarbodiimide (2.06 g, 10 mmol), Meldrum’s acid (1.44 g, 10 mmol), and 4- 
dimethylaminopyridine (1 . 2 2  g, 1 0  mmol) were added to the flask and allowed to stir at 
room temperature for 18 h. The reaction mixture was filtered and concentrated under 
vacuum to afford the title compound as a yellow oil (4.28 g, 8 6 %). The product was 
carried on without further purification. ]H NMR (500 MHz, CDCI3) 5 8.20 (d, J -  7.4 Hz, 
2H), 7.18 (m, 2H), 7.13 (m, 2H), 7.07 (m, 1H), 6.55 (d, J =  7.5 Hz, 2H), 5.61 (dd, 8.7,
3.4 Hz, 1H), 5.07 (d, 12.9 Hz, 1H), 4.92 (d, J -  12.9 Hz, 1H), 3.65 (m, 1H), 3.57 (m,
1H), 3.16 (s, 6 H), 2.48 (m, 1H), 1.97 (m, 1H), 1.88 -  1.81 (m, 3H), 1.61 (s, 6 H); ,3C 
NMR (126 MHz, CDC13) 6  196.4, 166.4, 156.9, 155.5, 141.6, 137.4, 128.5, 128.2, 127.3,
127.2, 127.1, 106.4, 101.2, 87.3, 66.1, 64.5, 48.0, 40.0, 31.8, 26.5, 26.4, 23.1; IR (neat) v 
3468, 2937, 1694, 1641, 1601, 1556, 1387, 1320, 1206 cm'1.
(5)-BenzyI 2-(3-((S)-4-isopropyl-2-oxooxazolidin-3-yl)-3-oxopropanoyl)pyrrolidine-
1-carboxylate (207)
A 100-mL round-bottomed flask equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet was charged with DMAP salt 206 (3.96 g, 8  mmol) and 
dichloromethane (60 mL)./?-Toluenesulfonic acid (2.07 g, 12 mmol) was added to the
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flask along with 4 A molecular sieves. The reaction was stirred at room temperature for 1 
h before being diluted with diethyl ether (40 mL) and cooled to 0 °C in an ice-water bath. 
The solution was filtered then concentrated by rotary evaporation. The residue was 
dissolved in toluene (60 mL). Chiral oxazolidinone 199 (1.04 g, 8 mmol) was added to 
the solution along with 4 A molecular sieves. The solution was heated to reflux for 2.5 h. 
The reaction mixture was then cooled to room temperature, filtered, and concentrated via 
rotary evaporation to yield a yellow oil. The crude product was purified by flash column 
chromatography on silica, eluting with a mobile phase of 20% ethyl acetate in hexane (Rf 
= 0.16) to afford the title compound as a clear oil, as a mixture o f carbamate rotamers 
(1.80 g, 56%). 'H NMR (500 MHz, CDCb) 5 7.37 -  7.29 (m, 10H), 5.20 - 5.06 (m, 4H),
4.47 -  4.46 (m, 3H), 4.40 (dd, 8.7, 4.3 Hz, 1H), 4.29, (t, J =  8.9 Hz, 2H), 4.22 (m, 
4H), 4.10, 4.05 (ABq, J  = 16.9 Hz, 2H), 3.65 -  3.48 (m, 4H), 2.49 -  2.39 (m, 2H), 2.31 -
2.22 (m, 2H), 2.20 -  2.16 (m, 1H), 2.12 -  2.03 (m, 1H), 2.02 -  1.93 (m, 2H), 1.91 -  1.84 
(m, 2H), 0.94 -  0.91 (m, 12H); 13C NMR (126 MHz, CDC13) 6 203.4, 203.3, 166.5, 166.3
155.4, 154.5, 154.3, 154.2, 136.6, 136.3, 128.6, 128.5, 128.3, 128.13, 128.06, 127.9, 68.6,
67.4, 67.2, 65.4, 65.2, 63.6, 63.2, 58.5, 48.4, 47.8, 47.4, 46.9, 32.6, 29.6, 28.4, 28.3, 24.4,




An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (9
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mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.11 mL, 1.1 mmol) was 
added to the flask followed by the dropwise addition of diiodomethane (0.09 mL, 1.1 
mL) via syringe. The solution was stirred at 0 °C for 10 min before the addition of 
pivaldehyde (0.07 mL, 0.66 mmol) and p-keto imide 207 (177 mg, 0.44 mmol). The 
reaction was stirred for 1 h before being quenched with saturated ammonium chloride (2 
mL) and diluted with saturated sodium chloride (10 mL). The aqueous layer was 
extracted with dichloromethane ( 3 x 1 0  mL). The organic layers were pooled, dried over 
anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to afford a 
viscous yellow oil. The crude product was purified by flash chromatography on silica, 
eluting with a mobile phase of 20% ethyl acetate in hexane (R f = 0.14) to yield 84 mg 
(38%) of hemiketal 215 as a colorless oil. 'H NMR (500 MHz, CDC13) 5 7.36 -  7.28 (m, 
5H), 5.16 -  5.10 (m, 2H), 4.51 -  4.40 (m, 2H), 4.30 -  4.06 (m, 4H), 3.61 (br s, 1H), 3.36 
(m, 1H), 2.51 -  2.13 (m, 4H), 1.99 -  1.75 (m, 3H), 0.92 -  0.85 (m, 15H); 13C NMR (126 
MHz, CDCb) 153.5, 136.8, 128.6, 128.0, 107.4, 91.9, 90.1, 67.2, 63.30, 63.28, 58.74, 
58.71, 47.7, 34.4, 28.7, 27.7, 26.0, 25.4, 18.2, 18.0, 14.9; IR (neat) v cm’1.
(5)-BenzyI 2-((2J?,4J?,55)-5-(/ert-butyI)-4-((,S')-4-isopropyI-2-oxooxazolidine-3-
carbonyl)tetrahydrofuran-2-yI)pyrro!idine-l-carboxylate (216)
An oven-dried, 10-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. Dichloromethane (5 mL) and hemiketal 215 (81 
mg, 0.16 mmol) were added to the flask and cooled to -78 °C in a dry ice-acetone bath. 
Triethylsilane (0.10 mL, 0.64 mmol) and boron trifluoride diethyl etherate (0.06 mL, 0.48 
mmol) were added to the solution in that order and allowed to stir at -78 °C for 1 h. The
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reaction was quenched with saturated sodium bicarbonate (2 mL). The aqueous layer was 
extracted with dichloromethane ( 3 x 5  mL). The organic layers were pooled, dried over 
anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation (20 mmHg, 20 
°C) to afford a a yellow oil. The crude product was purified by flash chromatography on 
silica, eluting with a mobile phase of 25% ethyl acetate in hexane (R f = 0.20) to yield 51 
mg (69%) of substituted tetrahydrofuran 216 as a clear oil. 'H NMR (400 MHz, CDCb) 5
7.38 -  7.29 (m, 5H), 5.19 -  5.06 (m, 2H), 4.44 (m, 1H), 4.26 (t, J =  9.0 Hz, 1H), 4.23 -
4.09 (m, 4H), 4.01 (d, J  = 6.6 Hz, 1H), 3.58 (m, 1H), 3.39 (m, 1H), 2.33 (septet of 
doublets, J=  6.8, 3.1 Hz, 1H), 2.18 -  1.78 (m, 6H), 0.91 (d, J=  7.1 Hz, 3H), 0.88 (s, 9H), 
0.85 (d, J =  7.0 Hz, 3H); 13C NMR (100 MHz, CDC13) 6 186.7, 174.0, 153.8, 137.1
128.5, 128.0, 127.9, 89.6, 80.9, 66.9, 63.1, 58.6, 47.4, 43.5, 42.5, 34.8, 33.9, 28.5, 28.3,
25.8, 18.1, 14.7; IR (neat) v cm'1.
(*S)-l-tosyIpyrrolidine-2-carboxylic acid (217)
A 100-mL round-bottomed flask was charged with L-proline (2.31 g, 20 mmol) and 2M 
sodium hydroxide (20 mL) then cooled to 0 °C in an ice-water bath. /?-Toluenesulfonyl 
chloride (4.03 g, 20 mmol) dissolved in diethyl ether (20 mL) was slowly added to the 
round-bottomed flask then allowed to stir at room temperature for 18 h. The aqueous 
layer was extracted with diethyl ether (4 x 20 mL). The combined organics were then 
dried over magnesium sulfate, filtered, and concentrated under vacuum to afford the title 
compound 217 as a white solid (4.68 g, 94%). The product was used without further 
purification, (m.p. 75 -  79 °C); 'H NMR (500 MHz, CDC13) 5 7.78 -  7.76 (m, 2H), 7.36 
-  7.34 (m, 2H), 4.27 (dd, J =  8.4, 3.7 Hz, 1H), 3.53 (ddd, J =  9.8, 6.6, 3.9 Hz, 1H), 3.26
137
(m, 1H), 2.45 (s, 3H), 2.16 (m, 1H), 2.00 -  1.90 (m, 2H), 1.76 (m, 1H); 13C NMR (126 
MHz, CDC13) 8  175.5, 144.3, 134.2, 130.0, 127.8, 60.6, 49.1, 30.6, 24.8, 21.7; IR(neat) v 
3561, 3480, 3315, 2966, 2899, 26.11, 2534, 1742, 1688, 1624, 1597, 1331, 1154, 1135 
cm"1.
(l//-Benzof«/][l,2,3]triazol-l-yl)((5)-l-tosyIpyrrolidin-2-yl)methanone (218)
Into an oven-dried, 100-mL round-bottomed flask, equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet, lH-l,2,3,-benzotriazole (7.15 g, 60 mmol) and 
anhydrous dichloromethane (75 mL) were mixed. Thionyl chloride (1.1 mL, 15 mmol) 
was added to the solution via syringe and allowed to stir for 30 min. (S)-l- 
tosyIpyrrolidine-2-carboxylic acid (217) was added to the flask turning the solution from 
yellow to clear. After stirring for 2 h the resulting white reaction mixture was filtered. 
The filtrate was washed with 2M sodium hydroxide (3 x 7 5  mL) then dried over 
magnesium sulfate, filtered and concentrated via rotary evaporation (20 mmHg, 20 °C) to 
afford 4.07 g (73%) of the title compound as a white solid, (m.p. 203.3 -  204.6); !H 
NMR (400 MHz, C D C I3 )  8  8.32 (m, 1H), 8.16 (dt, J =  8.3, 0.9 Hz, 1H), 7.88 -  7.78 (m, 
2H), 7.70 (ddd, J  = 8.2, 7.1, 1.0 Hz, 1H), 7.55 (ddd, J =  8.2, 7.1, 1.0 Hz, 1H), 7 .37-7 .34  
(m, 2H), 5.81 (dd, J=  9.0, 4.4 Hz, 1H), 3.72 (ddd, J =  9.6, 7.1, 5.1 Hz, 1H), 3.43 (dt J  =
9.6, 7.0 Hz, 1H), 2.44 (s, 3H), 2.38 (m, 1H), 2.23 -  2.04 (m, 2H), 1.85 (dtt, J=  12.4, 7.1,
5.0 Hz, 1H); 13C NMR (126 MHz, C D C I 3 )  8  170.6, 146.1, 144.0, 134.8, 131.3, 130.8,
129.9, 129.8, 127.6, 126.6, 120.3, 114.6, 60.6, 49.0, 31.9, 24.9, 21.6; IR (neat) 3099, 




An oven-dried, 250-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dry tetrahydrofuran 
(150 mL) and cooled to 0 °C in an ice-water bath. Diisopropylamine (2.8 mL, 20 mmol) 
was added, followed by the slow addition of 2.5M n-butyl lithium (8 mL, 20 mmol). The 
solution was stirred for 15 min to allow for formation of lithium diisopropylamine 
(LDA), then cooled to -78 °C in a dry ice-acetone bath. Acylated oxazolidinone 219 (3.71 
g, 20 mmol) was dissolved in tetrahydrofuran (20 mL) then slowly added to the LDA 
solution via syringe pump over 100 min. Benzotriazole-activated proline 218 (3.71 g, 10 
mmol) was dissolved in tetrahydrofuran (40 mL) and added to the reaction mixture then 
allowed to stir at -78 °C for 1 h. The reaction was quenched with 3M hydrochloric acid 
(10 mL) then extracted with ethyl acetate (3 x 20 mL). The organic layers were pooled, 
dried over anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation to 
afford a viscous yellow oil. The crude product was purified by flash chromatography on 
silica, eluting with a mobile phase of 40% ethyl acetate in hexane (Rf = 0.28) to yield |3- 
keto imide 120 (1.93 g, 46%) as a light yellow, viscous oil. 'HNMR (500 MHz, CDCb) 8 
7.72 (d, J=  8.6 Hz, 2H), 7.34 (d, J=  8.0 Hz, 2H), 4.58 (d, 17.3 Hz, 1H), 4.48 (dt, J  =
8.2, 3.7 Hz, 1H), 4.33 (m, 1H), 4.30 (d, J =  8.7 Hz, 1H), 4.23 {dd, J  = 9.1, 3.0 Hz, 1H), 
4.14 (m, 1H), 3.54 (ddd, J =  10.3, 7.3, 5.0 Hz, 1H), 3.27 (dt, 9.8, 7.6 Hz, 1H), 2.50 
(septet of doublets, J =  7.2, 3.6 Hz, 1H), 2.44 (s, 2H), 2.24 (m, 3H), 1.88 (ddd, J =  15.2,
10.5, 7.2 Hz, 1H), 1.67 (m, 1H), 1.53 (m, 1H), 0.95 (d, J -  6.7 Hz, 6H); 13C NMR (126 
MHz, CDCI3) 5 204.2, 166.8, 154.3, 144.1, 133.6, 129.9, 127.8, 67.3, 63.7, 58.5, 49.6,
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48.4, 29.0, 28.3, 24.6, 21.6, 17.9, 14.5; IR (neat) v 2965, 1774, 1724, 1699, 1389, 1334, 
1211, 1158 c m 1.
(45)-3-((25',37?)-2-(te/'t-Butyl)-5-hydroxy-5-((.Sr)-l-tosylpyrrolidin-2- 
yI)tetrahydrofuran-3-carbonyl)-4-isopropylixazolidin-2-one (220)
An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (15 
mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.15 mL, 1.5 mmol) was 
added to the flask, followed by the slow addition of diiodomethane (0.12 mL, 1.5 mmol) 
via syringe. The resulting solution was stirred for 10 min before adding pivaldehyde 
(0.07 mL, 0.6 mmol) then |3-keto imide 120 (212 mg, 0.5 mmol). The reaction was stirred 
at 0 °C for an additional 1 h before being quenched with saturated ammonium chloride (5 
mL). The aqueous layer was extracted with dichloromethane ( 3 x 5  mL). The organic 
layers were pooled, dried over anhydrous sodium sulfate, vacuum filtered, and 
concentrated by rotary evaporation to afford a yellow solid. The crude product was 
purified by flash chromatography on silica, eluting with a mobile phase of 25% ethyl 
acetate in hexane (R f = 0.13) to yield 155 mg (59%) of the title hemiketal 220 as a clear 
oil. Data reported for the major isomer: 'H NMR (500 MHz, C D C I 3 )  6 7.74 -  7.71 (m, 
2H), 7.33 -  7.28 (m, 2H), 4.68 (m, 1H), 4.54 (m, 1H), 4.34 (t, J =  9.2 Hz, 1H), 4.23 (m, 
1H), 4.07 -  4.02 (m, 2H), 3.46 -  3.34 (m, 2H), 2.92 (ddd, J  = 13.9, 11.3, 2.3 Hz, 1H),
2.43 (s, 3H), 2.32 (m, 1H), 2.18 (m, 1H), 2.05 -  1.93 (m, 2H), 1.44 -  1.34 (m, 2H), 0.94 -  
0.91 (m, 12H), 0.87 -  0.86 (m, 3H); 13C NMR (126 MHz, C D C I 3 )  5179.4, 153.4, 143.7,
140
135.0, 129.8, 127.7, 107.1, 91.2, 64.0, 63.3, 58.7, 49.9, 40.9, 40.0, 34.6, 28.7, 26.7, 25.4,
24.6,21.6, 18.0, 14.9; IR (neat) v 2962, 1777, 1698, 1667, 1387, 1341, 1201, 1159 cm'1.
(5)-3-((2S,3i?,5i?)-2-(fert-butyl)-5-((5)-l-tosylpyrrolidin-2-yl)tetrahydrofuran-3- 
carbonyl)-4-isopropyloxazolidin-2-one (222)
A 20-mL scintillation vial was equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet. The vial was charged with hemiketal 220 (95 mg, 0.18 mmol) in 
dichloromethane ( 6  mL). The vial was cooled to -78 °C in a dry ice-acetone bath. Once 
cooled, triethylsilane (0.12 mL, 0.74 mmol) and boron trifluoride diethyl etherate (0.07 
mL, 0.54 mmol) were added to the solution in order. The reaction was stirred at -78 °C 
for 45 min before being warmed to room temperature and quenched with saturated 
sodium bicarbonate (3 mL). The aqueous layer was extracted with diethyl ether ( 3 x 4  
mL). The organic layers were pooled, washed with saturated sodium chloride, dried over 
anhydrous magnesium sulfate, filtered, and concentrated by rotary evaporation to afford a 
single diastereomer as a white solid. The crude product was purified by preparative thin 
layer chromatography, eluting with a mobile phase of 1:2 hexane — diethyl ether (R f =  
0.43) to yield 22 mg (24%) of the title tetrahydrofuran 222 as a white solid, (m.p. 147.6 -
148.0 °C); ]H NMR (500 MHz, C6D6) 6  7.70 (d, J  = 8.1 Hz, 2H), 6.79 (d, J  = 8.0 Hz, 
2H), 4.77 (ddd, J =  9.9, 6.3, 3.9 Hz, 1H), 4.61 (ddd, J = 11.2, 7.1, 4.2 Hz, 1H), 4.49 (d, J  
= 7.1 Hz, 1H), 4.00 (dt, J=  8.3, 3.4 Hz, 1H), 3.95 (dt, J=  8.7, 4.5 Hz, 1H), 3.44 (dd, J  =
9.1.3.0 Hz, 1H), 3.37 (t, J  = 8.3 Hz, 1H), 3.27 -  3.18 (m, 2H), 2.53 (ddd, J =  12.7, 10.8,
9.4 Hz, 1H), 2.21 -  2.13 (m, 2H), 1.90 (s, 3H), 1.65 (m, 1H), 1.45 (tt, J =  13.8, 7.0, 1H), 
1.33 (tdt, J  = 12.8, 8.0, 8.0 Hz, 1H), 1.04 (s, 9H), 0.97 (m, 1H), 0.56 (d, J =  6.9 Hz, 3H),
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0.45 (d, J  = 7.0 Hz, 3H); 13C NMR (126 MHz, C6H6) 5 175.2, 154.0, 142.9, 135.6, 129.7,
128.2, 90.0, 80.9, 62.7, 60.9, 58.5, 50.3, 42.9, 34.5, 34.2, 28.6, 27.6, 26.1, 24.8, 21.1,
17.7, 14.5; IR (neat) v 2958, 2873, 1774, 1694, 1386, 1342, 1203, 1159 cm 1.
(S)-2-(l,3-Dioxoisoindolin-2-yl)-3-phenylpropanoic acid (225)U1 
A 50-mL, round-bottomed flask, equipped with a reflux condenser, and Dean-Stark trap 
was charged with toluene (30 mL). L-Phenylalanine (3.31 g, 20 mmol), phthalic 
anhydride (2.96 g, 20 mmol), and triethylamine (0.26 mL, 1.9 mmol) were added to the 
flask and heated at reflux for 2 h. The reaction was allowed to cool to room temperature 
before removing the volatile solvents via rotary evaporation. The crude solid was 
triturated from cold water (40 mL) and concentrated HC1 (0.4 mL) then recrystallized 
from ethyl acetate (12 mL) and water ( 8  mL) to afford the title compound as a crystalline 
white solid (5.44 g, 92%). (m.p. 181.2 -  181.7 °C, Lit. 183 -  185 °C)in ; !H NMR (500 
MHz, CDC13) 5 7.80-7.76 (m, 2H), 7.70-7.66 (m, 2H), 7.21-7.12 (m, 5H), 5.23 (dd, J  =
8.9, 7.7 Hz, 1H), 3.59 (d, J =  8 . 6  Hz, 2H); 13C NMR (126 MHz, CDCb) 5 174.8, 167.5,
136.5, 134.3, 131.6, 128.9, 128.7, 127.1, 123.7, 53.2, 34.5; IR (neat) 3252, 2925, 2871, 
1771, 1742, 1693, 1394, 1217, 1199, 1100 cm'1.
2-((S)-l-(l/f-Benzo[<f][l,2,3]triazoI-l-yl)-l-oxo-3-phenylpropan-2-yl)isoindoline-l,3- 
dione (230)
An oven-dried, 100-mL round-bottomed flask, equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet, was charged with dichloromethane and cooled to 0 °C in 
an ice-water bath. lH-l,2,3,-Benzotriazole (3.81 g, 32 mmol) was added to the flask
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followed by thionyl chloride (1.1 mL, 15 mmol). The resulting yellow solution was 
allowed to stir for 30 min. Compound 225 was added to the flask turning the solution 
clear. After stirring for 5 h the reaction was quenched with 2M sodium hydroxide (40 
mL). The organic layer was washed with 2M sodium hydroxide (2 x 40 mL) then dried 
over sodium sulfate, filtered and concentrated via rotary evaporation (20 mmHg, 20 °C) 
to afford 3.22 g (100%) of the title compound as a white solid. (Rf = 0.44, 1:1 hexane -  
ethyl acetate); (m.p. 109.3-112.0 °C); 'H NMR (400 MHz, CDCb) 5 8.28 (d, J =  8.2 Hz, 
1H), 8.08 (d, J=  8.2 Hz, 1H), 7.78 -  7.76 (m, 2H), 7.67-7.64 (m, 3H), 7.49 (t, J=  7.7 Hz, 
1H), 7.37 (d, J =  7.3 Hz, 2H), 7.24 (t, J  -  7.5 Hz, 2H), 7.19-7.16 (m, 1H), 6.39 (dd, J  =
10.1, 5.5 Hz, 1H), 3.90-3.80 (m, 2H); 13C NMR (100 MHz, CDCb) 5 167.35, 167.30,
145.8, 136.1, 134.3, 131.5, 131.3, 130.9, 129.3, 128.7, 127.2, 126.6, 123.7, 120.4, 114.5, 
55.1,35.0; IR (neat) 3065, 1776, 1743, 1713, 1381, 1365 cm'1.
2-((5)-5-((5)-4-Isopropyl-2-oxooxazolidin-3-yl)-3,5-dioxo-l-phenylpentan-2- 
yl)isoindoline-l,3-dione (231)
An oven-dried, 100-mL, round-bottomed flask equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet was charged with tetrahydrofuran (30 mL) and cooled to 0 
°C in an ice-water bath. Diisopropylamine (0.42 mL, 3 mmol) was added to the flask 
followed by the slow addition of 2.5M w-butyllithium (1.2 mL, 3 mmol). The solution 
was stirred for 15 min, forming lithium diisopropylamine (LDA), then cooled to -78 °C 
in a dry ice-acetone bath. A solution of acylated oxazolidinone 218 (523 mg, 3 mmol) in 
tetrahydrofuran (10 mL) was added to the LDA solution via syringe pump over 30 min. 
Benzotriazole-activated carboxylic acid 230 (595 mg, 1.5 mmol) was dissolved in
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tetrahydrofuran (10 mL) and added to the enolate solution. The reaction was stirred at -78 
°C for 30 min before being quenched with 1M hydrochloric acid (10 mL). The aqueous 
layer was extracted with ethyl acetate (3 x 10 mL). The organic layers were pooled, 
washed with saturated sodium chloride (50 mL), dried over anhydrous sodium sulfate, 
filtered, and concentrated by rotary evaporation to afford a yellow oil. The crude product 
was purified by flash chromatography on silica, eluting with a mobile phase of 40% ethyl 
acetate in hexane (Rf = 0.21) to yield 200 mg (30%) of the title |3-keto imide as a white 
solid (m.p. 148.6 -  149.2 °C). 'H NMR (500 MHz, CDC13) 5 7.79 -  7.76 (m, 2H), 7.71 -  
7.66 (m, 2H), 7.19 -  7.09 (m, 5H), 5.33 (dd, J =  11.4, 5.2 Hz, 1H), 4.47 (dt, J =  8.4, 3.1 
Hz, 1H), 4.30 (t, J =  9.1 Hz, 1H), 4.22 (dd, J =  9.1, 3.1 Hz, 1H), 4.18, 4.05 (ABq, J  =
16.5 Hz, 2H), 3.55 (dd, J  = 14.3, 5.2 Hz, 1H), 3.47 (dd, J =  14.3, 11.5 Hz, 1H), 2.41 
(septet of doublets, J =  7.0, 3.1 Hz, 1H), 0.91 (d, J =  7.0 Hz, 3H), 0.86 (d, J =  6.9 Hz, 
3H); n C NMR (126 MHz, CDC13) 5 198.1, 167.6, 165.9, 154.4, 136.5, 134.4, 131.6,
129.0, 128.7, 127.0, 123.7, 63.8, 60.0, 58.5, 48.3, 33.6, 28.3, 18.0, 14.7; IR (neat) v 2966, 
1774, 1711, 1383, 1330, 1211 cm 1.
2-((15)-l-((4i?,55)-5-(^r/-Butyl)-2-hydroxy-4-((5)-4-isopropyl-2-oxooxazolidine-3- 
carbonyl)tetrahydrofuran-2-yl)-2-phenylethyl)isoindoline-l,3-dione (232)
An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane ( 8  
mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.13 mL, 1.28 mmol) was 
added to the flask followed by the slow addition of diiodomethane (0.10 mL, 1.28 mmol). 
The resulting solution was stirred for 10 min before the addition of pivaldehyde (0.07
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mL, 0.65) and p-keto imide 231 (192 mg, 0.43 mmol) in order. The reaction was stirred 
for an additional 2 h at 0 °C before being quenched with saturated ammonium chloride 
(10 mL). The aqueous layer was extracted with ethyl acetate (3 x 20 mL). The organic 
layers were pooled, dried over anhydrous sodium sulfate, vacuum-filtered, and 
concentrated by rotary evaporation to afford an off white oil. The crude product was 
purified by flash chromatography on silica, with a mobile phase of 35% ethyl acetate in 
hexane to yield 28 mg (12%) of hemiketal 232 as a mixture of isomers. (Rf = 0.42, 1:1 
hexane -  ethyl acetate); 'H NMR (500 MHz, CDCb) Data reported for the major 
diastereomer: 5 7.82 (d, J=  7.1 Hz, 1H), 7.70 -  7.64 (m, 3H), 7.18 -  7.05 (m, 5H), 5.29 
(br s, 1H), 4.73 (dd, J=  11.9, 4.3 Hz, 1H), 4 .50 -4 .47  (m, 2H), 4.30 -  4.18 (m, 3H), 3.49 
(dd, J  = 14.3, 12.0 Hz, 1H), 3.13 (dd, J=  14.3, 4.4 Hz, 1H), 2.60 (ddd, J  13.5, 11.9, 1.7 
Hz, 1H), 2.36 (septet of doublets, J  = 6.9, 3.2 Hz, 1H) 2.11 (dd, J =  13.6, 4.3 Hz, 1H), 
0.91 (d, J  = 7.0 Hz, 3H), 0.86 (d, J  -  6.9 Hz, 3H), 0.81 (s, 9H); 13C NMR (126 MHz, 
CDCb) All resonances: 5 174.5, 170.8, 167.6, 153.7, 137.2, 134.1, 134.0, 131.6, 131.2,
128.9, 128.8, 128.5, 128.4, 126.6, 123.5, 123.2, 105.0, 91.1, 87.5, 63.2, 59.6, 58.7, 42.8,
42.7, 33.9, 33.7, 29.7, 28.3, 25.9, 25.5, 18.0, 14.6; IR (neat) v 2964, 1777, 1713, 1385, 
1208, 1059 cm 1.
2-((5)-l-((2i?,4ii,55)-5-(/ert-Butyl)-4-((5)-4-isopropyl-2-oxooxazolidine-3- 
carbonyl)tetrahydrofuran-2-yl)-2-phenylethyl)isoindoline-l,3-dione (233)
A 20-mL scintillation vial equipped with a small magnetic stir bar, rubber septum, and 
nitrogen gas inlet was charged with hemiketal 232 (7 mg, 0.01 mmol) in dichloromethane 
(1 mL). The vial was cooled to -78 °C in a dry ice-acetone bath. Triethylsilane (0.01 mL,
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0.04 mmol) and boron trifluoride diethyl etherate (0.01 mL, 0.03 mmol) were added to 
the vial in sequence and allowed to stir for 45 min. The reaction was quenched with 
saturated sodium bicarbonate and extracted with diethyl ether ( 3 x 4  mL). The organic 
layers were pooled, washed with saturated sodium chloride, dried over anhydrous 
magnesium sulfate, filtered, and concentrated by rotary evaporation to afford a clear 
residue. The crude product was purified by thin layer chromatography, eluting with a 1:1 
ethyl acetate -  hexane solution to yield the title compound as a colorless residue (1.9 mg, 
36%). 'H NMR (500 MHz, CDC12) 5 7.41 -  7.29 (m, 2H), 7 .21-7 .17  (m, 2H), 6.99 (dd, 
J=  8.3, 7.0 Hz, 2H), 6.91 -  6.85 (m, 1H), 6.71 (dd, J =  5.5, 3.0 Hz, 2H), 5.06 (td, J=  9.2,
6.1 Hz, 1H), 4.83 (ddd, J=  12.0, 8 .8 , 4.8 Hz, 1H), 4.69 (ddd, J  = 10.6, 6.5, 3.8 Hz, 1H), 
4.36 (d, J =  6.5 Hz, 1H), 3.98 (dt, J=  8 .6 , 3.4 Hz, 1H), 3.63 (d d ,/=  13.9, 11.9 Hz, 1H),
3.38 (dd, J=  9.1, 3.2 Hz, 1H), 3.26 (t, J =  8 . 8  Hz, 1H), 2.85 (dd, J  = 13.9, 4.8 Hz, 1H), 
2.23 -  1.98 (m, 3H), 0.95 (s, 9H), 0.49 (d, J=  6.9 Hz, 3H), 0.39 (d, J=  7.0 Hz, 3H); 13C 
NMR (126 MHz, CDC13) 5 175.0, 168.5, 153.9, 137.5, 133.8, 131.9, 129.0, 128.6, 126.7,
123.2, 89.3, 63.2, 58.6, 57.0, 43.2, 37.0, 34.3, 33.9, 29.9, 28.4, 25.8, 18.1, 14.7; IR (neat) 
v 2959, 1776, 1710, 1468, 1382, 1234, 1207, 1104 cm'1.
2-(/V-(4-Methoxybenzyl)-7V-tosylamino)acetic acid (234)
A 100-mL round-bottomed flask was charged with methyl ester 187 (2.64 g, 12.6 mmol) 
in 2M sodium hydroxide (25 mL). The solution was cooled to 0 °C in an ice-water bath 
and /?-toluenesulfonyl chloride (2.41 g, 12.6 mmol), dissolved in diethyl ether (13 mL), 
was slowly added. The reaction was stirred for 6  h before removing the ether layer. The 
remaining aqueous layer was washed with diethyl ether ( 2 x 1 0  mL) and acidified with
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3M hydrochloric acid to pH 2. The acidified aqueous layer was extracted with diethyl 
ether (3 x 30 mL). The organic layers were pooled, dried over anhydrous sodium sulfate, 
filtered, and concentrated by rotary evaporation to afford the carboxylic acid as a white 
solid (1.01 g, 23 %). (R f = 0.23, 1:1 hexane -  ethyl acetate); (m.p. = 136.8 -  137.8 °C); 
'H NMR (400 MHz, CDC13) 5 7.82 -  7.74 (m, 2H), 7.37 -  730 (m, 2H), 7.18 -  7.11 (m, 
2H), 6.89 -  6.80 (m, 2H), 4.40 (s, 2H), 3.91 (s, 2H), 3.80 (s, 3H), 2.45 (s, 3H); 13C NMR 
(126 MHz, CDCI3) 6  173.1, 159.6, 143.7, 136.7, 130.1, 129.7, 127.5, 126.6, 114.2, 55.3, 
50.9,46.2,21.6; IR (neat) v 2920, 2841, 1725, 1712, 1610, 1512, 1442, 1331, 1238 cm 1.
2-(7V-(4-methoxybenzyl)-./V-tosyIamino)-l-(l//-benzo[</][l,2,3]triazole-l-yl)ethanone
(235)
A dry, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, rubber 
septum, and.nitrogen gas inlet. The flask was charged with dichloromethane (12.5 mL) 
and l//-benzotriazole (0.91 g, 7.6 mmol) and cooled to 0 °C in an ice-water bath. 
Thionyl chloride (0.14 mL, 1.9 mmol) was added to the solution and stirred at 0 °C for 30 
min. Carboxylic acid 234 (0.66 g, 1.9 mmol) was added as a solid and stirred for 2 h. The 
reaction mixture was filtered and washed with 2M sodium hydroxide (3 xlO mL). The 
organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated by 
rotary evaporation to yield 0.81 g (94%) of the title compound as a white soild. 'H NMR 
(400 MHz, C C D C I3 )  8  8.17 (dd, J  = 8.3, 0.9 Hz, 1H), 8.10 (dd, J=  8.3, 0.9 Hz, 1H), 7.84 
(d, J=  8.2 Hz, 2H), 7.67 (m, 1H), 7.52 (ddd, J  = 8.2, 7.1, 1.0 Hz, 1H), 7.34 (dd, J=  7.8, 
0.9 Hz, 2H), 7.12 ( d , J -  8 . 6  Hz, 2H), 6.75 (d, J -  8.4 Hz, 2H), 5.00 (s, 2H), 4.55 (s, 2H), 
3.71 (s, 3H), 2.45 (s, 3H); l3CNMR (100 MHz, 167.4, 159.7, 146.0, 143.9, 136.8, 131.0,
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130.8, 130.2, 129.9, 127.7, 126.6, 126.5, 120.4, 114.32, 114.28,55.3,51.5,48.4,21.7; IR 
(neat) v 2930, 1611, 1597, 1513, 1304, 1250, 1153, 1091 cm'1.
(S)-fV-(4-(4-Isopropyl-2-oxooxazolidin-3-yl)-2,4-dioxobutyl)-lV-(4-inethoxybenzyl)-4- 
methylbenzenesulfonamide (236)
An oven-dried, 100-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane (20 
mL), benzotriazole-activated acid 235 (0.80 g, 1.8 mmol), and magnesium bromide 
diethyl etherate (0.42 g, 1.6 mmol). Acylated oxazolidinone 218 (0.26 g, 1.5 mmol) was 
added to the solution followed by the addition of Hunig’s base (0.35 mL, 2mmol). The 
reaction was allowed to stir for 18 h before the addition of IN hydrochloric acid (10 mL). 
The solution was stirred for an additional 5 min before being extracted with 
dichloromethane (3 x 10 mL). The organic layers were pooled, washed with saturated 
sodium bicarbonate (2 x 10 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated by rotary evaporation to afford a white oil. The crude product was purified 
by flash chromatography on silica, eluting with a mobile phase of 2 0 % ethyl acetate in 
hexane (R f = 0.22) to yield 122 mg (13%) of the title (3-keto imide 236 as a white solid. 
'H NMR 'H NMR (400 MHz, Chloroform-rf) 5 7.82 -  7.65 (m, 2H), 7.38 -  7.19 (m, 2H),
7.22 -  7.04 (m, 2H), 6.90 -  6.76 (m, 2H), 4.45 -  4.34 (m, 2H), 4.29 -  4.26 (m, 2H), 4.21 
(dd, J -  9.1, 3.1 Hz, 1H), 4 .16-4 .06 (m, 1H), 3.96 (d ,J =  18.5 Hz, 1H), 3.89 (d, J =  13.6 
Hz, 1H), 3.78 (s, 3H), 3.72 (d, J=  16.6 Hz, 1H), 2.43 (s, 3H), 2.38 (septet of doublets, J  =
7.0, 3.8 Hz, 1H), 0.90 (d, 7.0 Hz, 3H), 0.84 (d, J  = 6.9 Hz, 3H); l3C NMR (100 MHz,
CDC13) 5 198.8, 165.9, 159.7 154.2, 143.6, 136.6, 130.6, 129.7, 127.6, 126.9, 114.2, 63.7,
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58.4, 55.4, 54.6, 51.4, 48.1, 28.2, 21.7, 18.0, 14.5; IR (neat) v 2921, 1775, 1727, 1611, 




An oven-dried, 25-mL, round bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged with dichloromethane and 
cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.07 mL, 0.72 mmol) was added to 
the flask followed by the slow addition of diiodomethane (0.06 mL, 0.72 mmol) via 
syringe. The solution was stirred for 10 min before the addition of pivaldehyde (0.04 mL, 
0.36 mmol) and (5-keto imide 236 (0.122 g, 0.24 mmol) in order. The reaction was stirred 
at 0 °C for 1 h before being quenched with saturated ammonium chloride (3 mL). The 
aqueous layer was extracted with dichloromethane (3 x 5mL). The organic layers were 
pooled, dried over anhydrous sodium sulfate, vacuum-filtered, and concentrated by rotary 
evaporation to afford a light yellow oil.. The crude product was purified by flash 
chromatography on silica, eluting with a mobile phase of 25% ethyl acetate in hexane (Rf 
= 0.16) to yield 89 mg (71%) of hemiketal 237 as a colorless oil. 'H NMR (400 MHz, 
CDC13) 5 7.70 -  7.65 (m, 2H), 7.29 -  7.24 (m, 2H), 7.05 -  7.01 (m, 2H), 6.78 - 6.71 (m, 
2H), 5.15 (s, 1H), 4.64 -  4.54 (m, 2H), 4.52 -  4.41 (m, 2H), 4.32 -  4.28 (m, 1H), 4.24 -  
4.20 (m, 2H), 3.78 -  3.76 (m, 3H; contains 2 singlets in a 2:1 ratio), 3.55 -  3.32 (m, 2H; 
contains an ABq J  = 15.1 Hz, and br s in a 2:1 ratio), 2.43 — 2.42 (m, 3H contains 2 
singlets in a 2:1 ratio), 2.39 — 2.23 (m, 2H), 1.90 -  1.69 (m, 1H; contains a dd, J  -  13.8,
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2.4 Hz, and a br s in a 2:1 ratio), 0.93 -  0.87 (m, 12H), 0.85 -  0.84 (m, 3H); 13C NMR 
(100 MHz, CDCb) 5 177.9, 173.5, 159.2, 153.5, 143.3, 137.9, 130.6, 129.7, 127.5, 113.8,
105.6, 90.6, 63.3, 58.8, 55.3, 51.4, 51.2, 41.12, 41.08, 34.2, 28.7, 25.6, 21.6, 18.0, 14.8; 




A 20-scintillation vial was equipped with a magnetic stir bar, rubber septum, and nitrogen 
gas inlet. The vial was charged with hemiketal 237 ( 6 6  mg, 0.13 mmol) and 
dichloromethane (5 mL) then cooled to -78 °C in a dry ice-acetone bath. Triethylsilane 
(0.08 mL, 0.52 mmol) and boron trifluoride diethyl etherate (0.05 mL, 0.39 mmol) were 
added in order and allowed to stir at -78 ° for 1 h before being quenched with saturated 
sodium bicarbonate (2 mL). The aqueous layer was extracted with diethyl ether ( 3 x 5  
mL). The organic layers were pooled, washed with saturated sodium chloride, dried over 
anhydrous magnesium sulfate, filtered, and concentrated by rotary evaporation to afford a 
white solid. The crude product was purified by flash chromatography on silica, eluting 
with a mobile phase of 20% ethyl acetate in hexane (Rf = 0.2) to yield 44 mg (69%) of 
substituted tetrahydrofuran 238 as a white solid. 'H NMR (500 MHz, C&D6) 5 7.78 (d, J  =
8.2 Hz, 2H), 7.19 (d, J =  8 . 6  Hz, 2H), 6.81 (m, 2H), 6.69 (d, J =  8 . 6  Hz, 2H), 4.66 (d, J  =
7.3 Hz, 1H), 4.59 (d, J =  14.5 Hz, 1H), 4.50 (dt, 9.5, 7.4 Hz, 1H), 4.16 (ddd, J =  8.2, 3.9,
2.5 Hz, 1H), 3.98 (m, 1H), 3.96 (d, J  = 14.6 Hz, 1H), 3.70 (dd, J  = 14.3, 7.2 Hz, 1H),
3.47 (t, J =  8 . 8  Hz, 1H), 3.40 (dd, J =  9.1, 2.6 Hz, 1H), 3.26 (s, 3H), 3.02 (dd, J =  14.3,
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5.6 Hz, 1H), 2.37 (ddd, J =  12.6, 9.6, 6.2 Hz, 1H), 2.23 (dd, J  = 13.2, 6.2 Hz, 1H), 2.15 
(septet of doublets, J =  7.0, 4.0 Hz, 1H), 1.90 (s, 3H), 0.91 (s, 9H), 0.55 (d, J =  6.9 Hz, 
3H), 0.43 (d, J =  7.1 Hz, 3H); 13C NMR (126 MHz, C6D6) 5 174.8, 174.2, 159.8, 154.0,
142.8, 138.2, 130.5, 130.3, 129.8, 114.3, 8 8 .8 , 78.5, 77.9, 63.0, 58.9, 54.7, 53.4, 52.0,




A flame-dried, 20-mL, scintillation vial was equipped with a magnetic stir bar, rubber 
septum, and nitrogen gas inlet. The vial was charged with dichloromethane (3 mL) then 
cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.04 mL, 0.37 mmol) was added 
followed by the slow addition of diiodomethane (0.03 mL, 0.37 mmol) via syringe. The 
resulting solution was allowed to stir for 10 min before the addition of acetone (0.02 mL, 
0.22 mmol), after which |3-keto imide 120 (63 mg, 0.15 mmol) in dichloromethane (2 
mL) was added. The reaction was stirred at 0 °C for 1 h before being quenched with 
saturated ammonium chloride (1 mL) and extracted with dichloromethane ( 3 x 5  mL). 
The organic layers were pooled, dried over anhydrous magnesium sulfate, vacuum- 
filtered, and concentrated by rotary evaporation to afford a white oil. The crude product 
was purified by flash chromatography on silica, eluting with a mobile phase of 5:1 
hexane -  ethyl acetate (Rf = 0.09) to yield 30 mg (41%) of hemiketal 239 as a colorless 
oil. 'H NMR (400 mHz, C D C I3 )  5 7.72 (d, J  = 8.2 Hz, 2H), 7.35 -  7.27 (m, 2H), 4.53 -
4.43 (m, 1H), 4.34 (dd, J =  9.2, 7.9 Hz, 1H), 4.31 -  4.23 (m, 2H), 4.12 (q, J =  7.2 Hz,
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1H), 4.02 (dd, J  = 8.5, 2.7 Hz, 1H), 3.48 -  3.31 (m, 2H), 2.49 -  2.36 (m, 5H), 2.25 -  2.14 
(m, 3H), 2.03 -  1.91 (m, 1H), 1.47 (s, 3H), 1.35 (s, 3H), 0.96 (d, J =  7.0 Hz, 3H), 0.91 (d, 
J =  7.0 Hz, 3H); ,3C NMR (100 MHz, CDC13) 5 177.4, 154.0, 143.8, 135.2, 130.0, 127.9,
107.5, 86.2, 64.7, 63.6, 59.6, 50.6, 50.1, 38.5, 29.2, 28.6, 26.5, 26.4, 24.7, 21.8, 18.5, 
14.8; IR neat) v 3299, 2964, 1746, 1692, 1642, 1480, 1391, 1242, 1160 cm'1.
(45)-3-((3/?)-2,2-dimethyl-5-((5r)-l-tosylpyrrolidin-2-yI)tetrahydrofuran-3-carbonyl)-
4-isopropyloxazolidin-2-one (241)
A 20-mL scintillation vial was equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet. The vial was charged with dichloromethane (2 mL) and hemiketal 239 
(31 mg, 0.06 mmol) then cooled to -78 °C in a dry ice-acetone bath. Triethylsilane (0.04 
mL, 0.24 mmol) then boron trifluoride diethyl etherate (0.02 mL, 0.18 mmol) were added 
to the vial and allowed to stir for 1 h at -78 °C then for an additional 3 h at room 
temperature. The reaction was quenched with saturated sodium bicarbonate (1 mL) then 
extracted with dichloromethane ( 3 x 2  mL). The organic layers were pooled, dried over 
anhydrous magnesium sulfate, filtered, and concentrated by rotary evaporation to afford a 
clear oil. The crude product was purified by preparative thin layer chromatography, 
eluting with a mobile phase of 1:1 hexane -  ethyl acetate (R f = 0.42) to yield 5.6 mg 
(20%) of the title tetrahydrofuran 241 as a colorless residue. 'H  NMR (500 MHz, C D C I3 )  
5 7.73 (d, 8.2 Hz, 2H), 7.32 -  7.28 (m, 2H), 4.54 (ddd, J =  8.5, 6.9, 3.3 Hz, 1H), 4.48 (dt, 
J8 .3 , 3.1 Hz, 1H), 4.29 dd, J =  9.1, 8.3 Hz, 1H) 4.26 -  4.19 (m, 2H), 3.86 (dt, J =  8 .6 , 3.5 
Hz, 1H), 3.43 -  3.23 (m, 2H), 2.43 (s, 3H), 2.42 -  2.35 (m, 2H), 2.31 (ddd, 13.1, 6.9, 4.0 
Hz, 1H), 1.90 (m, 1H), 1.78 (dddd, J  = 12.8, 7.7, 5.2, 3.6 Hz, 1H), 1.66 (m, 1H), 1.53
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(app dq, J =  12.7, 8.4 Hz, 1H), 1.43 (s, 3H), 1.23 (s, 3H), 0.93 (d, J =  7.0 Hz, 3H), 0.89 
(d, / =  6 .8  Hz, 3H); 13C NMR (100 MHz, CDC13) 5 173.5, 154.1, 143.5, 135.2, 129.8,
127.8, 83.9, 81.5, 63.2, 62,2., 59.0, 50.7, 50.0, 32.2, 29.5, 28.6, 28.4, 21.7, 18.3, 14.7; IR 
(neat) v 2964, 2924, 1774, 1693, 1384, 1342, 1202, 1158 cm'1.
(45)-3-((25',3J?)-5-Hydroxy-2-phenyl-5-((5)-l-tosylpyrrolidin-2-yl)tetrahydrofuran-
3-carbonyl)-4-isopropyloxazolidin-2-one (245)
An oven-dried, 50-mL, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, and nitrogen gas inlet. The flask was charged dichloromethane (10 mL) 
and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.15 mL, 1.5 mmol) was added 
to the flask via syringe. |3-Keto imide 120 (211 mg, 0.5 mmol) was added to the solution 
and stirred for 10 min before the dropwise addition of diiodomethane (0.04 mL, 0.5 
mmol) via syringe. The reaction was stirred at 0 °C for 1.5 h before the addition of 
benzaldehyde (0.08 mL, 0.75 mmol). The reaction was stirred for an additional 2.5 h and 
was then quenched with saturated ammonium chloride (3 mL) and diluted with saturated 
sodium chloride (10 mL). The aqueous layer was extracted with dichloromethane ( 4x 10  
mL). The organic layers were pooled, dried over anhydrous sodium sulfate, vacuum 
filtered, and concentrated by rotary evaporation to afford a yellow oil. The crude product 
was purified by flash chromatography on silica, eluting with a gradient mobile phase of 
2%, 5%, 7%, 10%, 12%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50% ethyl acetate in 
hexane (R f = 0.28, 50% ethyl acetate in hexane) to yield 123 mg (45%) of the title 
compound 245 as a mixture of isomeric forms. 'H NMR (500 MHz, CDCI3) 5 7.86 -  7.65 
(m, 4H), 7.50 -  7.04 (m, 14H), 5.41 (d, J =  6 .8  Hz, 1H), 5.06 (m, 1H), 4.79 (m, 1H), 4.41
153
-  4.19 (m, 4H), 4.17 -  4.05 (m, 4H), 4.01 (td, J =  8 .6 , 8.0, 1.6 Hz, 1H), 3.60 -  3.42 (m, 
4H), 3.41 -  3.10 (m, 4H), 2.45 -  2.42 (m, 6 H), 2.35 -  2.17 (m, 4H), 2.01 -  1.81 (m, 3H),
1.60 -  1.49 (m, 2H), 1.43 -  1.33 (m, 2H), 1.19 (m, 1H), 0.77 -  0.63 (m, 6 H); 13 C NMR 
(126 MHz, CDC13) 5 208.7, 175.7, 174.9, 172.1, 171.9, 155.1, 153.5, 153.1, 144.02, 
143.95, 143.7, 141.5, 137.7, 137.6, 135.2, 129.9, 129.84, 129.81, 129.79, 128.77, 128.33, 
128.28, 128.11, 128.09, 128.06, 127.7, 127.6, 126.7, 126.4, 107.8, 105.4, 84.9, 81.4, 67.3,
66.9, 65.4, 65.1, 63.7, 63.5, 63.2, 62.9, 59.2, 58.87, 58.85, 58.5, 50.1, 49.7, 49.5, 49.3,
46.8, 46.3, 44.5, 39.7, 39.5, 38.3, 32.8, 29.9, 29.7, 29.6, 28.8, 28.42, 28.36, 27.1, 25.9,
24.7, 24.63, 24.56, 21.59, 21.55, 18.15, 18.12, 18.0, 17.9, 14.7, 14.6, 14.0, 13.9; IR (neat) 
v 3397, 2964, 1779, 1696, 1667, 1386, 1161 cm'1.
(5)-4-Isopropyl-3-((25,3i?,5i?)-2-phenyl-5-((5)-l-tosylpyrrolidin-2- 
yl)tetrahydrofuran-3-carbonyI)oxazoHdin-2-one (247)
A 20-mL, scintillation vial equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet was charged with hemiketal 245 (26 mg, 0.05 mmol) in 
dichloromethane (2 mL). The vial was cooled to -78 °C in a dry ice acetone bath. 
Triethylsilane (0.03 mL, 0.2 mmol) and boron trifluoride diethyl etherate were added in 
order then allowed to stir for 1 h. The reaction was quenched with saturated sodium 
bicarbonate (3 mL) then extracted with dichloromethane ( 3 x 3  mL). The organic layers 
were pooled, dried over anhydrous sodium sulfate, gravity filtered, and concentrated by 
rotary evaporation to afford a clear oil. The crude product was purified by flash 
chromatography on silica, eluting with a mobile phase of 35% ethyl acetate in hexane (Rf 
= 0.24) to yield 8  mg (30%) of substituted tetrahydrofuran 247 as a clear oil. 'H NMR
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(500 MHz, C6D6) 8  7.92 (d, J =  8.2 Hz, 2H), 7.67 -  7.61 (m, 2H), 7.17 (td, J =  7.3, 1.1 
Hz, 2H), 7.09 (m, 1H), 6.89 (d, J =  7.6, 2H), 5.28 (d, J =  8.5 Hz, 1H), 4.80 (td, 8 .6 , 
7.1 Hz, 1H), 4.38 (ddd, J =  8.1, 5.5, 2.2 Hz, 1H),4.25 (dt, J =  9.5, 5.9 Hz, 1H), 3.81 (d t,J  
= 8.4, 2.6 Hz, 1H), 3.44 (ddd, 10.1, 7.7, 3.8 Hz, 1H), 3.35 (dd, J =  9.1, 2.3 Hz, 1H), 3.25 
-  3.14 (m, 2H), 3.02 (ddd, J -  12.7, 9.4, 7.1 Hz, 1H), 2.34 (ddd, J =  13.4, 7.2, 3.7 Hz, 
1H), 2.29 (m, 1H), 1.99 (s, 3H), 1.77 (m, 1H), 1.67 (septet of doublets, J  = 7.0, 3.0 Hz, 
1H), 1.30 (ddt, J =  12.1,9.6, 7.9 Hz, 1H), 1.21 (m, 1H), 0.36 ( d, J= 7.1 Hz, 3H), 0.04 (d, 
J =  6.9 Hz, 3H); 13C NMR (126 MHz, C6D6) 5 172.0, 153.7, 142.8, 139.0, 136.3, 129.7, 
128.4, 128.3, 128.2, 127.9, 83.4, 81.1, 63.1, 62.5, 58.7, 49.4, 47.9, 34.0, 28.6, 27.1, 24.6, 
21.1, 17.9, 14.2; IR (neat) v 2962, 2875, 1776, 1694, 1386, 1363, 1342, 1206, 1160 cm'1.
(45)-3-((3R)-5-Hydroxy-5-((5)-l-tosylpyrrolidin-2-yl)tetrahydrofuran-3-carbonyl)-4- 
isopropyloxazoIidin-2-one (248)
An oven-dried, 2-necked, round-bottomed flask was equipped with a magnetic stir bar, 
rubber septum, nitrogen gas inlet, and solid addition funnel. The flask was charged with 
dichloromethane (8  mL) and cooled to 0 °C in an ice-water bath. Neat diethylzinc (0.13 
mL, 1.25 mmol) was added to the flask followed by the slow addition of diiodomethane 
(0.10 mL, 1.25 mmol) via syringe. The solution was stirred for 20 min before 
paraformaldehyde (198 mg) was added via the solid addition funnel. p-Keto imide 120 
(211 mg, 0.5 mmol) was added and the solution was stirred at 0 °C for 2 h before being 
quenched with saturated ammonium chloride (3 mL). The aqueous layer was extracted 
with dichloromethane (3x10  mL). The organic layers were pooled, dried over anhydrous 
sodium sulfate, vacuum filtered, and concentrated by rotary evaporation to afford a
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foamy white solid. The crude product was purified by flash chromatography on silica, 
eluting with a mobile phase of 1:1 ethyl acetate — hexane (Rf = 0.19) to yield 82 mg 
(35%) of the title hemiketal 248 as a white solid, (m.p. 6 6  -  6 8  °C); 'H NMR (500 MHZ, 
CDCI3) 5 7.75 -  7.69 (m, 2H), 7.35 -  7.31 (m, 2H), 4.61 -  4.18 (m, 5H), 4.15 -  3.77 (m, 
2H), 3.63 -  3.08 (m, 3H), 2.59 -  2.39 (m, 4H), 2.34 -  2.12 (m, 1H), 1.99 -  1.81 (m, 2H), 
1.58 -  1.26 (m, 2H), 0.97 -  0.87 (m, 6 H); 13C NMR (126 MHz, CDCI3) 5 209.1, 176.7,
174.2, 173.3, 154.6, 153.8, 144.1, 143.7, 130.0, 129.9, 129.8, 127.8, 127.77, 127.75, 
127.66, 127.6, 127.5, 108.3, 107.1, 72.5, 70.1, 67.4, 67.1, 67.0, 66.0, 65.4, 64.8, 64.1,
63.8, 63.7, 61.5, 60.4, 60.2, 59.1, 58.9, 58.7, 56.5, 50.3, 49.7, 43.6, 42.9, 41.4, 37.5, 36.9, 
36.5, 30.0, 28.8, 28.6, 28.4, 28.3, 27.1, 25.9, 24.7, 24.7, 24.5, 21.6, 21.1, 17.99, 17.96,
17.9, 15.0, 1495, 14.8; IR (neat) v 3507, 2964, 1774, 1697, 1387, 1340, 1204, 1158 c m 1.
(45)-4-Isopropyl-3-((3i?)-5-((5)-l-tosylpyrroIidin-2-yl)tetrahydrofuran-3- 
carbonyl)oxazolidin-2-one (250)
A 20-mL, scintillation vial was equipped with a magnetic stir bar, rubber septum, and 
nitrogen gas inlet. The vial was charged with hemiketal 248 (38 mg, 0.08 mmol) in 
dichloromethane (3 mL) then cooled to -78 °C in a dry ice-acetone bath. Triethylsilane 
(0.05 mL, 0.32 mmol) then boron trifluoride diethyl etherate (0.03 mL, 0.24 mmol) were 
added to the vial via syringe. The resulting solution was stirred at -78 °C for 1 h before 
being quenched with saturated sodium bicarbonate (5 mL) then extracted with 
dichloromethane ( 3 x 5  mL). The organic layers were pooled, dried over anhydrous 
sodium sulfate, gravity filtered, and concentrated by rotary evaporation to afford a clear
oil. The crude product was purified by flash chromatography on silica, eluting with a
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mobile phase of 40% ethyl acetate in hexane (Rf = 0.28) to yield 26 mg (71%) of the title 
tetrahydrofuran 250 as a clear oil. 'H  NMR (500 MHz, C6D6) 5 7.75 -  7.67 (m, 2H), 7.36 
-  7.30 (m, 2H), 4.48 (ddd, J =  8.2, 3.9, 2.5 Hz, 1H ) ,  4.35 (dd, J =  8.9, 8.3 Hz, 1H ) ,  4.29 -  
4.15 (m, 3H), 4.00 (m, 1H ) ,  3.95 (m, 1H), 3.79 (m, 1H ) ,  3.36 (m, 1H), 3.16 (dt, J =  10.7,
7.9 Hz, 1H), 2.48 (m, 1H), 2.43 (s, 3H), 2.41 -  2.30 (m, 2H), 1.94 (m, 1H), 1.82 (m, 1H), 
1.50 (ddt, J  = 15.5, 7.6, 3.7 Hz, 1H), 1.29 (m, 1H), 0.93 (d , J=7 . 1  Hz, 3H), 0.89 (d ,J  =
6.9 Hz, 3H); 13C NMR (126 MHz, CDC13) 8  173.8, 154.2, 143.6, 135.0, 129.9, 127.7,
81.2, 70.2, 63.8, 62.5, 59.2, 49.3, 43.7, 32.2, 28.8, 27.2, 24.0, 21.7, 18.2, 15.1; IR(neat) v 
2964, 2875, 1777, 1698, 1387, 1342, 1302, 1245, 1207, 1159 cm'1.
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